Single-cell analysis reveals protein abundance-dependent signaling network modulations by Lun, Xiaokang
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2018
Single-cell analysis reveals protein abundance-dependent signaling network
modulations
Lun, Xiaokang
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-159930
Dissertation
Published Version
Originally published at:
Lun, Xiaokang. Single-cell analysis reveals protein abundance-dependent signaling network modulations.
2018, University of Zurich, Faculty of Science.
 
 
 
 
Single-Cell Analysis Reveals Protein Abundance-Dependent Signaling 
Network Modulations 
 
 
 
 
Dissertation 
zur 
Erlangung der naturwissenschaftlichen Doktorwürde 
(Dr. sc. nat.) 
vorgelegt der 
Mathematisch-naturwissenschaftlichen Fakultät 
der Universität Zürich 
von 
Xiaokang LUN 
aus 
der V.R. China 
Promotionskommission 
Prof. Dr. Bernd Bodenmiller (Vorsitz und Leitung der Dissertation) 
Prof. Dr. Lucas Pelkmans 
Prof. Dr. Fabian Theis 
Zürich, 2018  
 
 
  
 
 
This work was carried out in the time between April 2012 and August 2017 in the 
laboratory of Prof. Dr. Bernd Bodenmiller at the Institute of Molecular Life Sciences, 
University of Zurich. 
  
 
 
 
1 
 
Summary 
Signaling network is central in controlling cellular processes including growth, proliferation, 
survival, differentiation, and responses to stress. Deregulation of signaling networks lead to 
uncontrolled cellular behaviors, causing the emergence of diseases, such as cancer. 
Independent of mutations which alter protein catalytic function, overexpression of signaling 
proteins has been shown to drive the development of many cancer types and identified as a key 
factor for drug resistance. However, the effects of overexpressed signaling proteins on the 
intracellular signaling networks have rarely been studied due to the facts that, first, cellular 
signaling heterogeneity and tumor genomic instability often leads to highly heterogeneous 
protein expression levels that signaling behaviors specific to each quantities of overexpression 
cannot be analyzed with conventional bulk measurement; and second, widely used single cell 
analysis profiles cell genomic and transcriptomic information that is known to poorly correlated 
with protein expression levels and cannot be used to predict protein phosphorylation. An 
approach that can measure signaling network behaviors in a multiplexed manner with single-cell 
resolution is a key to understand signaling protein abundance-modulated network states and 
dynamics. Mass cytometry is a recently developed technique that applies inductively coupled 
plasma time-of-flight mass spectrometry (ICP-TOF-MS) in combination with metal isotope-
labeled antibodies to quantify protein or protein modifications at single-cell level. Yet mass 
cytometry enables high throughput analysis with over 40 proteomic parameters that has been 
shown to be the most suitable approach for single-cell signaling network analysis. 
Using mass cytometry, in coupling with transient transfection which produces gradient 
expression levels for a GFP tagged protein of interest (POI), we established and thoroughly 
validated a method to quantify the network modulation induced by any overexpressed POI-GFP 
in an abundance-dependent manner. In a proof of principle analysis, we applied this method to 
20 central signaling proteins in human embryonic kidney HEK293T cells to reveal that by 
altering signaling protein expression levels, signaling network states and the dynamics in 
responses to extracellular stimulation are modulated. Further, we used this method in a kinome- 
and phosphatome-wide screen for protein abundance-dependent effects. In total of 649 GFP-
tagged POIs were individually overexpressed in HEK293T cells where signaling behaviors in the 
cancer-related signaling network were measured. We developed a statistical measure, called 
BP-R2, to quantify the signaling relationship strength between an overexpressed POI and a 
measured phosphorylation site that enables a classification of kinases and phosphatases based 
on their abundance-dependent effects. Comparing to a literature-curated signaling interaction 
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database, we detected 208 pairs of the novel signaling relationships. The follow-up in-depth 
analyses with 1-hour EGF stimulation time course revealed oncogenic-like signaling behaviors 
that, first, ERK specific phosphatase overexpression prolonged the duration of proliferative 
signal; and second, tyrosine kinase overexpression induced ligand-independent ERK signaling 
activation. Later in melanoma A375 cells that express BRAFV600E mutant, we validated the 
abundance-dependent signaling relationship to p-ERK as a potential biomarker for the 
resistance to BRAF inhibition. 
Importantly, we also found that mass cytometry-based single cell intracellular signaling analysis 
can be confounded by cell volume and cell cycle that usually biased computational analysis and 
resulted in unprecise data interpretation. Hence, we developed an experimental and 
computational approach called CellCycleTracer that can be used to correct for these 
confounding factors. Applying to data of TNF-a stimulated THP-1 cells, we showed 
CellCycleTracer improved the performance of follow-up analysis, especially for correlation- or 
mutual information-based network reconstruction. 
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Zusammenfassung 
Das Signalnetzwerk spielt eine zentrale Rolle bei der Steuerung zellulärer Prozesse, 
einschließlich Wachstum, Proliferation, Überleben, Differenzierung und Reaktionen auf Stress. 
Die Deregulierung von Signalnetzwerken führt zu unkontrolliertem zellulärem Verhalten, was zur 
Entstehung von Krankheiten wie Krebs führt. Unabhängig von Mutationen, die die katalytische 
Funktion des Proteins verändern, wurde gezeigt, dass die Überexpression von Signalproteinen 
die Entwicklung vieler Krebsarten vorantreibt und als Schlüsselfaktor für Arzneimittelresistenz 
identifiziert wurde. Die Auswirkungen von überexprimierten Signalproteinen auf die 
intrazellulären Signalnetzwerke sind jedoch selten untersucht worden, da die zelluläre 
Signalisierungsheterogenität und tumorgenomische Instabilität oft zu sehr heterogenen 
Proteinexpressionsniveaus führt, die Signalverhaltensweisen spezifisch für jede 
Überexpressionsmenge nicht können mit herkömmlicher Massenmessung analysiert werden; 
und zweitens weit verbreitete Einzelzellanalyse-Profile, genomische und transkriptomische 
Zellinformationen, von denen bekannt ist, dass sie schlecht mit Protein-Expressionsspiegeln 
korrelieren und nicht zur Vorhersage der Proteinphosphorylierung verwendet werden können. 
Ein Ansatz, der das Signalnetzwerkverhalten in einer multiplexen Art und Weise mit einer 
Einzelzellenauflösung messen kann, ist ein Schlüssel zum Verständnis von durch 
Signalprotonenhäufigkeiten modulierten Netzwerkzuständen und -dynamiken. Die 
Massenzytometrie ist eine kürzlich entwickelte Technik, die induktiv gekoppelte Plasma-
Flugzeit-Massenspektrometrie (ICP-TOF-MS) in Kombination mit Metallisotop-markierten 
Antikörpern zur Quantifizierung von Protein- oder Proteinmodifikationen auf Einzelzellniveau 
anwendet. Die Massenzytometrie ermöglicht jedoch eine Hochdurchsatzanalyse mit über 40 
proteomischen Parametern, die sich als der am besten geeignete Ansatz für die Einzelzellen-
Signalnetzwerkanalyse erwiesen hat. 
Unter Verwendung von Massenzytometrie, in Kopplung mit transienter Transfektion, die 
Gradientenexpressionsniveaus für ein GFP-markiertes Protein von Interesse (POI) erzeugt, 
haben wir eine Methode zur Quantifizierung der Netzwerkmodulation, induziert durch 
überexprimiertes POI-GFP, in abundanzabhängiger Weise etabliert und gründlich validiert . In 
einer "proof of principle" -Analyse haben wir diese Methode auf 20 zentrale Signalproteine in 
humanen embryonalen Nieren HEK293T-Zellen angewendet, um zu zeigen, dass durch 
Veränderung der Signalprotein-Expressionslevel die Signalnetzzustände und die Dynamik der 
extrazellulären Stimulation moduliert werden. Darüber hinaus verwendeten wir diese Methode in 
einem kinom- und phosphatomweiten Screening auf Protein-Häufigkeits-abhängige Effekte. 
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Insgesamt wurden 649 GFP-markierte POIs in HEK293T-Zellen individuell überexprimiert, 
wobei das Signalverhalten im krebsbezogenen Signalnetzwerk gemessen wurde. Wir haben ein 
statistisches Maß namens BP-R2 entwickelt, um die Signalstärke zwischen einem 
überexprimierten POI und einer gemessenen Phosphorylierungsstelle zu quantifizieren, die eine 
Klassifizierung von Kinasen und Phosphatasen basierend auf ihren abundanzabhängigen 
Effekten ermöglicht. Im Vergleich zu einer Literatur-kuratierten Signalinteraktionsdatenbank 
konnten wir 208 Paare der neuartigen Signalbeziehungen nachweisen. Die 
Nachuntersuchungen mit einem 1-stündigen EGF-Stimulationszeitverlauf zeigten onkogen-
ähnliche Signalverhaltensweisen, die zunächst eine ERK-spezifische Phosphatase-
Überexpression verlängerten die Dauer des proliferativen Signals; und zweitens induzierte 
Tyrosinkinase-Überexpression ligandenunabhängige ERK-Signalaktivierung. Später in 
Melanom-A375-Zellen, die BRAFV600E-Mutante exprimieren, validierten wir die Abundanz-
abhängige Signalisierungsbeziehung zu p-ERK als einen potentiellen Biomarker für die 
Resistenz gegen BRAF-Hemmung. 
Wir fanden auch heraus, dass die intrazelluläre Einzelzell-Signalanalyse auf der Basis der 
Massenzytometrie durch das Zellvolumen und den Zellzyklus verfälscht werden kann, was in 
der Regel zu einer ungenauen Dateninterpretation führte. Daher haben wir einen 
experimentellen und computergestützten Ansatz namens CellCycleTracer entwickelt, mit dem 
diese Störfaktoren korrigiert werden können. Bei der Anwendung von TNF-a-stimulierten THP-
1-Zellen konnten wir zeigen, dass CellCycleTracer die Leistung der Nachuntersuchung, 
insbesondere für Korrelations- oder wechselseitige informationsbasierte Netzwerkrekonstruktion, 
verbesserte. 
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Introduction 
Signaling transduction in cell 
Signaling is one of the central mechanisms that mediate cell communication and coordinate 
cellular functions, such as proliferation, differentiation, and energy metabolisms. The majority of 
signaling transduction pathways initiate at the plasma membrane (Groves and Kuriyan, 2010), 
where receptor proteins bind to their ligand signaling molecules, such as hormones and 
cytokines, or to surface proteins on an adjacent cell. In addition, signaling responses can be 
also triggered by changes of stress, ion concentration and extracellular environments (Clapham, 
2007; Hetz and Saxena, 2017; Yu et al., 2015). Ultimately, intracellular signaling transductions 
result in cellular transcriptional modulations, phenotypical switches, and cell fate decision. We 
briefly summarize here essential signaling pathways that are most commonly studied in health 
and disease, grouped by their functions in cells and tissues: 
 
Proliferation, growth and survival 
Receptor tyrosine kinase (RTK) is a large group of signaling proteins that share the same 
molecular architecture and the conserved activation mechanism (Lemmon and Schlessinger, 
2010). As key regulators of cell proliferation, growth, and survival, RTK signaling is commonly 
activated by the binding of a growth factor to the extracellular domain of RTK protein (Grecco et 
al., 2011). Then, series of downstream phosphorylation events occur consecutively, processing 
the signal transduction through pathways, including the PI3K/AKT/mTOR axis, the MAPK/ERK 
cascade, and the PKC pathways (Hennessy et al., 2005; Oliva et al., 2005; Steelman and 
Chappell, 2011), to rely signal from the activated RTKs into the nucleus where the induced 
transcriptional program happens (Schlessinger, 2000). In contrast to the RTK-related pathways, 
the Hippo pathway ceases cell proliferation and induces apoptosis via the inhibitory 
phosphorylation and ubiquitin-mediated degradation on transcriptional regulators YAP/TAZ, as a 
central mechanism controlling organ size and tissue homeostasis (Yu et al., 2015). 
 
Differentiation and homeostasis  
Several signaling pathways have been indicated to play central roles in stem cell differentiation, 
maintenance, and tissue development, including Wnt, Notch, Hedgehog (Hh) and the 
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transforming growth factor beta (TGF-β) signaling pathways. The canonical Wnt signaling 
pathway is essential in the embryonic development and the damage-induced tissue 
regeneration (Takebe et al., 2011). Activation mechanisms of Wnt signaling involve Wnt ligand 
binding with the heterodimeric receptor complex that is consisting of a Frizzled and an LRP5/6 
protein. The subsequently phosphorylated LRP6 recruits the β-catenin destruction complex to 
the membrane. The complex then falls apart, disrupting the GSK3-mediated inhibitory 
phosphorylation on  β-catenin, releasing free β-catenin molecules that are subsequently 
translocated into the nucleus to induce target gene transcription (Clevers and Nusse, 2012; Lien 
and Fuchs, 2014). The Hedgehog (Hh) signaling pathway functions in maintaining stem cell 
properties and controlling tissue polarity. Multiple hedgehog ligands (e.g., IHh, DHh, SHh) can 
activate the Hh signaling after binding to the transmembrane receptor patched (Ptch), allowing 
the activation of smoothened (SMO) and the release of Gli transcriptional factor into the nucleus 
(Takebe et al., 2011). Multiple phosphorylation sites on Gli proteins have been discovered that 
they determine the discrete states of Gli activity and tissue transcriptional landscape 
(Niewiadomski et al., 2014). Notch signaling regulates many processes in embryogenesis and 
tissue homeostasis. Activation of Notch signaling requires cell-to-cell contact that facilities 
ligand-receptor binding (e.g., Jagged1 to Notch1). The Notch receptor is then cleaved that 
enables Notch intracellular domain (NICD) to be transported into the nucleus for the 
transcriptional activation of target genes (Bray, 2016). TGF-β signaling is one of the most 
essential pathways in development that it is required in many developmental programs including 
differentiation, tissue hemostasis and regeneration. In the canonical TGF-β pathway, ligand 
binding induces the formation of a hetero-tetrameric receptor complex, from where the 
cytoplasmic Serine/Threonine kinase domain of TGF-β receptor is activated to phosphorylate 
downstream SMAD proteins. Upon the nuclear entry, transcription factors SMAD2/3 initiate the 
expression of TGF-β regulated genes (Massagué, 2012). 
 
Responses to stress 
MAPK branches, including the JNK and the p38 cascades, are primary responders to 
extracellular stress that they can be triggered by cytokine stimuli, such as tumor necrotic factor 
(TNF) and interleukin-1 (IL-1), and can be activated by environmental stresses, such as osmotic 
or heat shock, radiation and redox stress (Cuenda and Rousseau, 2007; Davis, 2000). Signaling 
dynamics on the JNK and p38 pathways determines cell fate: sustained activation of JNK and 
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p38 pathways leads to ROS-induced apoptosis, while their transient activation, on the contrary, 
promotes cell survival (Cuenda and Rousseau, 2007; Davis, 2000). Moreover, p53 senses the 
stress of DNA damage or the cellular hyperproliferation states, activating to induce transcription 
programs related to DNA repair mechanisms and to mediate growth arrest and apoptosis. The 
p53 pathways are crucial for innate tumor suppression given their key roles in the maintenance 
of genomic stability and controlled cell proliferation (Meek, 2009). Lastly, AMPK responds to the 
cellular nutrient stress and maintains energetic homeostasis by regulating multiple downstream 
pathways, including the inhibition of AKT/mTOR-mediated cell growth (Mihaylova and Shaw, 
2011).  
 
Immune cell signaling  
Regulation of the immune response is a complex process that involves the coordination of 
multiple ubiquitous or cell type-specific signaling pathways. In brief, the innate immune 
response initiates with the recognition of pathogen-associated molecular patterns (PAMPs) by 
the pattern recognition receptors (PRRs) expressed on the surface of many cell types, including 
macrophages, dendritic cells, monocytes and neutrophils (Newton and Dixit, 2012). As the 
major PRRs, toll-like receptors (TLRs), upon pathogenic ligand-engagement, activate the 
IKK/NKκB pathway and MAPK cascades (ERK, JNK and p38 branches) that lead to the 
expression of cytokines and pro-inflammatory mediators (Banerjee and Gerondakis, 2007). 
Meanwhile, the antigens can be recognized by the B cell receptor complex consisting of 
immunoglobulin (IgG) and CD79α/β that will trigger formation of the signalosome where kinases, 
including SYK, BTK and LYN can be phosphorylated. Subsequently, downstream signaling 
mediated by PI3K/AKT, PLCγ/PKC and NFκB pathways are activated to induce the proliferation 
of antigen-specific B cells (Woyach et al., 2012). Importantly for the activation of adaptive 
immune response, T cell receptor (TCR) is initiated after the recognition of cognate peptide–
MHC molecules. Similarly, signaling pathways of PI3K/AKT, PLCγ/PKC/NFκB axis and the 
MAPK cascades are activated to induce transcriptional programs regulating T cell activation, 
differentiation and the cytolytic activity (Brownlie and Zamoyska, 2013; Pennock et al., 2013). 
As a crucial part in the immune regulation, cytokine signaling pathways commonly activates the 
JAK/STAT kinases that rapidly transduces receptor signals into the nucleus, modulating 
transcriptional events that are specific to the cell types and stimuli (Bezbradica and Medzhitov, 
2009). 
14 
 
 
Signal computing as networks 
Pathway crosstalk 
Each of above pathways engages specific signaling transduction processes to determine 
transcriptional responses. However, signaling pathways are rarely independent in living 
organisms; rather, they are bridged by inter-pathway protein interactions, named crosstalk. In 
signaling response, diverged pathways can be stimulated by the same kinase or lipid responder, 
while pathways might also couple to combinatorically control one signaling output (Cohen and 
Frame, 2001; Corbalán-García and Gómez-Fernández, 2006; Nishi et al., 2015). For example, 
as a central coordinator between various signaling pathways, GSK3 can be directly regulated by 
a broad range of upstream signaling proteins, including AKT, mTOR, AMPK and PKC (Cohen 
and Frame, 2001), and can regulate the functional state of about 100 reported substrates 
(Sutherland, 2011). TGF-β signaling, besides the canonical pathways depending on the 
activation of SMAD2/3 as described above, also induces multiple non-canonical pathways by 
crosstalk that transduces signals into MAPK cascades, PI3K/AKT pathways and cell cycle 
regulating proteins (Derynck et al., 2014). Interestingly, the ERK-dependent SMAD2/3 activation 
and nuclear translocation has also been revealed and the inhibition of MEK can disrupt the 
SMAD function (Blanchette et al., 2001; Hayashida et al., 2003). Moreover, as most intensively 
studied, multiple classic crosstalk presents between the MAPK/ERK pathways and the 
PI3K/AKT/mTOR axis, co-regulating the cellular functions of proliferation, growth and survival 
(Steelman and Chappell, 2011). MAPK/ERK signaling can also crosstalk to the JAK/STAT 
pathway and the Hippo pathway (Rawlings et al., 2004; Romano et al., 2014). Indirectly, the 
pathway crosstalk can also be achieved via phosphatases which are often functionally 
unspecific and participate in the dephosphorylation of multiple substrates (Jeffrey et al., 2007).  
 
Study cell signaling in networks 
Signaling pathways, with the crosstalk connections, joint to form complex signaling networks 
that integrate several layers of signaling events and coordinate to compute the information from 
signaling inputs, such as extracellular stimuli, into transcriptional changes that determine cell 
phenotype and cell fate. The activity and dynamics of each specific signaling node is therefore 
multi-parametrically dependent within the network structure, which furthers the complexity in 
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studies of cell signaling behaviors. Critically, the primary cue to decipher the networked 
regulation of signaling response is to understand the signaling protein connectivity. To this end, 
studies implement biochemistry assays, including yeast-two-hybridization (Y2H), 
immunoprecipitation (IP) and luminescence reporter-based techniques, in combination with 
proteomics analysis at the systems level and computational network modelling and inference to 
promote a comprehensive and precise mapping of the protein interactome in global level and for 
particularly signaling pathways (Barrios-Rodiles et al., 2005; Breitkreutz et al., 2010; Couzens et 
al., 2013; Horn et al., 2011; Hughey et al., 2009; Linding et al., 2007; Tewari et al., 2004). 
Meanwhile, databases of protein interaction networks have been created and developed that 
largely promote the information accessibility and facilitate the researches applying network-
based prediction and modeling of signaling behaviors (Linding et al., 2007; Saez-Rodriguez et 
al., 2011). The STRING database (Szklarczyk et al., 2017) integrates diverse sources of data 
and information for protein physical interactions, as well as the known and predicted protein 
functional associations, allowing querying of protein connectivity and network-dependent 
functional enrichment analysis. Complementarily, the OmniPath (Türei et al., 2016) database 
assembles 34 literature-curated databases (e.g., SIGNOR (Perfetto et al., 2016) and 
PhosphoSite (Hornbeck et al., 2015)) for protein interactions that drastically enhance the 
network coverage and interaction confidence. 
 
Heterogeneity in cellular signaling network 
Achievements in protein interactome and network mapping have greatly contributed in 
understanding the biochemical processes of cellular signaling responses. However, for every 
defined cell types and under specific conditions, the network responses can be highly variable 
due to many sources of genetic and non-genetic heterogeneities. 
 
Signaling protein abundance 
One of the major determinants of network behaviors is the signaling protein abundance. A 
signaling network eventually assembles numerous biochemical reactions (e.g., phosphorylation 
and dephosphorylation), in which the substrate concentration determines the reaction rate 
(Heinrich et al., 2002). By regulating the presence and expression level of signaling proteins, 
cells modulate the kinetics of their signaling transduction processes and the network dynamics, 
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ultimately determining outputs (both transcriptomic and proteomic levels) in response to the 
same stimulation (Lun et al., 2017). Aberrant expression levels of signaling proteins are often 
disease-related and can be attributed to genetic or epigenetic reasons. The major genetic cause 
is chromosomal abnormalities, including chromosomal rearrangement, amplification and 
deletion, and the generation of neochromosomes (Garsed et al., 2014; Holland and Cleveland, 
2012), leading to gene copy number alteration (CNA) of signaling mediators, such as kinases 
and phosphatases, which has been identified in many cancer types (Fleuren et al., 2016; Julien 
et al., 2011). In humans, the epigenetic alterations are progressed with aging (Gonzalo, 2010) 
and can be induced in diseased-conditions, such as chronic inflammation that drives cancer 
progressions (Abu-Remaileh et al., 2015; Jeong et al., 2014). Additionally, deregulated 
transcription or translation of signaling proteins also leads to their abnormal expression levels, 
and can also be tumorigenesis (Bywater et al., 2013; Silvera et al., 2010). 
 
Mutation 
Protein mutants often alter the catalytic function of signaling nodes, leading to the re-shaping of 
signaling network structure and dynamics. Oncogenes, such as RAF, MEK and PI3K, and tumor 
suppressors, including PTEN and p53, once mutated, can drive the uncontrolled cell 
proliferation and growth, ultimately trigger cancer initiation (Mendoza et al., 2011). Six types of 
network-attacking mutations have been recently identified in a kinome-wide study with 
underlying signaling mechanisms (e.g., constitutive activation, network rewiring and genesis of 
phosphorylation sites) been categorized (Creixell et al., 2015). Importantly, due to the genomic 
instability, cancer progresses with accumulated and varied mutations (Abbas et al., 2013) that 
lead to discrete abnormities of signaling network behaviors at the single-cell level, which further 
complexes the network heterogeneity and can lead to treatment failures. 
 
Subcellular localization 
Signaling network responses even in cells with the same genetic background can also be highly 
variable. By altering the subcellular localization of signaling proteins, cells differ in their 
information processing in response to exogenous cues, contributing to the heterogeneity of 
cellular signaling network properties. For example, many known determinants, such as spatial 
constrain and lipid raft composition, influence density of receptor proteins on the plasma 
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membrane, resulting in differential downstream signal activities (Frechin et al., 2015; Grecco et 
al., 2011). Cells also modulate the dynamics of intracellular vesicular trafficking to intrinsically 
regulate protein localizations as a result of varied phenotypical states and signaling contexts, 
giving rise to heterogeneous signaling behaviors (Goh and Sorkin, 2013; Stallaert et al., 2017; 
Stenmark, 2009). Nuclear translocation is an important regulatory process for many cytosolic or 
surface signaling proteins functioning as transcriptional factors or co-regulators (Rawlings et al., 
2004; Steelman and Chappell, 2011; Takebe et al., 2011). Dynamics of nuclear translocation 
are often varied between cells (Regot et al., 2014), and can be highly oscillated (Kellogg and 
Tay, 2015), leading to varied signaling activities in cells. Interestingly, a recent study has 
discovered cytosolic compartmentalization generated from stress-induced liquid unmixing 
largely alter the intracellular concentration of functional kinases, thereby further complexing the 
signaling network behaviors and contributing to the network heterogeneity (Wippich et al., 2013). 
 
Microenvironment factors 
Microenvironment factors, including extracellular signaling ligands and matrix stiffness, cell-cell 
contacts and local crowding, are the extrinsic determinants for heterogeneous signaling network 
states and dynamics. Differential ligand binding determines the consistency of ERK signaling in 
PC-12 cells (a pheochromocytoma cell line derived from rat adrenal grand): treatment with EGF 
transiently activates the RAF/MEK/ERK cascade, resulting in cell proliferation; while NGF 
induces PKC activity which sustains the ERK signal, leading to differentiation (Santos et al., 
2007). The stiffness of extracellular matrix has been shown to influence cellular signaling 
responses in the human breast MCF-10A cell line due to the altered integrin conformation and 
the subsequent downstream PI3K pathway modulations (Chaudhuri et al., 2014). Cell also 
senses the surrounding neighbors that several contact inhibition mechanisms exist to impact 
signaling network behaviors (Kim et al., 2011; Stallaert et al., 2017). In addition, local crowding 
has been indicated to activate focal adhesion kinase (FAK) that results in the alteration in 
membrane homeostasis and the signaling responses in the lipid-dependent PI3K/AKT signaling 
pathways, influencing cell growth and proliferation (Frechin et al., 2015). 
Many other cellular variables, including the cell cycle stage (Rapsomaniki et al., 2018), also 
leads to differed signaling network states among single cells. This heterogeneity is crucial for 
biological process, such as cell differentiation, tissue development (Donati and Watt, 2015) and 
the maintenance of functional systems (Potente and Mäkinen, 2017). Nevertheless, for many 
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diseases including cancer, signaling heterogeneity also causes the increase of phenotypical 
complexity that may challenge the development of therapeutic interventions and reduce the 
treatment efficiency of a given drug intervention (McGranahan and Swanton, 2017). Thus, to 
understand the signaling network at single cell level, the causes of signaling heterogeneity and 
the related downstream effects on cellular transcription and phenotypical changes it is crucial 
and of great beneficial for health and disease. 
 
The single-cell era of signaling network analysis 
Single cell analysis has been performed since the invention of microscope. Conventional 
microscopic methods can be used to quantify protein abundance and study cellular and 
subcellular spatial properties, helped by genetic or immunological fluorescent protein tagging 
methods (Waters, 2009). Fluorescence resonance energy transfer (FRET) and proximity ligation 
assay (PLA) enable the application of microscopy in analyzing transient events during the 
dynamics process of signaling transduction and measuring stable interactions of signaling 
proteins at single-cell resolution (Ryu et al., 2015; Sundqvist et al., 2013). However, these 
methods are often limited by the multiplexing capacity that individual experiments using batches 
of different cells are required to measure series of variables, resulting in the loss of relationship 
between assessed markers and the difficulties to study signaling process mechanisms at the 
network level. The era of omics has made it possible to measure simultaneously the 
transcriptomic and proteomic information (Horgan and Kenny, 2011). Protein phosphorylation, 
one of the most critical post-translational modifications (PTMs) for signaling transduction can be 
globally analyzed with phosphoproteomic approaches (Riley and Coon, 2016). Yet these 
methods are not sensitive enough to be applied in single cell measurement. Developing 
approaches that combine multiplexed measurement with single cell-based analysis has been for 
decades the challenge for single-cell signaling network analysis. By multiplexing simultaneous 
antibody detection capacity in immune-single cell analysis (Angelo et al., 2014; Bandura et al., 
2009; Gerdes et al., 2013; Giesen et al., 2014; Jungmann et al., 2014; Lin et al., 2015) and 
applying single cell signal amplification to increase sensitivities for omics methods (Chen et al., 
2015; Ramsköld et al., 2012; Tang et al., 2009), recent innovations now allow exploring cellular 
phosphorylation landscapes or signaling regulatory network structure cell by cell in 
heterogeneous samples.  
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Non-spatial immuno-single cell analysis 
Flow cytometry 
As one of the earliest attempt of cell single-cell signaling network analysis, flow cytometry uses 
fluorophore-labeled antibodies to detect and quantify the protein phosphorylation abundance. It 
has been applied in measuring states and relationships between multiple phosphorylation sites, 
as well as the correlation between phosphorylation states, cell functional readouts, and lineage-
specific markers in complex populations (Perez and Nolan, 2002). Later, with the capability to 
measure 11 phosphoproteins and phospholipids simultaneously, flow cytometry-based single 
cell analysis are combined with inhibitor perturbation assays that enables the inference of 
signaling circuits and the reconstruction of signaling networks (Sachs et al., 2005). The 
development of fluorescent cell barcoding has greatly increased the throughput of flow 
cytometry-based intracellular signaling analysis which now can be implemented as a screening 
tool to quantify cellular response to kinase inhibitors for each individual cell type in 
heterogeneous populations (Krutzik and Nolan, 2006; Krutzik et al., 2008). However, due to the 
fluorescent spectrum overlapping, the multiplexity of flow cytometry remains limited that 
signaling network can only be sparsely or partially measured. 
Mass cytometry 
Mass cytometry is recent developed based on an inductively coupled plasma time-of-flight mass 
spectrometry (ICP-TOF-MS) and a single cell sample introduction system (Bandura et al., 2009). 
Mass cytometry-based measurement applies metal isotope-tagged antibodies to label proteins 
or protein modifications in cells that highly increase the multiplexity. During the measurement, 
each stained single cell is vaporized, atomized, and ionized before the subsequent formation of 
an ion cloud that carries information of all applied antibodies that can be quantitatively analyzed 
by the TOF and recorded as high-dimensional single-cell proteomic readout (Bandura et al., 
2009; Bendall et al., 2011). Mass cytometry is ready to quantify up to 50 intracellular 
phosphorylation sites simultaneously with high analytical throughput that can be stable around 
500 cells per second and millions of events per sample. A mass-tag barcoding strategy allows 
simultaneously measuring hundreds of samples,  eliminating batch effects that confounds 
conventional measurements, and largely reducing the workloads (Bodenmiller et al., 2012; 
Zivanovic et al., 2013; Zunder et al., 2015). Although minor spill-over between channels are 
found in mass cytometry data due to metal impurity, mass overlap, and oxidation(Bendall et al., 
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2012), they are manageable with proper experimental design and can be removed 
computationally (Chevrier et al., 2017a).  
Mass cytometry has been used in drug screening for high-dimensional signaling 
(phosphorylation) responses (Bodenmiller et al., 2012). Relationships between all pairs of 
measured phosphorylation sites can be computed to infer network responses to a stimulus 
(Krishnaswamy et al., 2014) or to trace the network reshaping process through a biological time 
of phenotypical transition (Krishnaswamy et al., 2017). Coupling to the transient overexpression 
technique, mass cytometry based signaling profiling has been able to assess the protein 
abundance dependency on intracellular signaling network states and dynamics, revealing novel 
signaling mechanisms in overexpression-related cancer progression and drug resistance (Lun 
et al., 2017). 
Single cell immuno-sequencing 
Although the multiplexity of immune-based single cell analysis has been largely increased by 
mass cytometry, the limited number of available and assessable metal isotopes is still 
preventing the deep profiling of phosphoprotein network with broad coverage of phosphorylation 
sites. Nevertheless, two recent developed techniques, termed RNA expression and protein 
sequencing assay (REAP-seq) and cellular indexing of transcriptomes and epitopes by 
sequencing (CITE-seq), barcode antibodies with oligonucleotides that allows detecting targeted 
proteins in single cell sequencing and simultaneously quantifying RNA transcriptomes in the 
very same cells (Peterson et al., 2017; Stoeckius et al., 2017). More than one million distinct 
barcodes can be generated with a 12-bp oligo (412), making the measurable parameters in 
these methods unlimited. REAP-seq and CITE-seq are ready for single cell phosphoprotein 
network analysis to generate more comprehensive global signaling profiling. 
Lab-on-chip and microfluidics  
With the lab-on-chip technologies, single-cell barcode chip (SCBC) and single-cell western 
blotting (scWesterns) have been developed. Compared to the above cytometric methods, SCBC 
and scWesterns are more sensitive in detecting low abundant targets and can be applied to 
assess samples with fewer cells (Hughes et al., 2014; Shi et al., 2012; Wei et al., 2016). These 
approaches have been applied to resolve singe cell signaling network variations and the 
functional heterogeneity (Shi et al., 2012; Wei et al., 2016). Meanwhile, investigations of single 
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cell signaling kinetics largely benefits from microfluidic systems which allow fine time resolution 
and accurate dose control for a to-be-profiled stimulus (Ng et al., 2015).  
 
Non-spatial omics single cell analysis 
Immunostaining-based techniques allow multi-dimensional deep profiling of signaling networks 
at single-cell resolution, but also face three main limitations: first, the selection of measured 
targets are often based on prior knowledge, making these methods not exploratory; second, not 
all targets of interest are measurable due to the high dependency on antibody availability; third, 
quantifications cannot be performed across different antibodies, given their varied antigen 
binding affinities. Nevertheless, the development of several antibody-free omics studies have 
provided complementary techniques void of the above limitations. 
Single cell proteomics by mass spectrometry 
A big challenge for single cell mass spectrometry is the relatively low sensitivity of the technique, 
partly due to the sample loss during processing. Often, protein extracts from single cells are not 
detectable. One recent study has applied tandem mass tags (TMT) labeling to embed single 
mammalian cells in hundreds of carrier cells to manage the sample loss (Budnik et al., 2018). 
This method measures proteome at single-cell resolution and can be furthered developed as 
single-cell phosphoproteomics for signaling network profiling. 
Single cell transcriptomics and epigenomics  
Single cell sequencing techniques (Buenrostro et al., 2015; Tang et al., 2009) do not directly 
measure the protein abundance and functional modifications that are typically used in signaling 
network analysis. However, with the strength to quantify the global RNA expression and identify 
whole-genome transcriptional regulation landscapes, these approaches infer the transcriptional 
regulatory network and the dynamics of signaling pathways in response to a stimulus. For 
example, single cell RNA-seq and has been used in uncovering a paracrine signaling-required 
repression of inflammatory program (Shalek et al., 2014). Single-cell epigenome can now be 
measured with the assay for transposase-accessible chromatin using sequencing (ATAC-seq) 
(Buenrostro et al., 2013; Cusanovich et al., 2015). Coupling single-cell transcriptomics and 
epigenomics analyses provides a powerful approach to profile the network of transcriptional 
regulation during stem cell differentiation and allows identification of curtail signaling pathways 
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during the transition states from quiescence to proliferation and differentiation (Buenrostro et al., 
2017; Guo et al., 2017).  
 
Spatial immuno-single cell analysis 
Spatial variables (e.g., cell contacts and protein localizations) might act as crucial determinants 
during the processing of cellular signaling information. These properties cannot be assessed 
with the above non-spatial single cell analytical methods as cell detachment is required for 
sample acquisition. Imaging-based cytometry, proteomic and transcriptomic techniques can 
preserve the cellular spatial information and are also capable to resolve in subcellular details for 
protein localization. The additional spatial dimension gained with these approaches is often a 
cue to understanding the source of cellular heterogeneity that helps the profiling and prediction 
of signaling network behaviors. 
Microscopic sequential imaging approaches 
Spatial information of protein localization and cell/tissue organization can be acquired through 
fluorescence microscopic measurements of cell monolayers or tissue sections. However, the 
fluorescence spectrum overlap limits detectable channels that can be detected in a 
simultaneous measurement. To achieve the high multiplexity required for signaling network 
profiling, technologies have been developed the very same specimen can be sequentially 
imaged for serial targets of interest without influencing the antigen abundance and disrupting 
the tissue structure. The first set of current sequential imaging approaches applies fluorophore-
labeled antibodies to detect targets of interest (Gerdes et al., 2013; Lin et al., 2015; Schubert et 
al., 2006). Specifically, multi-epitope-ligand cartography (MELC) implements photo-bleaching 
after each round of antibody staining and imaging circle to remove the remained fluorescence 
(Schubert et al., 2006). Alkaline oxidation chemistry has been used in a recent developed 
method, called multiplexed Immunofluorescence (MxIF), to chemically inactivate the fluorescent 
dyes after imaging (Gerdes et al., 2013; Li et al., 2014). Cyclic immunofluorescence (CycIF) 
combines the oxidative inactivation and enzymatic antibody cleavage for sequential imaging(Lin 
et al., 2015). The second set of approaches apply DNA-labeled antibodies (Goltsev et al., 2017; 
Jungmann et al., 2014; Wang et al., 2017). Unlike the above methods which require rounds of 
antibody staining and are usually time-consuming, DNA-labeled antibodies are simultaneously 
stained on the specimen. During the detection process, sequence of the DNA oligo serves as 
barcode for each antibody that it can be detected with fluorescent probes in Exchange-PAINT 
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(Jungmann et al., 2014) and DNA-Exchange-Imaging (DEI) (Wang et al., 2017), or with 
fluorophore-labelled dNTPs (Goltsev et al., 2017) in CO-Detection by indEXing (CODEX) 
(Goltsev et al., 2017). These approaches allow profiling the spatial signaling heterogeneity and 
the understanding of tissue organization-related network variations (Gerdes et al., 2013; Graf 
and Zavodszky, 2017). Multiplexed super resolution imaging also allows three-dimensional (3D) 
spatial profiling and can be further applied to analyze intercellular and subcellular signaling 
events in 3D (Jungmann et al., 2014; Wang et al., 2017). 
Mass spectrometry-based imaging approaches 
Imaging mass cytometry (IMC) implements laser ablation (LS) as the core of sampling platform 
that antibody-stained tissue samples can be ablated spot by spot. A mixed argon and helium 
stream then transports the ablated materials successively into a mass cytometer where proteins 
and protein modifications, such as phosphorylation, can be quantified and subcellular level 
(1μm2) spatial information is preserved (Bodenmiller, 2016; Giesen et al., 2014). With a recent 
improvement, IMC can analyze protein (including phosphoproteins) and RNAs in the same 
sample that enables, for example, research for understanding the transcriptional control under 
specific cellular and spatial signaling properties (Schulz et al., 2017).  
Similarly to IMC, multiplexed ion beam imaging (MIBI) also applies metal-labelled antibodies in 
tissue staining. MIBI then uses oxygen duoplasmatron primary ion beam to liberate the 
antibodies that generate the secondary ion beam. Subsequently, a magnetic sector mass 
spectrometer detects the isotope abundance from the second ion beam from every pixel of 
analyzed sample (Angelo et al., 2014). 
 
Spatial omics in single cell analysis 
Current technologies have greatly increased the resolution and sensitivity of proteomics and 
transcriptomics that single-cell level spatial analysis by these approaches can be achieved.  
MALDI-imaging 
Matrix-assisted laser desorption/ionization (MALDI) imaging mass spectrometry can be used to 
globally detect bio-molecules, including lipids, metabolites, peptides and proteins (Schwamborn 
and Caprioli, 2010). Although MALDI-imaging is mainly used at tissue-level resolution, it allows 
unbiased quantitative and spatial profiling of signal-mediating lipidome and metabolome 
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(Sugiura et al., 2015), and can be further used in systemic assessments of disease states or 
drug responses (Nielsen et al., 2016; Schwamborn and Caprioli, 2010). Yet, novel MALDI-
imaging platform has been developed with increased ionization efficiency, which pushes the 
resolution to a subcellular level of 5 m pe r pixe l, a nd will s oon re a ch 1μm resolution (Solt isch 
et al., 2015). 
Spatial transcriptomics 
Several spatial transcriptomics approaches have been established based on various techniques 
including fluorescent in situ sequencing (FISSEQ) (Lee et al., 2014), multiplexed error-robust 
FISH (MERFISH) (Chen et al., 2015) and spatial barcoding (Ståhl et al., 2016). These 
approaches are ready to, from the transcriptomic level, interpret signaling pathway activation 
states, and correlate such cellular variances to the cell-to-cell communication. Spatial 
transcriptomics are also powerful in understanding the remote cell signaling control mechanisms 
since mRNAs are used as expression readouts for secreted ligands (e.g., cytokines and 
chemokines) that are otherwise difficult to detect in proteome-based analysis (Schulz et al., 
2017). 
 
Live cell imaging 
It is important to note that cell signaling transduction is a dynamic process that it cannot be fully 
understood from snapshot measurement of transient network states. Information of the time 
dimension, in addition to the multiplexed signaling profiling, is therefore necessary to 
systematically  decode the causality of signaling behaviors and to characterize network kinetics 
(Koseska and Bastiaens, 2017). However, signaling events are mainly present intracellularly. 
They can be detected only after a fixation and permeabilization procedure that disrupts the 
signaling dynamics through time. Conventionally, serial snapshot information needs to be 
acquired to enable the rebuilding of time dimension and the computational reconstruction of 
signaling trajectories (Lun et al., 2017; Zi et al., 2011). Technically, these approaches cannot 
fully resolve to the transient events of signaling processing and the computation inference 
becomes complicated when measured signaling behaviors are highly heterogeneous. Several 
live cell imaging methods exploit the changes of protein physical properties (e.g., subcellular 
localization and proximity and modification) to monitor signaling events through time (Aoki et al., 
2013; Burack and Shaw, 2005; Kellogg and Tay, 2015; Kuchenov et al., 2016; Lee et al., 2009; 
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Regot et al., 2014; Ryu et al., 2015). Although these methods are not highly-multiplexed yet, 
capturing central signaling node through time allows tracing the pathway and network behaviors. 
FRET 
Fluorescence resonance energy transfer (FRET) technology is developed based on the energy 
transfer from two proximate fluorophores, leading to the shift of the emission spectrum that can 
be captured by microscope. FRET can be used in monitoring the proximity of interactive 
signaling proteins (Burack and Shaw, 2005) or as bio-sensors for phosphorylation events to 
indicate the pathway activity in real time (Aoki et al., 2013; Ryu et al., 2015). These studies 
characterize single-cell temporal signaling states and correlate them with functional readouts, 
such as proliferation and differentiation. Given the broad fluorescent spectrum occupancy from 
each FRET sensor, multiplexing FRET experiments to study more complexed signaling network 
behaviors can be challenging. Several approaches to increase FRET multiplexity have been 
developed that by expanding selectable fluorophores or promoting the image decoding and 
error propagation scheme, up to six protein interaction/phosphorylation events can be measured 
simultaneously in a multiplexed FRET setup (Bunt and Wouters, 2017; Geißler et al., 2013; 
Hoppe et al., 2013). Alternatively, FRET biosensors can be used in combination with a multi-
parameter imaging platform (FMIP) that the activity of 40 signaling proteins are imaged in 
individual cells to comprehensively infer network dynamics (Kuchenov et al., 2016). 
Kinase activity reporter 
Many kinases, such as ERK and NF B, have nuclear translocation property in their active 
forms. Thus, they have been used in tracing signaling activities in real-time (Kellogg and Tay, 
2015; Lee et al., 2009; Lidke et al., 2010). Studies applies single-cell kinase nuclear 
translocation methods have demonstrated the cellular heterogeneity in signaling dynamics (Lee 
et al., 2009) and noise-facilitated transcription output (Kellogg and Tay, 2015). A recently 
established system applies kinase translocation reporters (KTRs) to monitor the activity of key 
signaling mediators including JNK, p38 and ERK simultaneously, and uncovers temporal 
signaling response between the pathway crosstalk (Regot et al., 2014). An important strength of 
these live cell imaging technologies is the preservation of cellular natural states. The same 
imaged samples can be re-analyzed in other compatible single cell methods. For instance, a 
study has couple NFκB nuclear translocation analysis with single cell RNA-sequencing that 
reveals three distinct cell subpopulations with differential NFκB dynamic-related transcription 
profiles (Lane et al., 2017).   
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Computational method for signaling network analysis using single cell information 
Advanced single-cell experimental approaches share one important common fact of generating 
high-dimensional multivariable datasets which bring challenges for conventional computation 
tools in analyzing signaling network properties. Nevertheless, multiplexed measurements allow 
systematically assess network states and dynamics in one single experiment in which the 
multivariate dependence and high-dimensional distribution are precisely preserved. Recent 
developed computational approaches apply statistical inference to reconstruct signaling network 
structure (Chan et al., 2017; Huang et al., 2016; Krishnaswamy et al., 2014; Sachs et al., 2005) 
and use mechanistic model to characterize network dynamics (Hasenauer et al., 2014; Loos et 
al., 2017). 
For the reconstruction of signaling network, Bayesian model has been applied in flow cytometry 
measurement of 11 intracellular phosphorylation sites with individual treatments of nine small 
molecule inhibitors. Exploiting the nature cellular variances and the re-shaping of multivariate 
distributions upon perturbations, a probabilistic network can be assembled that it replicates 
known pathway relationships and predicts novel network causalities (Sachs et al., 2005). 
Alternatively, correlation based statistics quantify the relationship and dependency between 
measured parameters, and are therefore widely used to assess strength of signaling circuits 
and infer network structure and dynamics in both flow cytometry and transcriptomics data 
(Redell et al., 2013; Yuan et al., 2011). However, in complex signaling regulatory network, 
relationships between a pair of signaling proteins are often multi-parametric dependent and non-
monotonic in shape. Correlation analysis often fails to reflect the true strength of these 
relationships. Based on the information theory, mutual information (MI) and maximal information 
coefficient (MIC) measure relationship between two variables independent of their linearity and 
continuity, allowing quantification of diverse and complex relationships (Kraskov et al., 2004; 
Reshef et al., 2011). Following the same line, a more advanced measure termed conditional 
Density Resampled Estimate of Mutual Information (DREMI) has been recently developed to 
quantify the mutual information in a density independent manner that removes the bias of cell 
distribution along the measured variables (Krishnaswamy et al., 2014). Network reconstructed 
and quantified by DREMI recapitulates well-known signaling processes. In combination with 
methods to trace biological time in a cell transition process (Bendall et al., 2014), DREMI is able 
to study the signaling network reprogramming during cellular phenotypical shifts (Krishnaswamy 
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et al., 2017). Another density independent measure, binned pseudo-R2 (BP-R2), applies the 
classical R2 statistics that is shown to precisely reflects strength of signaling relationships in 
steady states and dynamics (Lun et al., 2017). 
As complementary methods, mechanistic models reveal biochemical insights of a given 
signaling network and the functional heterogeneity within a cell population. Ordinary differential 
equation (ODE) is commonly applied in such modeling that it uses mass action kinetics to 
determine the concentration of signaling nodes over time. ODE model is capable to study 
important network features, such as feedback loops (Hughey et al., 2009). A pilot single cell 
analysis has used ODE constrained mixture modeling to study the variability of phosphorylated 
ERK in the PC12 cell line responding to the NGF stimulation and mechanistically described two 
cell subpopulations with differential signaling responses caused by varied receptor abundance 
(Hasenauer et al., 2014). Further exploiting the cell variabilities, a hierarchal population model 
has been developed, in combination with the single cell modeling, to explain multiple levels of 
heterogeneity in NGF-treated PC12 cells simultaneously (Loos et al., 2017). 
 
Accounting for confounding factors 
Single-cell technologies have enabled characterization of differential signaling behaviors in a 
heterogeneous cell population that are often masked in conventional batch measurements. 
However, these advantages also come along with the challenge that multiple levels of 
confounding factors, including cell cycle and cell size, can bias the single-cell readouts 
(Behbehani et al., 2012; Buettner et al., 2015; Kowalczyk et al., 2015; Marguerat and Bähler, 
2012; McDavid et al., 2016; Padovan-Merhar et al., 2015; Rapsomaniki et al., 2018) and need 
to be appropriately treated in the single-cell analysis. 
One of the most important biological confounding factors is the cell cycle, as cells regulate 
differential signaling and transcriptional programs through the cell cycle phases to control 
cellular events, such as protein synthesis and DNA replication. Particularly in the cell signaling 
level, phosphorylation of signaling proteins have been shown to involve in the cell cycle 
regulation and vary through the cell cycle progression (Fisher et al., 2012; Gut et al., 2015). For 
single cell analysis, it is essential to distinguish the cell varieties caused by the cell cycle 
progression from other sources of heterogeneity. Multiple computational methods are now 
available to account for the cell cycle effects in single cell transcriptomes data, mass cytometry-
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based single cell proteomics data and microscopic imaging analysis (Behbehani et al., 2012; 
Buettner et al., 2015; Gut et al., 2015; Rapsomaniki et al., 2018). 
Single cell measurements typically use the abundance readouts of measured targets. However, 
as signaling network is an integration of biochemical reactions, the rate of signaling transduction 
event is determined by the substrate concentration (Hasenauer et al., 2014; Heinrich et al., 
2002) which cannot be directly interpreted form the abundance measurement. Cell size has 
been demonstrated in multiple studies to confound single-cell abundance measurement that it 
linearly correlates with most of the measured mRNA or protein (modification) levels (Padovan-
Merhar et al., 2015; Rapsomaniki et al., 2018). To account for the cell size, method has been 
developed to experimentally estimate cell size by a total protein measure. Subsequently, by 
normalizing measured single-cell parameters to the cell size, (relative) concentration information 
can be gained (Rapsomaniki et al., 2018). 
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Objectives 
Currently technologies have allowed systematically profiling cellular phenotypical and functional 
properties at single-cell resolution. Mass cytometry enables high throughput single-cell 
proteomic analysis with the capacity to measure more than 40 proteins or protein modifications. 
Using mass cytometry, intracellular signaling networks are ready to be quantified at steady and 
dynamic states, in health and disease. This will largely contribute to the systematic 
characterization of signaling responses and the understanding of signaling variances in 
heterogeneous populations. 
Signaling transduction network is a key to many biological processes, including cell proliferation, 
growth, differentiation, survival, and responses to stress. Deregulated signaling networks are 
often cues to the initiation of abnormal cellular behaviors that can lead diseases, such as cancer. 
As a prime cause of signaling network aberrances, mutations on signaling protein cause protein 
conformational changes, altering catalytic function of the signaling protein. Independent of 
mutations, abnormalities in protein expression levels also change signaling network responses. 
However, dissimilar to mutations which lead to more discretized phenotypes, network 
modulation induced by protein expression changes is a continuous remodeling process as a 
function of protein expression level. Conventional bulk measurement techniques average 
measured parameters in all measured cell and are therefore incapable to analyze such protein 
abundance-dependent effects. Moreover, in cancer cells, the genomic instability induces high 
protein expression heterogeneity, leading to another layer of complexity. Thus, attempts to 
decipher, for example, protein overexpression-induced network states results in unprecise 
biological interpretations that overexpression, although has been identified with highly relevance 
in many cancer types, remains unclear for the signaling mechanism causing oncogenic 
behaviors. 
The aims of this thesis are the following. First, we aim to develop a mass cytometry-based 
experimental method that can enable analysis of signaling protein overexpression-induced 
effects on signaling networks; by exploiting the gradient protein expression level resulting from 
transient transfection, we try to study the network modulation as a continuum, related to the 
expression levels of the analyzed protein. Second, as protein concentration determines cellular 
biochemical reaction rates, overexpressed signaling proteins can alter cellular signaling 
dynamics in response to extracellular stimuli, which can be quantified by our mass cytometry 
based approach. Third, given the capacity of mass cytometry to perform high throughput single 
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cells analysis, we aim to use the then established method in a kinome- and phosphatome-wide 
screen in which the signaling protein abundance-dependent effects on a cancer-related 
signaling network can be systematically quantified; novel signaling relationships and new 
abundance-dependent functions can be identified and assigned to the analyzed kinases and 
phosphatases, especially those have not been fully characterized; and overexpression-related 
oncogenic signaling responses can be identified. 
In addition to the technical development for an protein abundance-dependency measurement 
approach, the thesis also aim to provide biological insights in signaling transduction and 
regulatory mechanisms in several major cancer-related signaling pathways, including the 
MAPK/ERK cascade, the AKT pathways, the PKC pathways, stress response pathways and 
many STAT proteins. Ultimately, our analysis can result in unique data that will facilitate 
computational biology analysis, including signaling network reconstruction, network modeling 
and mechanistic modeling. 
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Result 1: Influence of node abundance on signaling network state and 
dynamics analyzed by mass cytometry 
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Abstract 
Signaling networks are key regulators of cellular function. Although the concentrations 
of signaling proteins are perturbed in disease states, such as cancer, and are modulated 
by drug therapies, our understanding of how such changes shape the properties of 
signaling networks is limited. Here we couple mass cytometry-based single-cell analysis 
with overexpression of tagged signaling proteins to study the dependence of signaling 
relationships and dynamics on protein node abundance. Focusing on the epidermal 
growth factor receptor (EGFR) signaling network in HEK293T cells, we analyze 20 
signaling proteins during a one hour EGF stimulation time course using a panel of 35 
antibodies. Data analysis with BP-R2, a measure that quantifies complex signaling 
relationships, reveals abundance-dependent network states and identifies novel 
signaling relationships. Further, we show that upstream signaling proteins have 
abundance-dependent effects on downstream signaling dynamics. Our approach 
elucidates the influence of node abundance on signal transduction networks and will 
further our understanding of signaling in health and disease.  
 
Introduction 
Signaling networks are at the core of cellular information processing and transform external 
signals into cellular responses. Signals are transduced by modulating enzymatic activities 
mainly via protein phosphorylation, and cells implement sophisticated mechanisms, such as 
feedback loops, pathway crosstalk, and differential enzyme localization, to integrate signals and 
drive cellular processes and physiological outputs. The abundance of individual signaling 
pathway components (nodes) is central to the activity and output of a signaling network (Wolf-
Yadlin et al., 2006). Changes in node abundance are tightly regulated and control biological 
programs such as stem cell differentiation and embryogenesis (De Los Angeles et al., 2015). 
Abundance deregulation of particular signaling network nodes via genomic, transcriptional, or 
post-transcriptional regulatory defects (Bywater et al., 2013; Feinberg, 2007; Silvera et al., 2010) 
underlies human diseases, the prime example being cancer (Santarius et al., 2010). Copy 
number alterations of genes encoding critical proteins (Eralp et al., 2008; Govindarajan et al., 
2007; Han et al., 2015), independent of mutations that constitutively change enzymatic activity 
(Davies et al., 2002), drive progression of many cancer types. Genomic instability in cancer cells 
causes abnormally broad distributions of signaling protein abundances in a given tumor (Wang 
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et al., 2015), yet the consequences of the protein abundance levels on signaling properties is 
poorly understood limiting our ability to rationally design therapies.   
 
The epidermal growth factor receptor (EGFR) signaling network is affected by gene copy 
number alterations that deregulate protein abundances (e.g., of EGFR, HER2, ERK and AKT) in 
a number of cancer types (Eralp et al., 2008; Govindarajan et al., 2007; Han et al., 2015). EGFR 
signaling controls cell growth, motility, survival, differentiation, and metabolism (Citri and Yarden, 
2006). Many drugs target the activity of the EGFR signaling network (Roberts and Der, 2007; 
Tebbutt et al., 2013). The receptor tyrosine kinase (RTK) function of EGFR is activated by its 
dimerization upon ligand binding. EGFR auto-phosphorylation recruits adaptor proteins that 
typically activate the MAPK/ERK and AKT signaling pathways. The MAPK/ERK branch 
activates the GTPase RAS, which triggers a kinase phosphorylation cascade consisting of RAF, 
MEK, ERK, and p90RSK. The output of the MAPK/ERK branch is transcription of genes 
regulating growth and division (Mendoza et al., 2011; Olayioye et al., 2000). Signal transduction 
through the AKT branch starts by PI3K activation, producing PIP3, which recruits AKT and 
PDK1 to the plasma membrane. PDK1 phosphorylates AKT (Manning and Cantley, 2007; 
Mendoza et al., 2011), which mediates signaling through the mTORC1 complex to modulate 
translation via p70S6K and 4EBP1 (Manning and Cantley, 2007). Other AKT targets are GSK3β, 
PRAS40, and TSC2. The AKT pathway controls cell survival, proliferation, and migration 
(Manning and Cantley, 2007). STAT proteins and the PKC pathway can also be activated by 
EGFR-mediated signaling (Bowman et al., 2000; Oliva et al., 2005). EGFR signaling involves 
crosstalk and feedback loops both internally (e.g., active ERK attenuates upstream RAF or MEK 
signaling via negative feedback) (Mendoza et al., 2011) and with other signaling pathways (e.g., 
WNT and TGF-β pathways) (Kim et al., 2007; Massague, 2003). 
 
Classically, two approaches are used to characterize the effect of proteins on signal 
transduction. The first approach analyzes cell populations. Here, western blotting, mass 
spectrometry, RNA-microarrays, and synthetic lethality screens are used to identify signaling 
relationships (Corcoran et al., 2013; Kim et al., 2012; Zhang et al., 2005). Protein-protein 
interaction analyses are used to determine which proteins in a network directly interact (Kim et 
al., 2012; Tewari et al., 2004). Population-based methods yield a comprehensive view of 
signaling but are difficult to use in analysis of protein abundance dependencies due to inherent 
limitations: Proteins must be expressed at different abundances or cells must be sorted to yield 
a non-continuous abundance titration. Such methods result in a large number of samples and 
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cell-to-cell protein abundance variations within each sample remain masked. The second 
approach studies signaling relationships in single cells. Here fluorescence microscopy and flow 
cytometry (FACS) are used with a variety of assays, including proximity ligation assay (PLA) 
(Sundqvist et al., 2013) or fluorescence resonance energy transfer (FRET) (Aoki et al., 2013). 
These approaches allow study of signaling relationships and dynamics through time and space; 
however, only a few signaling nodes can be measured simultaneously. 
 
A recently developed single-cell analysis technology, called mass cytometry, allows for the 
simultaneous measurement of over 40 signaling nodes in single cells using metal-isotope 
tagged antibodies (Bendall et al., 2011; Bodenmiller et al., 2012). This capability makes mass 
cytometry uniquely suited to comprehensively query the function of nodes in signaling networks 
within heterogeneous cell populations. Mass cytometry is quantitative and, in combination with 
mass-tag cellular barcoding (MCB), a powerful screening tool (Bodenmiller et al., 2012). 
Algorithms to analyze multiplexed single-cell mass cytometry data allow quantification of 
signaling relationships, therefore helping to decipher the highly complex network behaviors that 
operate even in simple biological systems (Krishnaswamy et al., 2014). 
 
Here, we coupled protein overexpression with mass cytometry to measure the effect of varying 
node abundance on the activation state and signaling relationships of an unstimulated EGFR 
signaling network, as well as the signaling dynamics of the network in response to EGF 
stimulation. We exploited the finding that transient protein overexpression in a cell population 
typically produces a continuous abundance range of the target protein over four orders of 
magnitude. We overexpressed 20 central EGFR signaling network proteins individually in 
human embryonic kidney (HEK) 293T cells, sampled during an EGF stimulation time course 
over 60 minutes totaling 360 conditions. An average of 11,000 cells per condition was analyzed 
with a panel of 35 antibodies to provide a comprehensive single-cell proteomic EGFR network 
analysis. To identify signaling relationships in this dataset, we developed a statistical measure 
that we call 'binned pseudo R-squared' (BP-R2) that recapitulated known signaling relationships 
and identified relationships that were –to the best of our knowledge- not described previously. 
Thus, our experimental and computational approach enables study of how the strength and 
dynamics of signal transduction are tuned by node abundances.   
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Results 
Analyzing continuous protein abundance dependencies 
To systematically identify and characterize protein abundance-dependent signaling relationships, 
dynamics, and network activation states, we exploited the variation and large dynamic range of 
protein abundance induced by transient transfection and used mass cytometry to quantify the 
abundance of the transfected protein of interest (POI) in conjunction with comprehensive 
signaling network readouts in single cells. We cloned POIs genes into vectors containing a 
cytomegalovirus (CMV) promoter and a GFP-tag sequence (Couzens et al., 2013) to transiently 
overexpress GFP-tagged POIs in HEK293T cells (Fig. 1a). The tagged protein abundance was 
measured by mass cytometry using an anti-GFP antibody (Fig. 1a). Ordering the measured 
cells based on the GFP signal provided a continuous POI titration (Fig. 1b). Typically, not all 
cells were transfected, yielding an internal control for every experiment. To measure the single-
cell EGFR signaling network states, we designed and validated a panel of 35 antibodies that 
mostly detect phosphorylation sites on signaling proteins (Supplementary Tables 1-3). These 
data were used to determine the abundance dependencies of network activation state and 
signaling dynamics (Fig. 1b).  
 
To validate our system we confirmed that, first, the GFP tag was reliably detected by mass 
cytometry (Supplementary Fig. 1); second, the GFP tag did not affect the localization and 
activity of the POI (Supplementary Fig. 2, 3, Supplementary Table 4, Supplementary File 1); 
third, POI expression levels were linearly related to GFP abundance, validating GFP as readout 
of the total POI abundance (Supplementary Fig. 4a, c); fourth, POI overexpression for 18 hours 
(i.e., the time point of our experiments) did not alter the underlying network structure 
(Supplementary Fig. 4b, c); fifth, the antibody-based GFP quantification by mass cytometry was 
comparable to FACS (Supplementary Fig. 5); sixth, the cell culture media and cell detachment 
did not alter signaling processing in the EGFR network (Supplementary Fig. 6, 7); and, seventh, 
the levels of the GFP-tagged POIs were stable during the 1-hour EGF stimulation time course 
(Supplementary Fig. 8, Supplementary Video 1). We also found that the method is robust and 
highly reproducible as evidenced by the high concordance between the three individual 
experiment replicates (Supplementary Fig. 9, Supplementary File 2).  
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KRASG12V and MEK1DD abundance effect on signaling 
We first studied a well-known signaling circuit: Constitutively active mutants of KRAS and MEK1 
(KRASG12V and MEK1DD) lead to ERK phosphorylation and activate components downstream in 
the MAPK/ERK pathway. As expected, we found that overexpression of KRASG12V-GFP or 
MEK1DD-GFP increased phosphorylation on Thr202 and Tyr204 of ERK1/2 (Fig. 2a). Our 
approach also elucidated the abundance-dependent effects on these signaling relationships: 
The relationship between KRASG12V-GFP and p-ERK1/2 was bow-like as high levels of 
KRASG12V-GFP corresponded to reduced phosphorylation of ERK1/2. By contrast, the MEK1DD-
GFP abundance relationship with p-ERK1/2 was monotonic as p-ERK1/2 increased with 
MEK1DD-GFP expression (Fig. 2a). These results verified the oncogenic activation of p-ERK1/2 
induced by KRASG12V and MEK1DD. 
 
Next, we analyzed the impact of KRASG12V-GFP and MEK1DD-GFP abundance on all measured 
phosphorylation sites. We divided the measured cells into 10 bins according to the GFP signals 
and plotted the bin medians (Fig. 2b, Supplementary Fig. 9b-e). This analysis revealed that the 
phosphorylation site abundances on ERK1/2 and its direct downstream target Ser380 of 
p90RSK had similar relationships to the abundances of KRASG12V-GFP or MEK1DD-GFP. 
Phosphorylation of AKT on Ser473 and its direct target Ser9 of GSK3  a ls o had parallel trends 
and showed reduced levels when the MAPK/ERK signal peaked, suggesting inter-pathway 
regulation. We also observed increased JNK phosphorylation on Thr183/Tyr185 induced by the 
KRASG12V mutant (Fig. 2b) as reported previously (Zhou et al., 2010). This shows that our 
approach recapitulates known signaling relationships and identifies abundance-determined 
signaling responses.  
 
We then systematically evaluated signaling relationships between all pairs of measured markers 
modulated by KRASG12V-GFP or MEK1DD-GFP overexpression. We exploited the fact that 
overexpression of one protein increases signaling (i.e., phosphorylation levels) and thus 
expands the dynamic range of many measured markers (Fig. 2c). This enabled the use of 
correlation analysis to distinguish signaling relationships (high correlation) from biological and 
technical noise (low correlation). For example, overexpression of KRASG12V-GFP resulted in an 
increased Spearman correlation between p-ERK1/2 and p-p90RSK compared to control (Fig. 
2c), whereas ERK-independent phosphorylation sites, such as Tyr551 of BTK/ITK, showed low 
correlation with p-ERK1/2 levels in both control and overexpression conditions (Fig. 2d).  
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Identifying changes in pairwise Spearman correlations for all measured markers in the 
KRASG12V-GFP and MEK1DD-GFP overexpression data compared to the FLAG-GFP control 
enabled systematic analysis of signaling relationship patterns (Fig. 2e, f). Phosphorylation levels 
of proteins in the MAPK/ERK pathways showed strong increases in correlation, and pathway 
members clustered together (Fig. 2e, f, green squares). We also observed that 
phosphorylations of MAPK/p38 pathway members and STAT proteins (STAT1 and STAT5) 
were increasingly correlated with levels of MAPK/ERK pathway members as MEKDD-GFP levels 
increased (Fig. 2f, purple rectangle), indicating crosstalk between MAPK and STAT pathways. 
These results reveal relationships among many measured markers and show that increases in 
correlation reflect pathways and grouped biological processes.  
 
Automated analysis of abundance-induced signaling 
Spearman correlation analysis can uncover strictly monotonic relationships between 
phosphorylation levels on signaling proteins; however, protein abundance-dependent signaling 
responses can be complex (Fig. 2a, see KRASG12V). We therefore developed a density-
independent measure termed 'binned pseudo R-squared' (BP-R2) to quantify the strengths of 
relationships between the abundance of a POI and measured phosphorylation sites. BP-R2 
creates 10 bins across the POI-GFP expression range and calculates the relationship strength 
considering bin medians and the global mean (Supplementary Fig. 10a, b, Methods, 
Supplementary Software). Using the BP-R2 values for all negative controls, a cutoff for strong 
signaling relationships was determined (Supplementary Fig. 10c). Benchmarking BP-R2 in 
identifying strong signaling relationships from the overexpression datasets showed that BP-R2 
outperformed methods often used for this task (Krishnaswamy et al., 2014; Redell et al., 2013) 
(Supplementary Fig. 11a, b). The strong relationships identified by BP-R2 were plotted in a two-
dimensional layout guided by canonical pathways (Fig. 2g, h). The directionality of measured 
signaling relationships was determined by Spearman correlation of the bin medians 
(Supplementary Fig. 10b, Methods). A positive correlation indicates that cells show generally 
increasing marker levels and a negative correlation indicates generally decreasing marker levels 
as POI-GFP levels increase. 
 
Analysis of KRASG12V-GFP and MEK1DD-GFP overexpression versus all measured markers 
using BP-R2 revealed strong, positively correlated relationships of MEKDD-GFP to downstream 
MAPK/ERK pathway nodes. KRASG12V-GFP levels, although also positively correlated with 
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MAPK/ERK nodes, exhibited the same, but weaker relationships (Fig. 2a, b, g, h). Together, 
these results suggest that feedback regulation of upstream MAPK nodes differs between the 
studied mutants. Additionally, this network view revealed that MEK1DD-GFP abundance had a 
strong positive impact on nodes in the MAPK/p38 pathway; the previously observed KRASG12V-
induced phosphorylation of JNK (Zhou et al., 2010) was dependent on KRASG12V abundance 
(Fig. 2g, h). These results show that overexpression of signaling proteins, in conjunction with 
BP-R2 and correlation analysis, identifies known relationships and is a valid platform for 
discovery of signaling relationships in a comprehensive and abundance-dependent manner. 
 
Node abundance dependency analyses of the EGFR network 
To study the node abundance dependency of signaling relationships and dynamics in the EGFR 
signaling network, we overexpressed 20 EGFR-related signaling proteins individually in 
HEK293T cells (Table 1). Each of the 20 GFP-tagged POIs was validated in previous studies 
(Supplementary Table 5) and in our system (Supplementary Fig. 2, 3, Supplementary File 1). 18 
hours after transfection, we treated cells with EGF and quantified signaling by mass cytometry 
over a 60-min time course. To exclude signaling relationships caused by channel-to-channel 
spillover, we applied a stringent experimental filter (Supplementary Fig. 12, Methods). The 
median marker intensities during the time course are shown in Supplementary Fig. 13a. Based 
on these data we performed two sets of analyses. In the first, we used BP-R2 analysis and 
Spearman correlations to evaluate how the abundance of overexpressed proteins influenced 
phosphorylation at the measured sites (Fig. 3, Supplementary Fig. 13b and Supplementary Files 
2-4). In the second, we examined how features of signaling dynamics depend on protein 
abundance (Fig. 4). 
In the first analysis, strong and broad signaling responses to overexpression were identified for 
the upstream kinases PDK1-, GSK3β-, SRC-, and ASK1-GFP without EGF stimulation (Fig. 3. 
Overall, we identified 59 strong signaling relationships in the unstimulated conditions. 
Overexpression of many kinases induced strong and positively correlated signaling relationships 
with their own phosphorylation (Fig. 3, Supplementary File 4). Overexpression of CRAF-, KRAS-, 
p70S6K-GFP, and others only induced signaling responses upon EGF stimulation (Fig. 3). 
Notably, under stimulated conditions, KRAS-, CRAF-, and MEK1-GFP levels negatively 
correlated with phosphorylation levels of downstream kinases p-ERK1/2 and p-p90RSK (Fig. 3). 
Activating mutations in KRAS and CRAF (Fig. 2), but not protein overexpression alone, may 
activate oncogenic signaling.  
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To systematically assess signaling relationships identified by BP-R2, we used the literature-
based signaling network, SIGNOR (Perfetto et al., 2016). For each relationship, we computed 
the shortest signed directed path length according to the SIGNOR network (Supplementary 
Table 6). We found that 76% of the strong relationships identified in the unstimulated conditions 
had paths with a maximum of three steps, highlighting that our approach identifies rather direct 
signaling relationships. Only 14 abundance-dependent relationships with four or more path 
steps were identified. Comparison of our strong signaling relationships with literature indicated 
that many EGF signaling connections that we identified were previously reported. We also 
propose many relationships that have—to our knowledge—not been previously reported, for 
example: p90RSK to PDK1 (Ser241), GSK3β to SHP2 (Tyr580), JNK1 to MAPKAPK2 (Thr334), 
p110α to MKK3 (Ser189), p110α to MKK6 (Ser207), ASK1 to PDK1 (Ser241), ASK1 to GSK3β 
(Ser9), and ASK1 to AMPKα (Thr172) (Table 2).  
 
Phosphorylation levels of many members of the MAPK/ERK pathways showed complex 
relationships (i.e., measured phosphorylation levels varied over the analyzed POI-GFP range 
and the relationships did not fit linear, sigmoidal, or quadratic models) with levels of POI-GFPs 
upon EGF stimulation. These relationships can be explained by abundance-dependent 
modulation of the signaling dynamics in response to EGF. Thus, in the second set of analyses 
we examined how signaling dynamics, as quantified by amplitude and peak-time, depended on 
abundance of an overexpressed protein (Fig. 4). In order to view signaling trajectories as 
functions of protein abundance, we binned the POI-GFP levels into 10 bins (Fig. 4a, 
Supplementary File 2). This allowed tracing the signaling trajectories of cells with similar protein 
overexpression levels (i.e., those in the same bin) over the EGF stimulation time course (Fig. 4b, 
Supplementary File 5). Strong and robust changes in signaling amplitudes (Fig. 4c-i) and peak-
times (Supplementary Fig. 14) were found. Notably, the maximum amplitudes were independent 
of the overexpression range of a given POI (Supplementary Fig. 15). 
 
We found that high CRAF-GFP and KRAS-GFP abundance strongly reduced signaling 
amplitudes of p-ERK1/2 and p-p90RSK (Fig. 4c, d, i), whereas high abundance of MEK1-GFP 
strongly reduced amplitudes and delayed peak-times for p-p90RSK (Fig. 4i, Supplementary Fig. 
14). Overexpression of ERK2-GFP led to complex abundance-dependent responses of p-
p90RSK and p-ERK1/2 after EGF stimulation (Fig. 4e-h). p-ERK1/2 amplitudes increased and 
peak-times delayed as a function of ERK2-GFP abundance level (Fig. 4g-i, Supplementary Fig. 
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14). Intermediate abundance levels of ERK2-GFP also delayed the p-p90RSK peak-times 
relative to low ERK2-GFP abundance, whereas cells with high ERK2-GFP levels exhibited 
minimal p-p90RSK signaling dynamics (Fig. 4e, f, i, Supplementary Fig. 14). Overexpression of 
p90RSK-GFP modulated the signaling amplitude of its potential crosstalk phosphorylation site, 
Ser241 of PDK1, in an abundance-dependent manner, and increasing expression of p90RSK 
increased p-PDK1 amplitudes (Fig. 4i). Thus, we observed abundance-dependent signaling 
dynamics across the range of overexpression levels. Overexpression of upstream signaling 
proteins (KRAS-, CRAF-, MEK1-, and ERK2-GFP) in the MAPK/ERK pathway led to reduced 
signaling amplitudes and delayed peak-times of their downstream targets. These observations 
show that our approach can quantify the role of protein abundance in determining the dynamic 
signaling response to an extracellular stimulation.  
 
Discussion 
Here we present an approach coupling transient overexpression with mass cytometry-based 
single-cell measurements to characterize signaling network activation states and signaling 
dynamics over a quasi-continuous, high dynamic range of protein abundance. To highlight the 
utility of our approach, we present a comprehensive single-cell proteomic analysis of the EGFR 
network that enabled an analysis of abundance-dependent effects of signaling proteins on state 
and dynamics of the signaling network. We evaluated the effects of overexpressing 20 EGFR 
network key nodes with a 60-minute EGF stimulation time course. In each of the 360 conditions, 
we measured the effect of a POI over a four order of magnitude abundance range on 35 
markers by mass cytometry providing a unique and valuable quantitative single-cell resource of 
abundance dependencies of EGFR signaling. 
 
Previously, the heterogeneity of protein levels after transient transfection was considered 
problematic. Here, we took advantage of this cell-to-cell variation as it results in a continuous 
titration of protein abundance over four orders of magnitude. Untransfected cells also provided 
an internal control for each experiment. We used the multiplexing capabilities of mass cytometry 
to characterize abundance dependencies of signaling network state and dynamics. Applied to 
the EGFR signaling network, our approach recapitulated known relationships, suggested 
previously not described ones, and revealed the intricate modulation of signal amplitudes and 
peak-times as functions of continuous protein abundance.  
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Our approach contributes to the understanding of signaling on several levels. First, the 
approach can be used to study uncharacterized proteins and to suggest additional roles to 
characterized ones. Second, we were able to directly relate POI abundance with the 
comprehensive analysis of signaling dynamics in response to stimulation. Such analyses are 
necessary for understanding of differential signal processing in identical cell types and in 
disease states characterized by heterogeneity in protein expression such as cancer. Third, the 
overexpression yields a large dynamic range of signaling activity and can reveal signaling 
relationships masked by stochastic processes and technical noise under otherwise similar 
conditions, facilitating the computational analysis of signaling relationships. Fourth, we present a 
metric termed BP-R2, which allows the quantification of the strengths of arbitrary shaped 
signaling relationships. BP-R2 was superior to state-of-the-art methods for analysis of our 
dataset. Fifth, and finally, we were able to infer protein abundance-dependent signaling kinetics 
from single-cell snapshot data.  
 
Our approach recapitulated known oncogenic signaling behaviors induced by the constitutively 
active mutants KRASG12V and MEK1DD and identified novel abundance-dependent signaling 
relationships. For example, p-ERK1/2 was attenuated in cells with highly overexpressed 
KRASG12V-GFP, potentially due to negative feedback loops or senescence (Xu et al., 2014). 
Overexpression of the wild-type KRAS-GFP and MEK1-GFP did not induce downstream 
signaling activation, suggesting that mutations on KRAS or MEK1 are the main drivers of 
oncogenic signaling. Further, our approach allows study of abundance-dependent signaling 
dynamics. In the MAPK/ERK pathway, high abundance of upstream signaling mediators KRAS, 
CRAF, MEK1, or ERK2 reduced amplitudes and delayed peak-times of downstream 
phosphorylation sites. One possible explanation is that the signal transduction is determined by 
the competition between active and inactive forms of a signaling protein for substrates. 
Overexpression increases the total abundance but may reduce the percentage of the active 
form. 
 
KRAS amplification has been identified in many cancer types. Amplification, however, is not 
correlated with the phosphorylation of ERK1/2 (Rahman et al., 2013). Rather, KRAS 
amplification mediates resistance to inhibitors targeting growth pathway related kinases, 
including EGFR, MET and MEK1/2; KRAS knockdown diminishes the drug resistance (Cepero 
et al., 2010; Little et al., 2011; Valtorta et al., 2013). Our results indicate that due to reduced 
downstream signaling amplitudes in response to EGF stimulation, the dependency of cells on 
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the MAPK/ERK pathway may decrease upon KRAS overexpression, suggesting a mechanism 
for cancer cell resistance to inhibitors.  
 
Comparing the identified strong signaling relationships with those in the SIGNOR database, we 
propose previously not described signaling relationships, e.g.: 1) Our data suggest that p90RSK 
potentially forms a positive feedback loop and activates the upstream signaling protein PDK1. 2) 
GSK3β has been identified as a central signaling controller and has multiple substrates (Cohen 
and Frame, 2001); our results suggest that SHP2 is a potential direct or indirect target of GSK3β. 
3) We also propose that JNK1 is a MAPKAPK2 activator. 4) PI3K and MKK3/6 are known to be 
regulated by RAC1 (Shin et al., 2005); our results suggest PI3K activates MKK3/6 
independently. 5) Recent studies indicate that ASK1 contributes in negative regulation of PDK1 
through phosphorylation on Thr254 of PDK1 (Seong et al., 2010); We observe ASK1 
overexpression-induced PDK1 phosphorylation on Ser241, inducing PDK1 activity and 
downstream GSK3β phosphorylation on Ser9. 6) In addition to the known AMPK-mediated 
ASK1 activation (Lee et al., 2010), our data indicates ASK1 activation of AMPKα via 
phosphorylation on Thr172. 7) We have also observed negative correlations between the 
abundance of p70S6K or PDK1 to the phosphorylation level of S6 (Ser235/Ser236), indicating 
overexpression-induced-negative feedback regulations. 
 
Our method has several limitations. First, we do not measure the endogenous expression level 
of the POI. However, exogenous expression is linearly correlated with the total protein level 
(Supplementary Fig. 4a), validating GFP as readout of the total POI. Second, all results in mass 
cytometry rely on antibodies; for this work, all antibodies were thoroughly validated 
(Supplementary Table 3). Third, we do not measure the abundance range of the studied 
proteins in cancer cells, however, proteome studies of cancer cells and databases such as 
PaxDb (Wang et al., 2015) indicate a range similar to those studied here. Fourth, high 
expression levels of a protein kinase may induce non-specific phosphorylation; however, our 
data allows choosing the analyzed expression range in silico, thus such effects can be excluded. 
 
The approach described here provides a method to study how the abundance variance of 
signaling proteins in different tissues and cell lines results in distinct signaling behaviors. The 
application of our approach to synthetic biology, stem cell biology, developmental biology, and 
cancer-related processes, such as the epithelial-mesenchymal transition, will enable 
quantitative identification of key proteins and signaling determinants in cell differentiation at 
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phenotypical switching points. We envision that determining which signaling relationships and 
thresholds enable diseased cells to overcome drug treatment will be a highly relevant 
application. 
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All data and working illustrations are available on Cytobank.org under the project 725. The BP-
R2-based analysis is provided as Supplementary Software and the GitHub repository 
https://github.com/BodenmillerGroup/Adnet.  
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Figure legends 
Figure 1: Workflow of abundance-dependent network analysis. (a) Experimental workflow. 
Signaling POIs are cloned into vectors containing a CMV promoter and a GFP-tag sequence to 
transiently overexpress GFP-tagged POIs in HEK293T cells. We quantify anti-GFP antibody as 
readout of POI-GFP abundance, together with other 35 markers, by mass cytometry. (b) Data 
analysis workflow. Cells were ordered based on the GFP signal, providing a continuous POI 
titration, which was then coupled to other signaling markers to determine the abundance 
dependencies of network activation state and signaling dynamics in the network after 
transfection. The network in the illustration does not represent an actual biological example.  
 
Figure 2: MAPK/ERK pathway mutants induce oncogenic signaling. (a) Biaxial plots of GFP, 
representing the abundance of the overexpressed mutant POIs, versus abundance of 
phosphorylation on Thr202/Tyr204 on ERK1/2. Constitutively active KRASG12V-GFP shows a 
downregulation on Thr202/Tyr204 on ERK1/2 at the highest levels of KRASG12V-GFP. 
Constitutively active MEK1DD-GFP directly phosphorylates Thr202/Tyr204 on ERK1/2, and the 
abundance of the POI-GFP is correlated with amount of ERK1/2 phosphorylated at these sites. 
The FLAG-GFP control does not affect ERK phosphorylation sites. (b) The abundances of 
measured phosphorylation sites are plotted over the range of the KRASG12V-GFP and MEK1DD-
GFP expression. Phosphorylation sites of the same pathway (e.g., on ERK1/2 and p90RSK, 
AKT and GSK3β, or p38 and JNK) show similar trends. An individual experiment is shown here. 
Plots for 3 replicates are shown in Supplementary Fig. 9b-e. (c) Strong single-cell correlations 
within biaxial plots indicate co-regulated phosphorylation sites. (d) Unchanged and reduced 
correlations indicate unrelated phosphorylation sites. (e) and (f) Heat maps showing for all pairs 
of measured markers the change in Fisher-transformed Spearman correlation values for 
overexpression of (e) KRASG12V-GFP and (f) MEK1DD-GFP when compared to the FLAG-GFP 
overexpression control. (g) and (h) BP-R2 scores and Spearman correlations of bin medians for 
all measured markers in cells where (g) KRASG12V-GFP or (h) MEK1DD-GFP was overexpressed 
overlaid on a literature-based graph of canonical signaling pathways (Cardaci et al., 2012; 
Hendriks et al., 2014; Kim et al., 2012; Massague, 2003; Mendoza et al., 2011; Mitra et al., 2005; 
Nyati et al., 2006; Rawlings et al., 2004; Roberts and Der, 2007; Xu et al., 2014). Strong 
relationships identified from the BP-R2 analysis are plotted on the signaling maps as colored 
circles. The sizes of circles indicate relationship strengths quantified by BP-R2. The 
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directionalities of relationships, as judged by Spearman correlation of bin medians, are shown 
by the color of the circles (positive correlation indicates that cells show generally increasing 
marker levels, and a negative correlation indicates decreasing marker levels as POI-GFP levels 
increase). For (e) to (h), data from 3 individual experiment replicates were used. 
 
Figure 3: Analysis of dynamics of EGFR signaling. HEK293T cells overexpressing GFP-tagged 
signaling proteins listed in Table 1 were treated with EGF for 0, 5, 15, 30, and 60 min. Strong 
abundance-dependent signaling relationships (Supplementary Fig. 10c) are plotted on the 
signaling map with circle sizes and colors indicating strengths (BP-R2 score) and directionalities 
(Spearman correlation of bin medians), respectively. The miniaturized network is the same as 
used in Fig. 2. Overexpression of S6-GFP did not induce any strong signaling relationships 
(data not shown). For all analyses, data from 3 individual experiment replicates were used. 
 
Figure 4: Analysis of node abundance-dependent EGFR signaling dynamics. (a, b) Schematic 
plots of amplitude and peak-time analysis. (a) The x-axis (i.e., overexpressed protein as 
determined by the GFP measurement) was split into 10 bins. (b) Median phosphorylation 
abundance in each bin was plotted on the y-axis versus time (x-axis) to visualize abundance 
dependency of signaling dynamics. (c, d) Mass cytometry ion counts (arcsinh transformed, 
Methods) measured for p-p90RSK (y-axis) as a function of ion counts measured for abundance 
of CRAF-GFP (x-axis) and EGF stimulation time. The same layouts for (e, f) ERK2-GFP 
abundance-determined p-p90RSK levels and (g, h) p-ERK1/2 levels are shown. (i) Heat map 
showing protein abundances with strong influences on signaling amplitudes with color indicating 
normalized signaling amplitudes. Only overexpressed proteins with an amplitude-ratio higher 
than 3 fold for more than two of the three replicates were identified as strong influences and are 
included in the heat map. For (a) to (h), representative examples from the 3 individual 
experiment replicates are shown. Other replicates are presented in Supplementary File 5. In (i), 
all replicate data are shown. 
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Table 1: Overexpressed signaling proteins 
Overexpressed 
proteins 
Gene ID UniProt 
Entry 
SRC SRC P12931 
PDK1 PDPK1 O15530 
AKT1 AKT1 P31749 
GSK3β GSK3B P49841 
MKK7 MAP2K7 O14733 
MKK6 MAP2K6 P52564 
p38α MAPK14 Q16539 
ERK2 MAPK1 P28482 
p90RSK RPS6KA1 Q15418 
CRAF RAF1 P04049 
JNK1 MAPK8 P45983 
p110α PIK3CA P42336 
BRAF BRAF P15056 
ASK1 MAP3K5 Q99683 
p70S6K RPS6KB1 P23443 
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MEK1 MAP2K1 Q02750 
KRAS KRAS P01116 
HRAS HRAS P01112 
SHP2 PTPN11 Q06124 
S6 RPS6 P62753 
 
 
Table 2: Relationships with shortest singed directed path length above 3 in the SIGNOR 
database 
Overexpressed 
POI 
Target Sign Shortest Signed 
Directed Path 
(SIGNOR) 
Literature Information 
SRC p-BTK/ITK 1 6 SRC family kinases 
phosphorylate BTK 
(Hendriks et al., 2014) 
SHP2 p-S6 -1 5 Known regulation (Marin 
et al., 2008) 
ASK1 p-PDK1 1 5 Potential novel 
relationship 
SRC p-PLCγ2 1 5 SRC family kinases 
activates PLCγ2 
(Hendriks et al., 2014) 
ASK1 p-AMPKα 1 4 Potential novel 
relationship 
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GSK3β p-SHP2 1 4 Potential novel 
relationship 
p90RSK p-PDK1 1 4 Potential novel 
relationship 
JNK1 p-STAT1 1 4 JNK activates STAT1 
(Wei et al., 2014) 
JNK1 p-MAPKAPK2 1 4 Potential novel 
relationship 
p110α p-MKK3/6 1 4 Potential novel 
relationships 
HRAS p-SMAD2/3 1 4 Known crosstalk 
(Massague, 2003) 
ASK1 p-GSK3β 1 4 Potential novel 
relationships 
PDK1 p-S6 -1 4 Overexpression-induced 
negative regulation 
p70S6K p-S6 -1 4 Overexpression-induced 
negative regulation 
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Methods 
Data availability 
All raw data are available at http://www.cytobank.org/bodenmillerlab. 
 
Cloning 
DNA sequences of the genes of interest were provided in entry clones by William Hahn and 
David Root(Yang et al., 2011) (via Addgene and NEXUS Personalized Health Technologies at 
ETH Zurich). Destination vectors, including pDEST pcDNA5 FRT TO-eGFP, pDEST 5' Triple 
Flag pCDNA5 FRT TO and pDEST 3' Triple Flag pcDNA5 FRT TO, were kindly provided by Dr. 
Anne-Claude Gingras at Mount Sinai Hospital, Toronto, Canada(Couzens et al., 2013). 
Expression vectors encoding the FLAG- or GFP-tagged fusion proteins were generated via 
Gateway Cloning and sequenced before transfection. 
 
Cell culture 
HEK293T cells, obtained from ATCC, were cultured in DMEM (D5671, SIGMA), supplemented 
with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin. For cell 
passaging or harvesting, cells were incubated with 1X TrypLE™ Express (Life Technologies) for 
2 minutes at 37 °C. 
 
Transfection and stimulation 
HEK293T cells were seeded at the density of 0.7 million per well in 6-well plates. After 24 hours, 
cells were transfected with 2 μg plasmid and 4 μl of jetPRIME (PolyPlus) per well with the 
standard protocol provided by the manufacturer. At 18 hours after transfection, EGF (Peprotech) 
was added to a final concentration of 100 ng/ml. At 20 minutes before a given EGF stimulation 
time point, 5-iodo-deoxycytidine (IdU) was added to the medium at the final concentration of 10 
μM. At 2 minutes before a given EGF stimulation time point, medium was replaced by 1X 
TrypLE to induce cell detachment. At the time point, paraformaldehyde (PFA, from Electron 
Microscopy Sciences) was added to the cell suspension to a final percentage of 1.6%, and cells 
were incubated at room temperature for 10 minutes. If EGF stimulation was not necessary in the 
experiment, cells were directly harvested and crosslinked with PFA. Crosslinked cells were 
washed twice with cell staining media (CSM, PBS with 0.5% BSA, 0.02% NaN3) and after 
centrifugation, ice-cold methanol was used to resuspend the cells, followed by a 10-minute 
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permeabilization on ice or for long-term storage at -80 °C. Three biological replicates were 
performed for each experiment. In each replicate, the experimental procedures were performed 
on different days.  
 
Cell sorting 
HEK293T cells overexpressing FLAG-GFP were detached from the plates as described above 
and resuspended in the FACS buffer (PBS with 0.5% BSA and 5 mM EDTA). Cells were sorted 
with BD FACSAria III Cell Sorter into GFP low, intermediate, and high levels with the strategy 
indicated in Supplementary Fig. 5. 
 
Live cell imaging 
HEK293T cells were seeded in CultureWell™ Chambered Coverglass (Thermo Fisher Scientific) 
pre-coated with fibronectin. Transfection of FLAG-GFP was performed as described above. At 
18 hours after transfection, cells were imaged with a Leica DMI 6000 inverted microscope at 
37 °C and 5% CO2. Images were taken every 2 minutes for 1 hour. 
 
Immunofluorescence staining 
Cells were cultured in 16-well glass chamber slides (Thermo Fisher Scientific). Transfection was 
done as described above. Before staining, culture medium was removed and the slide was then 
washed with PBS. To crosslink cells, 4% PFA was added, and cells were incubated at room 
temperature for 20 minutes. Slides were washed with PBS three times, and cells were 
permeabilized for 5 minutes with 0.1% TritonX-100 dissolved in PBS at room temperature. After 
washing three times with PBS, cells were incubated in blocking buffer (10% goat serum diluted 
in PBS) for 30 minutes at room temperature. Primary (anti-GFP, FM264G, BioLegend, 1:200) 
and secondary (Goat anti-Rat Alexa Fluor® 568, 1:500, supplemented with Hoechst 33342 at a 
final concentration of 100 μg/ml) antibodies were diluted in blocking buffer and applied to slides. 
A total protein stain of Alexa Fluor 647 Succinimidyl Ester (Life Technologies) was used to 
indicate cell outlines. Cells were washed three times with PBS after each incubation step. Slides 
were mounted with ProLong Gold Antifade Reagent (Life Technologies) before imaging with a 
CLSM Leica TCS SP8 microscope. 
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Antibody conjugation 
The MaxPAR antibody conjugation kit (Fluidigm) was used to generate isotope-labeled 
antibodies using the manufacturer’s standard protocol. After conjugation, the antibody yield was 
determined based on absorbance of 280 nm. Candor PBS Antibody Stabilization solution 
(Candor Bioscience GmbH) was used to dilute antibodies for long-term storage at 4 °C.    
 
Barcoding and staining protocol 
Formalin-crosslinked and methanol-permeabilized cells were washed three times with CSM and 
once with PBS. Cells were incubated in PBS containing barcoding reagents (102Pd, 104Pd, 105Pd, 
106Pd, 108Pd, 110Pd, 113In and 115In) at a final concentration of 100 nM for 30 minutes at room 
temperature and then washed three times with CSM(Bodenmiller et al., 2012). Barcoded cells 
were then pooled and stained with the metal-conjugated antibody mix (Supplementary Table 1) 
at room temperature for 1 hour. The antibody mix was removed by washing cells three times 
with CSM and once with PBS. For DNA staining, iridium-containing intercalator (Fluidigm) 
diluted in PBS with 1.6% PFA was incubated with the cells at 4 °C overnight. On the day of the 
measurement, the intercalator solution was removed, and cells were washed with CSM, PBS, 
and ddH2O. After the last washing step, cells were resuspended in ddH2O and filtered through a 
70-μm strainer. 
 
Mass cytometry analysis 
EQTM Four Element Calibration Beads (Fluidigm) were added to cell suspensions in a 1:10 ratio 
(v/v). Samples were analyzed on a CyTOF2 (Fluidigm). The manufacturer’s standard operation 
procedures were used for acquisition at a cell rate of ~500 cells per second. After the 
acquisition, all FCS files from the same barcoded sample were concatenated(Bodenmiller et al., 
2012). Data were then normalized, and bead events were removed(Finck et al., 2013) before 
doublet removal and de-barcoding of cells into their corresponding wells using a doublet-filtering 
scheme and single-cell deconvolution algorithm(Zunder et al., 2015). Subsequently, data was 
processed using Cytobank (http://www.cytobank.org/). Additional gating on the DNA channels 
(191Ir and 193Ir) and 139La/141Pr was used to remove remained doublets, debris and contaminating 
particulate. 
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Data visualization and analysis 
Bi-axis scatter plots 
Bi-axis scatter plots were generated in Cytobank (http://www.cytobank.org/). 
 
Data preprocessing  
Raw data was transformed using the inverse hyperbolic sine transform with a cofactor of 5: 
 
𝑑𝑑𝑑𝑑 = 𝑑𝑎𝑎𝑎𝑎ℎ(𝑑𝑑𝑑𝑑𝑟𝑟𝑟/5) 
 
Except where use of raw data values is specifically noted, all visualizations and analyses were 
performed using transformed data.    
 
Data binning 
For data binning, the range between the lower and upper 2.5% of observations was divided into 
ten equal bins bin1,...,bin10. The observations in the lower and upper 2.5% were assigned to the 
lowest and highest bins, respectively. In order to be able to compare expression levels between 
samples within a time course replicate, all observations of the time course were used to 
determine the binning. 
 
Correlation analysis  
Spearman correlation (rij) was calculated between all marker pairs i, j for each replicate and 
condition. Fisher’s z-transformation: 
𝑧𝑖,𝑗 = 𝑑𝑎𝑑𝑑𝑎ℎ(𝑎𝑖𝑗) 
was used to compare pairwise correlation coefficients across conditions. For each 
overexpression, the change in correlation matrix was calculated by subtracting the median ?̃?𝑖𝑗 
value (across replicates) of the FLAG-GFP controls from the median ?̃?𝑖𝑗 value (across replicates) 
of the overexpression condition.  
 
∆?̃?𝑖𝑗 = ?̃?𝑖𝑗 𝑜𝑜𝑜𝑟𝑜𝑜𝑜𝑟𝑜𝑜𝑜𝑖𝑜𝑜 −  ?̃?𝑖𝑗 𝐹𝐹𝐹𝐹−𝐹𝐹𝐺  
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The resulting matrix of differences in Fisher transformed correlation values was hierarchically 
clustered using the Ward method and Euclidean distances(Ward, 1963). 
 
BP-R2 
Relationships between overexpression levels and markers can include non-monotonic 
relationships that are not properly captured with correlation metrics such as Spearman 
correlation. Furthermore, although the shapes induced by an overexpression were highly 
reproducible, the number of cells with a given expression intensity level were not. Thus, in order 
to quantify the strength of arbitrarily shaped relationships between markers and overexpression 
levels over the whole overexpression range, a density agnostic metric termed binned pseudo R-
squared (BP-R2) was developed. For this metric, the middle 95% of POI-GFP levels over a time-
course replicate was divided into 10 equal-width bins. Bins with less than 25 cells were 
discarded. For each bin 𝑎, the median of a measured marker (𝑦�𝑖) was calculated. Additionally, 
the overall mean of the medians of all the 10 bins (𝜇𝑦� ) was calculated. Then, for each bin, we 
computed the sum of squared deviations from the bin medians and the sum of squared 
deviations from the overall mean of medians These values were summed over all bins and the 
BP-R2 was defined as one minus the ratio between them: 
 
𝑅𝐵𝐺
2 =  1 − ∑ 1𝑎𝑖 ∑ (𝑦𝑖𝑗 − 𝑦�𝑖)2𝑜𝑖𝑗=1𝑜𝑛𝑖𝑜𝑜𝑖=1
∑ 1𝑎𝑖 ∑ (𝑦𝑖𝑗 − 𝜇𝑦�)2𝑜𝑖𝑗=1𝑜𝑛𝑖𝑜𝑜𝑖=1  
Following the rationale of classical R-squared statistics, BP-R2 quantifies the average reduction 
in squared deviations per bin when modeling the data as piecewise constant within each bin 
(based on the bin medians) compared to using the mean over all bin medians. The BP-R2 metric 
represents the relationship strength between a marker and the overexpressed signaling protein 
relative to the overall variability of the marker. By using the median instead of mean, the BP-R2 
selects unimodal relationships with low noise over noisy, multimodal relationships. Notably this 
measure works with arbitrary interaction shapes and is largely robust against density in 
homogeneities. In order to aggregate the sample replicates, we considered the median BP-R2 
value across the experimental triplicates. 
 
Threshold determination 
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We observed many relationships with low BP-R2 between overexpressed proteins and 
measured phosphorylation markers, even within control samples (overexpression of FLAG-
GFP). We proposed such weak relationships are more likely to result from indirect biological 
mechanisms; therefore, we focused on relationships that were stronger than all relationships 
seen in the controls (FLAG-GFP overexpression and untransfected cells). We chose the 
maximum median (across replicates) BP-R2 of all controls (FLAG-GFP overexpression and 
untransfected cells) as a cutoff. Relationships that had a median BP-R2 higher than this 
threshold were considered as sufficiently strong to be of interest.  
 
Kinetic analysis 
For each overexpression condition, replicates of EGF stimulation time courses were processed, 
stained, and measured together. Simultaneous processing enabled direct quantitative 
comparisons of the measured POI-GFP counts in these time courses. Samples representing all 
time points in a time course replicate were combined and binned by POI-GFP intensity as 
described in the data binning section. As the binning was performed over all samples of the 
same time course, the range of GFP intensity of bins with the same bin index directly 
corresponds to cells with similar abundance levels of POI-GFP in each of the different time 
points. As POI-GFP levels stay quasi-constant over the timescale of the 60-minute time course 
(Supplementary Fig. 8, Supplementary Movie 1), tracking how the median marker levels in a 
specific bin change over the time course reflects the kinetics of cells with a similar abundance 
level upon stimulation. Thus, the kinetic responses over a range of low-abundance to high-
abundance cells can be compared and analyzed using classical signal processing readouts 
such as signal response amplitude and peak-time. For this analysis, only POI-GFP marker pairs 
with at least one strong relationship over the time course were considered. 
 
Amplitude analysis 
The response amplitude for each binned abundance level was calculated using raw counts. For 
each measured marker and time point, the median marker level of each POI-GFP bin was 
divided by the median level of the marker in the corresponding bin of the unstimulated sample 
(EGF 0 min) to calculate amplitude as a fold change. The amplitude for each bin was identified 
as the maximum fold change over all time points. Robust and strong abundance-dependent 
changes were identified by comparing the amplitude-ratio between the second highest and the 
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second lowest bin-amplitude. Of those identified as robust and strong, overexpressed proteins 
with an amplitude-ratio higher than 3 folds for more than two of the three replicates were 
identified as interesting and plotted as a heat map. 
 
Peak-time analysis 
Interesting examples for overexpression changes in bin peak-time were defined by identifying 
the time point with maximum amplitude for each bin as the peak-time. Consistent and robust 
examples were selected by the following criteria: Monotonically increasing or decreasing peak-
times over the increasing overexpression bins and a clear change in amplitude (>3 fold) in at 
least 2 of the 3 replicates. 
 
Signor database comparison 
To compare the consistency between the strong signaling relationships detected by BP-R2 
analysis with the relationships predicted by the Signor database(Perfetto et al., 2016), the 
python NetworkX(Hagberg et al., 2008) package was used to construct a signed directed Signor 
network from the UniProt entries of overexpressed POIs and measured phosphoproteins. 
NetworkX also calculates a shortest path length within the signed directed network. Antibodies 
may bind to the same phosphorylation sites on more than one protein that belong to a family, 
making the mapping between antibodies and UniProt entries ambiguous. In this case, the 
shortest path value was calculated between the overexpressed POI and any possible antibody 
targets.  
 
The analysis was preformed including the directionalities of signaling relationships as identified 
by the Spearman correlation of the bin medians in our analysis, and by exploiting the SIGNOR 
annotations in the following way: Simple paths between the overexpressed protein and the 
targeted phosphorylation sites were analyzed, starting from the shortest path to longer paths, 
until a sign-consistent path was found. To identify sign consistency, all edges in the SIGNOR 
network were classified as positive, negative or ambiguous based on the SIGNOR ‘Effect’ 
annotation: down-regulates...=negative, up-regulates...=positive, something else=ambiguous. In 
case there were multiple interaction types possible for an edge (positive and negative), the 
overall sign was taken to be ambiguous. In cases where the last edge was annotated to be 
affecting exactly the residue (SIGNOR annotation ‘Residue’) measured by the phospho specific 
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antibody through (de)phosphorylation (SIGNOR annotation ‘Mechanism’), the directionality sign 
of this edge was determined to be phosphorylation=positive, dephosphorylation=negative or the 
inverse in cases the antibody was measuring the non-phospho site (e.g., Ser33/37/Thr41 on β-
catenin). Measured phosphorylation sites responsible for inactivating a protein (e.g., Ser9 on 
GSK3β) were also signed as phosphorylation=negative. 
 
A path was determined sign consistent if the product of the signs of all its edges were in 
accordance with the relationship direction as measured by the spearman correlation over the 
bins or ambiguous. 
 
Systematic spillover exclusion  
A stringent spillover filter was applied to systematically remove strong signaling relationships 
potentially affected by channel-to-channel spillover: For any measured channel that had events 
with ion counts over 500, we checked for spillover due to: first, isotope impurity (channels with 
isotopes of the same metal); second, mass resolution (-1 and +1 channels); third, oxidation (+16 
channels). Any strong relationships (BP-R2) with GFP and markers from these sets of channels 
were selected for additional verification experiments, in which the staining was done in 3 groups: 
1. All antibodies in a set 
2. All antibodies in a set except for the one that potentially causes spillover  
3. Only the antibody potentially causing spillover  
 
When spillover-induced background contributed to over 10% of the actual ion counts, the 
channel was discarded from further analysis (Supplementary Fig. 13). 
 
Based on our spillover exclusion protocol, we found the following channels were affected by 
spillover. They were excluded from the analysis performed in this manuscript, and should not be 
considered in any subsequent analyses using this data: 
 
In SRC overexpression: 
  142Nd p-SHP2 
  159Tb p-SMAD1/5 
 
In PDK1 overexpression: 
  142Nd p-SHP2 
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  143Nd p-FAK 
  145Nd p-MAPKAPK2 
  160Gd p-MKK3/MKK6 
  162Dy p-BTK/ITK 
 
In GSK3β overexpression: 
  146Nd p-p70S6K 
 
In p90RSK overexpression: 
  142Nd p-SHP2 
  147Sm p-MKK3 
  162Dy p-BTK/ITK 
  164Dy p-SMAD2/3 
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Supplementary Figure 1 
Technique validation. 
(a) Detection of GFP-N-terminal, FLAG-C-terminal, and FLAG-N-terminal tagged proteins. All GFP-tagged 
fusion proteins, but only 20 of the 25 FLAG-C-terminal tagged and only 22 of the 25 FLAG-N-terminal tagged 
proteins, were detected using mass cytometry. (b) HEK293T cells overexpressing GFP-GFP, FLAG-C-
terminal-GFP, and FLAG-N-terminal-GFP fusion proteins were co-stained with anti-GFP and anti-FLAG 
antibodies. The fusion protein FLAG-C-terminal-GFP was detected by the anti-GFP antibody but not with the 
anti-FLAG antibody. This indicates that in certain contexts the FLAG tag is not accessible to the anti-FLAG 
antibody. The FLAG epitope may be masked due to protein folding or by the denaturation process that is part 
of our experimental protocol. 
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Supplementary Figure 2 
GFP-tagged POIs have normal localization. 
HEK293T cells that overexpressed the GFP-tagged POIs used in this study were imaged with confocal 
microscopy. For each POI, the main panel shows the image in a given z-depth; the bottom panel and the side 
panel shows x-z and y-z cross-sectional images, respectively. POI-GFP subcellular localization was 
determined by overlapping with two control stains: Hoechst 33343 for the nucleus and Alexa Fluor 647 
carboxylic acid succinimidyl ester indicating the cell outline. The POI-GFP localization was verified by 
comparison with information of the UniProt subcellular localization database (Supplementary Table 4). 
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Supplementary Figure 3 
GFP tag does not disrupt catalytic activities of POIs. 
(a-d) Catalytic activities of GFP-tagged POIs were compared with FLAG-C-terminal and FLAG-N-terminal 
tagged POIs. The examples shown here indicate that the GFP tag did not alter signaling relationships or 
signaling dynamics after EGF stimulation (the complete dataset with comparison of all constructs used in this 
study is shown in Supplementary File 1). (e) Heat map showing abundance-dependent signaling relationship 
strengths from overexpressed POIs with three different tags as determined by BP-R2 analysis (Supplementary 
Figure 11 and Methods). Measured markers showing at least one strong relationship in any of the conditions 
were included in the heat map. Strong relationships were detected independently of tag. BP-R2 values slightly 
vary for the 3 tags, due to the antibody accessibility and differences in transfection efficiencies (Supplementary 
Figure 1). 
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Supplementary Figure 4 
Total protein antibody staining of HEK293T cells overexpressing a GFP-tagged POI. 
(a) HEK293T cells transfected with KRAS-GFP, HRAS-GFP, MEK1-GFP, ERK2-GFP, AKT1-GFP, GSK3 -
GFP, or S6-GFP for 18 h were stained with anti-total POI and anti-GFP antibodies. A linear regression analysis 
for each pair was performed in the original scale. R2 ranges from 0.74 to 0.88, indicating the total POI is 
linearly correlated with GFP and that the POI overexpression does not alter the expression of the endogenous 
POI. (b) The same cells were stained with nine antibodies to quantify total protein as well as with a GFP 
antibody. Median ion counts for all measured markers are shown. Overexpression of a POI-GFP for 18 h does 
not cause notable changes in the measured network nodes. (c) ERK2-GFP transfected HEK293T cells and the 
untransfected control with or without EGF stimulation were stained for total-ERK and phospho-ERK 
(Thr202/Tyr204). The dynamic range in the overexpression condition allows observation of abundance-
dependent signaling relationships. With total ERK staining, the same signaling relationships as shown in the 
Supplementary Figure 2b is recapitulated, verifying GFP as an indicator of POI expression level. 
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Supplementary Figure 5 
Comparison of mass cytometry and flow cytometry (FACS). 
HEK293T cells were transfected with the FLAG-GFP overexpression vector. With flow cytometry, cells were 
gated into GFP low, medium, and high populations with the gating strategy shown in the left panel. With mass 
cytometry, each of the three sorted populations was measured independently to determine the gating windows. 
Unsorted cells were then assessed by the mass cytometry. The maximum difference in population percentage 
between mass cytometry and flow cytometry was less than 3%. 
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Supplementary Figure 6 
Comparison of EGF stimulations in starved (FBS is absent) and non-starved (FBS is present) cell culture 
conditions. 
HEK293T cells were stimulated with EGF with or without FBS over a 1-h time course. In the non-starved 
condition basal signaling states of the major MAPK/ERK or AKT pathway components were higher than in 
starved conditions, but these elevated levels did not affect the signaling responses to the EGF stimulation. 
Mean value of each sample is shown with circle. Standard deviation is indicated by shaded area. 
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Supplementary Figure 7 
TrypLE treatment time course. 
HEK293T cells were treated with TrypLE for 30 s, 1 min, 2 min, or 4 min with or without EGF stimulation for 5 
min (time from EGF addition to PFA crosslinking). Within the first 2-min TrypLE treatment (i.e., the time after 
which we quenched cells in all experiments), only phosphorylation of Ser167/170 on MARCKS varied 
relatively. Mean value of each sample is shown with circle. Standard deviation is indicated by shaded area. 
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Supplementary Figure 8 
Live imaging of GFP fluorescence at 18 to 19 h after HEK293T cells were transfected with a FLAG-GFP 
construct. 
Quantification of the GFP intensity showed a slight increase of 5.4% over the 1-hr time course. There was a 
fluctuation in total GFP signal, indicating that the 5.4% increase is most likely attributable to technical variability 
of the measurement. The analysis of signaling relationships in our study was performed based on a binning 
strategy on arcsinh transformed GFP ion counts (mass cytometry). Thus, the measured change will not 
significantly affect the binning over the time course. Standard deviation is indicated by shaded area. 
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Supplementary Figure 9 
Reproducibility test. 
Different batches of HEK293T cells were transfected with JNK1-GFP, P38α-GFP, PDK1-GFP, or p90RSK-
GFP constructs, stained, and analyzed by mass cytometry on three different days. Highly consistent signaling 
responses were observed among the three biological replicates. 
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Supplementary Figure 10 
Abundance-dependent signaling analysis performed in replicates for the shown mutants. 
Panels (a) and (b) show analyses of representative phosphorylation sites in the MAPK/ERK, AKT, stress 
pathways, and the STAT5 protein in cells in which (a) KRASG12V-GFP and (b) MEK1DD-GFP was 
overexpressed. Panels (c) and (d) show all relationships that passed the BP-R2 threshold (see Methods for 
details) for the (c) KRASG12V-GFP and (d) MEK1DD-GFP overexpression experiments. 
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Supplementary Figure 11 
Binned pseudo R2 (BP-R2) analysis. 
(a) BP-R2 analysis considers deviation from bin median versus the global mean of bin medians. (b) Examples 
of BP-R2 and Spearman correlation of bin medians values. The top left and top right plots show examples of 
positive and negative Spearman correlations of bin medians. The top left and bottom left plots show replicates 
of the same overexpression condition and how a (supposedly) increased noisiness affects the BP-R2 values. 
The bottom right plot shows a complex signaling relationship with the corresponding BP-R2 value. The BP-R2 
metric detects complex arbitrary relationship (bottom right). (c) Density distribution of the median BP-R2 values 
for the 700 POI-GFP-marker relationships from the negative controls (FLAG-GFP, untransfected) and the 3500 
POI-GFP-marker relationships of the signaling node overexpression conditions. Cutoff for strong signaling 
relationships were determined at a median BP-R2 value of 0.11, the highest median BP-R2 of the negative 
controls. 
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Supplementary Figure 12 
Benchmark of BP-R2 against other methods used to identify relationships in mass cytometry data. 
(a) Venn diagram of strong relationships detected by BP-R2, Spearman correlation, and DREMI in our dataset 
using the same cutoff - the 99 percentile of the BP-R2 / Spearman correlation / DREMI score in the control 
groups (FLAG-GFP overexpression and the untransfected cells). BP-R2 outperforms the other two measures. 
(b) BP-R2, Spearman correlation, and DREMI measurements of signaling relationship strength between p-
ERK1/2 and overexpressed ERK2-GFP. BP-R2 is suitable for analyzing non-monotonic signaling relationships 
and outperforms the other two measures in representing actual signaling activation status. 
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Supplementary Figure 13 
Analysis of signal spill over among mass channels. 
(a) Strategy to exclude spill over among mass channels. When strong signaling relationships as determined by 
BP-R2 were identified (measured phosphorylation of p70S6K in the p90RSK-GFP overexpression is shown 
here as a selected example), all other potentially affected channels (details in Methods) were evaluated for 
spillover that might have led to a high BP-R2 value. Using an experimental spillover filter (b), spillover-affected 
relationships were discarded. Here three groups of antibody stains were performed simultaneously: First, all 
antibodies; second, all antibodies except for the one that potentially causes spillover; third, only the antibody 
that potentially causes spillover. If spillover induced background was over 10% of the actual ion counts, the 
channel was discarded from the analysis. 
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Supplementary Figure 14 
Heat map of median intensities of all measured markers at 0, 5, 15, 30, and 60 min post-EGF stimulation in all 
overexpression conditions (Table 1). 
Data visualized as log2 of the ratio of the median signals divided by the mean of median signals of the FLAG-
GFP controls at time point 0. 
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Supplementary Figure 15 
Heat map of BP-R2 values of all measured markers versus GFP signals at 0, 5, 15, 30, and 60 min post-EGF 
stimulation in all overexpression conditions. 
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Supplementary Figure 16 
Heat map of consistent and robust examples for overexpression-induced phosphorylation site abundance peak 
time changes after EGF stimulation for each of the three replicates. 
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Supplementary Figure 17 
Post-transcriptional constraint analysis of overexpressed POIs. 
(a) Coefficient of variation (CV) was computed for each strong signaling relationship that had a BP-R2 value 
above 0.11 (i.e., a strong signaling relationship), and CVs were plotted against BP-R2. No correlation was 
observed. (b) Overexpression ranges (median value of GFP in Bin10 minus the median value of GFP in Bin1) 
calculated for all POIs. (c) Maximum amplitudes of phosphorylation sites were independent of the level of 
overexpression of the POIs. 
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Abstract 
Kinase and phosphatase overexpression drives tumorigenesis and drug resistance in many 
cancer types. Signaling networks reprogrammed by protein overexpression remain largely 
uncharacterized, hindering discovery of paths to therapeutic intervention. We previously 
developed a single cell proteomics approach based on mass cytometry that enables quantitative 
assessment of overexpression effects on the signaling network. Here we applied this approach 
in a human kinome- and phosphatome-wide study to assess how 649 individually 
overexpressed proteins modulate the cancer-related signaling network in HEK293T cells. Based 
on these data we expanded the functional classification of human kinases and phosphatases 
and detected 208 novel signaling relationships. In the signaling dynamics analysis, we showed 
that increased ERK-specific phosphatases sustained proliferative signaling, and using a novel 
combinatorial overexpression approach, we confirmed this phosphatase-driven mechanism of 
cancer progression. Finally, we identified 54 proteins that caused ligand-independent ERK 
activation with potential as biomarkers for drug resistance in cells carrying BRAF mutations. 
 
Introduction 
Kinases and phosphatases control the reversible process of phosphorylation, which regulates 
protein structure, activity, and localization. Kinases and phosphatases are organized as 
signaling networks that compute extracellular signals into transcriptional, functional, and 
phenotypical responses. Deregulation of signaling networks can lead to the initiation and 
progression of many types of human disease including cancer (Fleuren et al., 2016; Julien et al., 
2007), consequently they are a focal point of life science research. Kinases and phosphatases 
have been classified based on genomic and proteomic analyses (Chen et al., 2017; Manning et 
al., 2002; Sacco et al., 2012a). Signaling network structure has been studied by mapping 
physical interactions of kinases and phosphatases in steady and dynamic states using 
biochemical approaches and reporter assays in yeast and human cells (Barrios-Rodiles et al., 
2005; Breitkreutz et al., 2010; Couzens et al., 2013; Horn et al., 2011). Using in vitro kinase 
assays and motif-based predictions, the specificity and targets of many kinases have been 
revealed (Linding et al., 2007; Mok et al., 2010; Yu et al., 2009). Kinase and phosphatase 
perturbations have also been applied to systematically determine phosphorylation abundance 
changes in yeast and human cells (Bodenmiller et al., 2010; Ochoa et al., 2016; Sacco et al., 
2012b). A systematic analysis of how each human kinase and phosphatase modulates signaling 
network structure and dynamics, however, so far is absent.  
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Mutation-induced signaling network rewiring and modulation of signaling dynamics have been 
systematically characterized (Creixell et al., 2015; Pawson and Warner, 2007), providing a basis 
for identification of targeted therapies in cancer (Hennessy et al., 2005; Logue and Morrison, 
2012). Independently of mutations, kinase overexpression drives tumorigenesis in multiple 
cancer types and is a critical factor in drug resistance (Eralp et al., 2008; Santarius et al., 2010; 
Shaffer et al., 2017). Overexpression of phosphatases has been shown to mediate cancer 
progression and has been linked to the poor prognosis of patients (Julien et al., 2011; Liu et al., 
2016; De Vriendt et al., 2013). Overexpression-induced signaling modulation remains largely 
uncharacterized because factors such as genetic instability induce highly heterogeneous 
quantities of deregulated signaling proteins in cancer (Abbas et al., 2013), making conventional 
cell population-based analysis inapplicable. Only recently have technologies emerged that 
account for such heterogeneity, and can comprehensively quantify signaling network behavior 
with single-cell resolution. This resolution is required to characterize the abundance-related 
cellular signaling states and phenotypical alterations caused by a given kinase and phosphatase 
of interest (Bendall et al., 2011; Budnik et al., 2018; Lun et al., 2017).  
 
Mass cytometry allows simultaneous quantification of over 40 proteins and protein modifications 
at single-cell resolution and thus enables profiling of complex cellular behaviors in highly 
heterogeneous samples (Bendall et al., 2011; Bodenmiller et al., 2012; Chevrier et al., 2017b). 
We have recently established and thoroughly validated an approach that couples transient 
protein overexpression to mass cytometry-based single-cell analysis and have revealed that 
protein overexpression induces signaling network modulations in an abundance-dependent 
manner (Lun et al., 2017).  
 
Here, we applied this technique in a human kinome- and phosphatome-wide screen. To achieve 
this, we generated a library of DNA vectors encoding 541 GFP-tagged kinases and 108 GFP-
tagged phosphatases and transfected these vectors into human embryonic kidney HEK293T 
cells. Single-cell signaling states were determined by simultaneous measurement of 30 
phosphorylation sites known to be involved in regulation of growth, proliferation, survival, and 
stress signaling pathways. Over 10 million individual cells were analyzed in the 659 
overexpression conditions with or without 10-minute EGF stimulation, averaging approximately 
7,000 measured cells per sample. Assessing the dependence of each measured 
phosphorylation site on kinase or phosphatase abundance using BP-R2, a measure to quantify 
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signaling relationships in single cell analysis (Lun et al., 2017), we identified 1,323 pairs of 
strong signaling relationships (determined using 108 control experiments). This analysis 
enabled a functional classification of human kinases and phosphatases based on their 
abundance-dependent impacts on the signaling network. Furthermore, 208 pairs of previously 
unknown signaling relationships were identified when compared to the OmniPath database 
(Türei et al., 2016). By characterizing signaling response dynamics in a follow-up 1-hour EGF 
stimulation time course, we demonstrated ligand-independent MAPK/ERK activation induced by 
tyrosine kinase overexpression. We found that in melanoma A375 cells this activation gives rise 
to BRAFV600E inhibitor resistance. Our screen also revealed that overexpression of ERK-specific 
phosphatases sustained cell proliferative signals. We confirmed this pro-cancer signaling 
response using a novel kinase-phosphatase combinatorial overexpression assay.  
 
Results 
Analysis of the human kinome and phosphatome to study the overexpression effects on 
signaling network states 
Protein abundance variance is often observed in tumors as heterogeneous genomic 
abnormalities accumulate (Du and Elemento, 2015). We observed up to 50-fold differences in 
kinase and phosphatase mRNA expression levels among tumor samples in bulk measurements 
(Figure S1A). This inter-tumoral heterogeneity presumably results in highly variable signaling 
network states and responses to stimuli or treatments. In addition, a high degree of intra-tumoral 
expression heterogeneity further challenges cancer therapeutic interventions (McGranahan and 
Swanton, 2017; Patel et al., 2014). To understand the signaling network modulation in cells that 
overexpress a defined kinase or phosphatase at various levels, we applied our abundance-
dependent signaling network measurement system (Lun et al., 2017) in a kinome- and 
phosphatome-wide screen.  
 
We cloned open reading frames (ORFs) from the human kinase library (Johannessen et al., 
2010) and the human phosphatase library into a vector, enabling expression of GFP-tagged 
proteins (Couzens et al., 2013). The generated 541 kinase and 108 phosphatase expression 
clones were transiently transfected into HEK293T cells, individually. Unstimulated cells and cells 
stimulated for 10 minutes with EGF were harvested and processed with a 126-plex barcoding 
strategy (adapted from Bodenmiller et al., 2012; Zunder et al., 2015) for simultaneous antibody 
staining and multiplexed mass cytometry measurement (Figure 1A).  
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Transient transfection generates a gradient of the GFP-tagged protein of interest (POI) 
expression levels with a range of up to 103-fold enhancement relative to endogenous POI 
expression range (Lun et al., 2017). The abundance variation of each overexpressed kinase or 
phosphatase was quantified by mass cytometry with detection by a metal-conjugated anti-GFP 
antibody. In addition, we simultaneously quantified 30 phosphorylation states of proteins 
involved in key cancer-related signaling pathways, including the AKT, PKC, STAT, MAPK/ERK, 
and stress pathways, and five non-signaling markers to indicate cell physiological states (Table 
S1). Relationship strength between the abundance of GFP-tagged POI and a measured 
phosphorylation site was quantified by the binned pseudo-R2 (BP-R2) method (Lun et al., 2017). 
 
We analyzed 108 control samples (FLAG-GFP overexpression or untransfected cells) and used 
the highest BP-R2 score (0.13) of all controls as the cutoff to consider a signaling relationship as 
“strong”. In total, our human kinome and phosphatome analysis detected 1,323 pairs of strong 
relationships between POIs and phosphorylation sites (Figure 1B). Among the 649 kinases and 
phosphatases, 327 had at least one strong signaling relationship (BP-R2 > 0.13) to the cancer-
related signaling network when overexpressed. Of these, 245 had narrow influences with 
modulation of one to five signaling nodes, and 26 overexpressed proteins had broad effects on 
the network with more than ten of measured phosphorylation sites influenced (Figure S1B). We 
identified 52 kinases or phosphatases that specifically regulated the AKT pathway when 
overexpressed. Of the 132 POIs that had abundance-dependent effects on the MAPK/ERK 
pathway, the majority (104 proteins) also initiated cellular stress responses. We also identified 
49 proteins that impacted all of the measured signaling pathways, including 11 receptor proteins 
(e.g., MET, FGFR1, and PDGFRA), and many MAPK cascade activators (e.g., MAP4K1, 
MAP4K2, and MAP4K5) (Figure 1C). 
 
Functional classification of kinases and phosphatases based on signaling network 
modulations 
Our kinome and phosphatome screen characterized effects induced by hundreds of POIs on 30 
phosphorylation sites in the cancer-related signaling network with and without EGF stimulation 
(a total of 60 parameters), yielding an unprecedented view on the effects of each kinase and 
phosphatase. We indicated the sign for signaling relationships (according to their directionality) 
to the BP-R2, generating signed-BP-R2 scores that were used for subsequent analyses (Table 
S2, Methods). To understand the regulatory and functional similarity of overexpressed POIs, we 
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first applied the dimensional reduction algorithm t-SNE (Maaten and Hinton, 2008) to the matrix 
of all 60 measured signaling parameters (as signed-BP-R2 scores) over the 327 signaling 
network-influential kinases and phosphatases (Figure 1D). As expected, homologous groups 
(paralogs) of kinases and of phosphatases showed nearly identical influences on signaling and 
overlapped with each other on the t-SNE plot (Figure 1D, green boxes). This demonstrates that 
our method sensitively, specifically, and reproducibly detected abundance-modulated signaling 
behaviors. Interestingly, all the eight overexpressed SRC family members, SRC, YES1, BLK, 
LCK, LYN, HCK, FGR, and FRK, co-localized in the t-SNE analysis (Figure 1D, purple box), 
indicating that these kinases have similar functions despite the previously revealed differential 
patterns of expression (Parsons and Parsons, 2004). Members of protein tyrosine phosphatase 
(PTPN1, PTPN2, and PTPN5) and dual-specificity phosphatase (DUSP3, DUSP4, DUSP6, 
DUSP7, DUSP10, and DUSP16) families were grouped together, suggesting similarities in 
regulating the measured cancer signaling network (Figure 1D, orange box).  
 
We then applied hierarchical clustering based on signed-BP-R2 scores of all measured 
phosphorylation sites (Figure S1C) to analyze functional similarities among all kinases and 
phosphatases. Based on this analysis we identified 10 major signaling response clusters (color-
coded on the t-SNE plot in Figure 1D). Correspondence analysis was performed between these 
identified clusters and the previously described classes of kinases and phosphatases based on 
their sequences of the catalytic domain (Johannessen et al., 2010; Sacco et al., 2012a) (Figure 
S1D). In certain cases, proteins with partial sequence identity had similar influences on 
signaling. For example, all kinases in cluster 1 were receptor or non-receptor tyrosine kinases 
(Figure S1D). These kinases were early responders to stimuli, with pleiotropic functions in the 
signaling networks, as shown in the literature-based graph of canonical EGFR networks (Figure 
1E). Clusters 5, 9, and 10 include non-receptor serine/threonine kinases and kinases classified 
in the group of “other” (i.e., kinases do not fit into any of the major groups) (Figure S1D). 
Despite conserved catalytic domain sequences, kinases in clusters 5, 9, and 10 induced 
different cellular responses (Figure 1E). Overexpression of members in cluster 5 activated the 
PDK1/AKT pathway. Cluster 10 kinases had positive signaling relationships to p90RSK 
(Ser380), p70S6K (Thr389), PDK1 (Ser241), and MEK1/2 (Ser221) as well as many STAT 
proteins. Overexpression of cluster 9 components affected proteins involved in the stress 
response, including MKK4/7 (Ser257/Thr261), p38 (Thr180/Tyr182), and JNK (Thr183/Tyr185). 
Cluster 9 kinases, when overexpressed, also weakened signaling relationships to MAPK/ERK 
pathway members, such as MEK1/2 (Ser221), ERK1/2 (Thr202/Tyr204), and p90RSK (Ser380) 
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after EGF stimulation (Figure 1E). Cluster 7 proteins had negative relationships with the 
signaling mediators of MAPK/ERK pathway when cells were treated with EGF (Figure 1E). 
Cluster 7 mostly consists of protein tyrosine phosphatases, but also includes a few proteins 
from the classes of non-receptor serine/threonine kinase and lipid kinases (Figure S1D). 
Clusters 2, 3, and 4 consist of kinases and phosphatases from multiple sequence-based 
classes (Figure S1D). This suggests that these proteins induce similar signaling outcomes 
despite the differences in catalytic domain sequences. In summary, the human kinome- and 
phosphatome-wide overexpression analysis identified 10 clusters of kinases and phosphatases 
that partially matched the sequence-based classification. Distinct signaling patterns were found 
for each cluster. 
 
Functional enrichment analysis for identified kinase and phosphates clusters 
Our analysis indicated that kinases and phosphatases with different catalytic domain sequences 
could impact signaling networks similarly when overexpressed. To understand this, we 
performed functional enrichment analysis using the STRING database (Szklarczyk et al., 2017) 
on the 10 identified clusters (Figure 1D and 2A). We found that seven of the 10 clusters had 
significant functional enrichment (p < 0.01, Table S3, statistical details in Methods). For each of 
these clusters, the top five specific functions are shown (Figure 2A). Physical and functional 
interaction enrichments are shown as protein-protein association networks for clusters 1 and 7 
as examples in Figures 2B and 2C and for all other clusters in Figure S2.  
 
As expected, proteins in cluster 1 are enriched for membrane and non-membrane tyrosine 
kinases with autophosphorylation ability (Figure 2B) with the significance being robust after the 
removal of redundancy (homology) effects (Table S3, Methods). Although these kinases are 
closely associated (Figure 2B), we did not find significantly enriched terms for specific signaling 
pathways or physiological functions (Table S3). Given that all tyrosine kinases of this group 
generate highly similar signaling events in the measured network (Figure S1C), other factors 
such as their expression patterns or regulatory protein complexes likely drive their diverse 
functions in regulating cell phenotypes.  
 
Cluster 7 is enriched for protein tyrosine phosphatases that negatively regulate MAPK pathways. 
Intriguingly, several kinases are present in this cluster as well, including KSR1 and ARAF, which 
have similar negative regulatory effects on the MAPK/ERK signaling pathway (Figure 2C). 
KSR1 and ARAF are core components of the KSR-RAF dimeric protein complex that 
86 
 
transduces signal in the MAPK/ERK cascade (Lavoie and Therrien, 2015). Overexpressing one 
subunit of this protein complex might result in competitive inhibition, diminishing the downstream 
signal activities in a similar manner as phosphatase overexpression. These analyses 
demonstrated that proteins with different catalytic functions can mediate highly related signaling 
responses when overexpressed.  
 
Other clusters were enriched for homologous kinases (clusters 5 and 10) and the protein 
phosphatase type 2A complex (cluster 2) (Figure S2). We also found that certain kinases 
associated with the same signaling pathway modulated the measured network differently when 
overexpressed (Figure S2). Examples are MAPK1 (cluster 6) and RPS6KA1 (cluster 10), which 
regulate the MAPK/ERK pathway, and PDPK1 (cluster 10) and AKT1 (cluster 4), which regulate 
the PDK1/AKT pathway. These results suggest that kinase overexpression impacts signaling 
networks differently to direct kinase activation. Thus, variances in overexpression-induced 
signaling network modulation are not fully explained by the catalytic functions of kinases and 
phosphatases. In cells, signaling pathway activity is determined not only by phosphorylation but 
also by many intrinsic factors, such as protein subcellular localization and protein complex 
formation. 
 
Detecting novel signaling relationships from the kinome- and phosphatome-wide 
analysis 
The functions of many kinases and phosphatases analyzed in our screen are unknown or only 
poorly characterized. We therefore hypothesized that our global analysis could lead to the 
identification of novel signaling relationships. To assess this, we performed a systematic 
comparison between all identified overexpression-induced signaling relationships and records in 
OmniPath, an integrated database of literature-curated signaling interaction information (Türei et 
al., 2016). We first mapped all pairs of relationships to the OmniPath signaling network, then 
computed the signed, directed paths for each pair of relationship (Krumsiek et al., 2011; Perfetto 
et al., 2016). The distance between an overexpressed protein and a measured phosphorylation 
site is represented by the length of the path (Figure 3A). For example, a distance of zero 
indicates the relationship between the overexpressed POI and its own phosphorylation levels. 
Of 14 pairs of signaling relationships with a known distance of zero, with and without 10-minute 
EGF stimulation, 12 had strong BP-R2 values (Figure 3A), revealing that the phosphorylation 
abundance of kinases is often determined by their own expression level, even in the absence of 
additional perturbation. 
87 
 
 
We detected 208 (16%) strong relationships (BP-R2 > 0.13) with infinite distance (Figure 3A, 
Table S4), indicative of connections not described previously. In total, 93 overexpressed POIs 
contributed to these signaling relationships, which were enriched (in absolute count) in clusters 
2, 3, and 4, and to a less extend in cluster 6 (Figure 3B). We did not detect any relationship with 
infinite distance in clusters 9 and 10 (Figure 3B); POIs from these clusters participate in MAPK 
signal transduction (Figure 2A), which is one of the best studied signaling pathways. We also 
assessed the distribution of infinite paths for each sequence-based kinase and phosphatase 
class and did not detect any enrichment (Figure S3A). There were also 132 pairs of strong 
relationships between proteins with length of signed directed path above three in OmniPath, 
suggesting potentially undiscovered direct or short-range connections (Figure 3A). 
 
Many of the identified novel signaling relationships (i.e., those with infinite path length) and the 
associated POIs were related to disease and to newly identified kinases (Figures 3C, 3D, S3B, 
and S3C). For instance, RIOK2 (highlighted in Figure 3C) has been recently shown to correlate 
with poor prognosis of patients with non-small cell lung cancer, but the underlying signaling 
mechanisms are unclear (Liu et al., 2016). We discovered that RIOK2 overexpression impacted 
several phosphorylation sites, most strongly Thr172 on AMPKα, Ser257/Thr261 on MKK4/7, 
and Thr180/Tyr182 on p38 (Figure 3C), indicating the activation of the AMPK/p38 axis upon 
RIOK2 overexpression. The AMPK/p38 axis regulates cellular energy metastasis, contributing to 
cancer cell survival in nutrient-deficient conditions (Chaube et al., 2015; Zadra et al., 2015). We 
also found that MGC42105 (NIM1K) (highlighted in Figure 3D), a newly identified kinase in 
cluster 5, regulated the AKT pathway. Overexpression of MGC42105 altered phosphorylation of 
Ser241 on PDK1, Thr389 on p70S6K, and Ser235/Ser236 on S6. Overexpression of 
MGC42105 also contributed to the activation of stress pathways, as strong relationships to p-
p53 (Ser15) and p-AMPKα (Thr172) were observed (Figure 3D). In summary, mapping our 
identified signaling relationships to the OmniPath database enabled the identification and 
assignment of novel signaling functions to many kinases and phosphatases. We also reveal 
potential novel signaling mechanisms associated with poor prognosis of cancer patients (e.g., 
for RIOK2). 
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In-depth analysis of signaling dynamics reveals overexpression-dependent MAPK/ERK 
activity 
Signaling dynamics are essential for understanding of diseased signaling circuits within a 
network and in the prediction of drug efficiency (Du and Elemento, 2015; Hughey et al., 2009). 
We have previously shown that altering expression levels of central signaling proteins in the 
EGFR signaling network results in complex changes in network dynamics (Lun et al., 2017). 
Given the key role of signaling dynamics on cell proliferation, growth, and differentiation 
(Koseska and Bastiaens, 2017), we systematically evaluated kinases and phosphatases from 
the 10 identified clusters for overexpression-induced signaling dynamic modulations. We 
calculated the differences in signed-BP-R2 scores between the EGF-stimulated (10 min) and 
unstimulated conditions to identify cases in which overexpression modulates signaling dynamics 
(i.e., the strength and the shape of abundance-dependent signaling relationship changes 
between the unstimulated and the 10-minute EGF stimulated conditions). We found that POIs in 
clusters of 1, 6, 7, 9, and 10 strongly modulated signaling network dynamics when 
overexpressed (Figure S4A). We then analyzed the overexpression effects of the 39 strongest 
signaling dynamics influential POIs (criteria described in Methods) over a 1-hour EGF 
stimulation time course in depth (Figures 4 and S4). The dynamic responses of all measured 
phosphorylation sites are shown in Figure 4A. Features of the signaling dynamics, such as 
signaling amplitudes and peak times (see Methods) are shown in Figures S5 and S6.  
 
Hierarchical clustering of the overexpression-induced EGFR signaling dynamics of the 39 
selected proteins revealed six groups (Figure 4A). Each of these six groups typically reflected 
one or two of the 10 major signaling response clusters identified in the previous sections (Figure 
1D); the correspondence is shown in Figure S4B. Signaling network responses for one 
representative kinase or phosphatase from each of the six identified groups are illustrated in 
Figure 4B. Interestingly, the EGF stimulation-influenced relationships were mostly observed for 
phosphorylation sites within the MAPK/ERK signaling cascade, including p-MEK1/2 (Ser221), p-
ERK1/2 (Thr202/Tyr204), p-p90RSK (Ser380), and p-S6 (Ser235/Ser236), rather than AKT, 
PKC, STAT, or stress response pathways (Figure 4A). Given that the MAPK/ERK is the major 
proliferative pathway that is known to be involved in tumor progression and drug response, we 
focused our subsequent analyses on this pathway to identify novel regulatory mechanisms 
potentially relevant to cancer. 
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EGFR overexpression (as an example of group B) mediated activation of the MAPK/ERK 
pathway (Figure 4B), multiple STAT kinases, PLCγ2, and the stress signaling pathways. 
Phosphorylation of Thr202/Tyr204 on ERK1/2 was elevated in cells with high levels of GFP-
tagged EGFR in the absence of EGF stimulation (Figure 4C). These cells responded weakly to 
EGF stimulation, indicating ligand-independent ERK activation (Figures 4C and S5B). 
Overexpression of other members of group B, including MST1R, MET, FGFR1, TYRO3, TEC, 
and ABL1, influenced signaling dynamics of p-ERK1/2 and p-90RSK in a manner similar to that 
of EGFR overexpression (Figure 4A). These proteins correspond to the global cluster 1 (Figure 
S4B), and members of this class mediate oncogenic signaling for many cancer types (Duan et 
al., 2016; Paul and Mukhopadhyay, 2004; Salgia, 2017). Taken together, this suggests that 
ligand-independent MAPK/ERK signaling activation causes uncontrolled cell proliferation.  
 
Interestingly, in the absence of EGF stimulation, overexpression of phosphatases DUSP4 (from 
group E) and PTPN2 (from group F) did not affect levels of phosphorylation in the MAPK/ERK 
pathway (Ser221 on MEK1/2, Thr202/Tyr204 on ERK1/2, or Ser380 on p90RSK) (Figures 4B, 
4D-4G, S4C, and S4D). This suggests either a mechanism compensates for phosphatase 
overexpression to maintain basal MAPK/ERK signaling or the overexpressed phosphatases are 
inactive without EGF stimulation. Upon EGF stimulation, signaling dynamics on phosphorylation 
sites of the MAPK/ERK pathway were modulated by DUSP4 and PTPN2 in an abundance-
dependent manner, as negative signaling relationships to p-ERK1/2 and p-p90RSK were 
detected (Figures 4B, 4D, 4E, S4C and S4D). DUSP4 or PTPN2 overexpression also resulted in 
reduced signaling amplitudes on p-ERK1/2 and p-p90RSK (Figure S5C). Intriguingly, different p-
MEK1/2 dynamics were observed in cells overexpressing these two phosphatases. There was a 
strong positive relationship between GFP-tagged DUSP4 and p-MEK1/2 beginning at 10 
minutes after EGF addition (signed-BP-R2 = 0.23) with relationship strength constantly 
increasing until the 30-minute time point (Figure 4F), indicating a more sustained MEK1/2 
phosphorylation in cells with higher levels of DUSP4 than in cells with lower DUSP4 expression. 
In contrast, a negative relationship between GFP-tagged PTPN2 and p-MEK1/2 was observed 
during EGF stimulation with a strong relationship at the 5-minute (signed-BP-R2 = -0.23) and 10-
minute (signed-BP-R2 = -0.14) time points (Figure 4G). DUSP4 is known to selectively de-
phosphorylate ERK1 and ERK2 (Guan and Butch, 1995). Our data indicate that during EGF 
stimulation, DUSP4 overexpression diminishes ERK1/2 phosphorylation, and, in turn, the 
negative feedback from ERK1/2 to MEK1/2 is likely attenuated, resulting in constant activation 
of MEK1/2. Substrates of PTPN2 are primarily membrane kinases including EGFR (Mattila et al., 
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2005). Overexpression of PTPN2, therefore, downregulates activation states of all measured 
signaling proteins known to be downstream of EGFR, including MEK1/2 and ERK1/2 (Figure 4h). 
Systematic analysis of all overexpressed phosphatases over the 1-hour time course after EGF 
addition confirmed that all other phosphatases in group E (DUSP6, DUSP7, DUSP10, DUSP16, 
PTPN5, and PTPN7) target phosphorylation sites of Thr202/Tyr204 on ERK1/2, thereby 
decreasing the negative feedback from ERK1/2 to MEK1/2 and causing sustained MEK1/2 
activation (Figures 4A and 4H).  
 
In conclusion, these signaling dynamic analyses indicate that first, overexpression of tyrosine 
kinases including EGFR induce EGF ligand-independent MAPK/ERK signaling activation. 
Second, phosphatases differentially regulate MAPK/ERK signaling responses determined by 
their substrate specificities. Third, the ERK-specific phosphatases control the strength of the 
negative feedback loop from ERK1/2 to MEK1/2 in an abundance-dependent manner. 
 
Pairwise overexpression analysis reveals phosphatase sustains the kinase-induced 
MAPK/ERK signaling 
Phosphatase overexpression is oncogenic in different tumor types, but the signaling 
mechanisms remain unclear (Julien et al., 2007, 2011). Recent work indicates that 
overexpressed phosphatases increase the malignancy of cancers that have a hyper-activated 
MAPK/ERK pathway (Julien et al., 2007; Low and Zhang, 2016; De Vriendt et al., 2013). Our 
result in the previous section suggested a mechanism through which overexpression of ERK-
specific phosphatases sustains MEK phosphorylation levels (Figures 4F and 4H). To assess 
whether an additional, secondary signaling input that increases MAPK pathway activity could 
lead to oncogenic-like signaling, we developed a combinatorial transfection assay in which 
overexpression of a kinase and a phosphatase were detected via a FLAG-tag and a GFP-tag, 
respectively, providing a two-dimensional analysis of abundance-dependent signaling 
modulation on the single cell level (Figure 5A). Using this approach, we analyzed the MAP2K2, 
MAPK1, and RPS6KA1 (also known as MEK2, ERK2, and p90RSK1) kinases, and the DUSP4, 
DUSP7, and PTPN2 phosphatases in nine combinations of double overexpression over a 1-
hour EGF stimulation time course (Figure 5B). After measurement, we subdivided cells 
according to the expression levels of the FLAG-tagged kinase and GFP-tagged phosphatase 
into 25 bins within the two-dimensional overexpression space. For each bin, signaling states as 
defined by phosphorylation levels, and signaling trajectories with respect to all individual bins 
over the 1-hour EGF time course were analyzed. 
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When overexpressed individually, we observed that DUSP4 overexpression sustained the 
phosphorylation of Ser221 on MEK1/2 over the 1-hour EGF stimulation time course likely due to 
the weakened ERK to MEK negative feedback (Figures 5C and 5D). MAP2K2 (MEK2)-FLAG 
overexpression led to an increased MEK1/2 phosphorylation (Figure 5C). Interestingly, 
combined signaling inputs from MAP2K2-FLAG and DUSP4-GFP co-overexpression further 
increased the hyper-activated states of MEK1/2 over the 1-hour EGF stimulation time course 
compared to the activation induced by MAP2K2-FLAG overexpression alone (Figures 5C-5E, 
brown arrow). Moreover, in cells with simultaneously overexpressed MAP2K2-FLAG and 
DUSP4-GFP, the downstream ERK1/2 phosphorylation on Thr202 and Tyr204 were inhibited 
(Figures 5C-5E). Highly activated MEK1/2 could lead to ERK-independent oncogenic-like 
signaling as revealed previously (Burgermeister and Seger, 2008; Takahashi-Yanaga et al., 
2004). In contrast, double overexpression of MAP2K2-FLAG and PTPN2-GFP (the latter a 
phosphatase targeting EGFR) did not sustain the MEK1/2 signaling; rather, it dampened the 
MEK1/2 signaling amplitudes in response to EGF stimulation (Figure S7). 
 
Overexpression of FLAG-tagged MAPK1 (ERK2) drastically augmented ERK1/2 
phosphorylation state during EGF stimulation (Figure 5F), increased p-ERK1/2 amplitudes, and 
delayed p-ERK1/2 peak times (Figure 5G). These results are in agreement with findings of 
previous studied MAPK1 overexpression effects (Lun et al., 2017). The simultaneous 
overexpression of MAPK1-FLAG and DUSP7-GFP decreased p-ERK1/2 levels at all time points 
and reduced the signaling amplitudes. Further, DUSP7 delayed p-ERK1/2 peak times upon 
EGF stimulation: in cells with the highest MAPK1 abundance and mid-level overexpression of 
DUSP7, ERK1/2 phosphorylation peaked at 30 minutes after EGF addition (Figures 5F and 5G, 
purple arrow), whereas in untransfected cells, p-ERK1/2 peaked at the 5-minute time point 
(Figures 5F and 5G). As expected, DUSP7 overexpression also resulted in constant MEK1/2 
phosphorylation (Figures 5F and 5G, green arrow). Compared to cells only overexpressing 
MAPK1 (ERK2), which induced strong but transient ERK activation, the additional low-to-mid 
levels of DUSP7 decreased the ERK1/2 phosphorylation amplitude and partially limited the 
negative feedback signal from ERK to MEK, inducing a sustained MEK activation and prolonged 
ERK signal. 
 
Assessing signaling responses in the pairwise overexpression assay, we demonstrated kinase 
and phosphatase coregulatory mechanisms in the MAPK/ERK cascade. We confirmed that 
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phosphatase overexpression does not dampen signaling activity at the steady states, even with 
activated oncogenic signaling. Further, our analysis indicates that the overexpression of certain 
phosphatases, such as DUSP4 and DUSP7, lead to sustained activation of ERK due to the 
reduced negative feedback strength. This mechanism might underlie the pro-cancer effects of 
phosphatase overexpression. 
 
Signaling relationship to p-ERK1/2 predicts overexpression-induced vemurafenib 
resistance in melanoma A375 cells 
As protein overexpression has been correlated with drug resistance of cancer cells 
(Johannessen et al., 2010; Shaffer et al., 2017), we next sought to determine whether our 
kinome- and phosphatome-wide signaling network profiles could identify kinases or 
phosphatases that, when overexpressed, induce drug resistance; these enzymes can be 
potential biomarkers of drug resistance. In melanoma cells carrying the BRAFV600E mutation, 
overexpression of certain kinases is associated with de novo or acquired resistance to RAF 
inhibition; Johannessen et al. has identified nine kinases that drive resistance when 
overexpressed in a cell-based assay (Johannessen et al., 2010). Eight of these proteins were 
analyzed in our screen, and interestingly, six had abundance-dependent signaling modulations 
to p-ERK1/2 (Thr202/Tyr204) in unstimulated cells (Figure S8A). The 10-minute EGF 
stimulation reduced relationship strengths for each of these six kinases (Figure S8B), indicating 
that these overexpression-related ERK activations were ligand-binding independent (i.e., cells 
with high POI-GFP levels did not respond to EGF stimulation, Figure 4C). These data suggest 
that overexpression of kinases that induce ligand-independent MAPK/ERK pathway activation 
might underlie resistance to BRAFV600E-targeted inhibitors.  
 
To determine whether signaling relationships to p-ERK1/2 in our kinome- and phosphatome-
wide analysis have potential as biomarkers for drug resistance, we examined kinases in our 
screen with the highest signed-BP-R2 values in relation to p-ERK1/2 in the absence of EGF 
stimulation, including ABL1, BLK, FES, MAP3K2, MAP3K8, MOS, NTRK2, SRC, and YES1. 
These kinases, and MEK1DD as positive control, were overexpressed in A375 cells that express 
BRAFV600E. Cells were subsequently treated for 48 hours with the BRAFV600E inhibitor 
vemurafenib or DMSO as a control (Figure 6A, all experiments performed in three replicates). In 
A375 cells, the BRAF substrate MEK1/2 is activated and basal levels of p-ERK1/2 are high. As 
expected, overexpression of MEK1DD, which constitutively phosphorylates Thr202 and Tyr204 
on ERK1/2 (Johannessen et al., 2010; Lun et al., 2017), only slightly enhanced ERK1/2 
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phosphorylation in cells treated with DMSO (Figure 6B). A weak signaling relationship was 
observed between GFP-tagged MEK1DD and p-ERK1/2 with a signed-BP-R2 of 0.11 (Figure 6B, 
left). Compared to the DMSO control, treatment with vemurafenib inhibited BRAFV600E activity 
and reduced p-ERK1/2 levels in untransfected cells and in cells with low MEK1DD expression 
levels. However, cells with high levels of MEK1DD were insensitive to vemurafenib, such that 
hyper-phosphorylated ERK1/2 remained after the 48-hour treatment (signed-BP-R2 value of 
0.53, Figure 6B, right). In the control cells without MEKDD overexpression, the effect of 
vemurafenib on p-ERK1/2 levels did not alter signaling relationships as quantified by signed-BP-
R2 (Figures S8C and S8D).  
 
Similar as observed in cells overexpressing GFP-tagged MEK1DD, vemurafenib treatment also 
increased signaling relationships between all our analyzed GFP-tagged kinases (ABL1, BLK, 
FES, MAP3K2, MAP3K8, MOS, NTRK2, SRC, and YES1) and p-ERK1/2 (Figure 6C). A closer 
inspection of the signed-BP-R2 signaling strength of cells treated for 48 hours with vemurafenib 
and DMSO-treated cells showed that eight of the nine tested kinases had higher values than 
those of negative controls (Figure 6D). These results indicate that overexpression of ERK-
activating kinases limits the effects of vemurafenib in reducing p-ERK1/2 signaling, similarly as 
the MEKDD positive control. 
 
To assess the survival of cells with different expression levels of each kinase, we assigned each 
single cell into one of four bins based on the abundance of GFP-tagged POI and calculated the 
percentage of the number of cells in each bin relative to the total cell count (Figure 6B). As 
expected, the positive control cells that expressed MEK1DD-GFP had significant cell enrichment 
in the fourth bin (i.e., the bin with the highest expression level of the GFP-tagged POI), with four 
times higher percentage of cells at this level after 48 hours of vemurafenib treatment compared 
to the DMSO-treated control (Figure 6E). Similarly, all nine examined kinases showed 
enrichment of cell abundance in the fourth bin: in six cases, this enrichment was statistically 
significant (Figure 6E). 
 
These results indicate that, in melanoma A375 cells, overexpression of kinases capable of 
ligand-independent ERK activation reduces cellular dependency on signaling inputs from 
BRAFV600E for proliferation, rendering the cells less sensitive to the BRAFV600E inhibitor 
vemurafenib (Figure 6F). In the absence of inhibitor, however, cells overexpressing ERK-
activating POIs do not acquire proliferative advantage (Figure 6F). As has been shown 
94 
 
previously, the hyperactivity of ERK induces cell senescence and apoptosis (Cagnol and 
Chambard, 2010; Xu et al., 2014). Our kinome and phosphatome screen detected 54 POIs that, 
when overexpressed, caused EGF-independent ERK activation (Table S5). These proteins can 
potentially be used as biomarkers to predict resistance to BRAFV600E inhibitors in melanoma 
patients carrying BRAF mutations.  
 
Discussion 
The data described here are unique for the broad coverage of the human kinome and 
phosphatome, the multiplexed measurement of cellular phosphorylation states and dynamics at 
single-cell resolution, and the wide abundance range (over three orders of magnitude) over 
which proteins of interest were studied. Our analyses enabled protein abundance-determined 
functional classification, signaling kinetics quantification, and the identification of potential 
biomarkers of drug resistance. 
 
Extending our previously established approach (Lun et al., 2017) for analysis of the dependence 
of signaling behaviors on protein expression levels to the human kinome and phosphatome, we 
transiently transfected a library of 649 plasmids encoding GFP-tagged kinases and 
phosphatases individually into HEK293T cells, yielding gradient overexpression levels for each 
GFP-tagged POI. The abundance of each overexpressed kinase or phosphatase was quantified 
simultaneously with 30 cancer-related phosphorylation sites and five non-signaling markers 
(Table S1) using a mass cytometry-based multiplexed single-cell assay. Signaling states and 
dynamics over the expression continuum for every analyzed POI were comprehensively profiled. 
We applied the recently developed statistical measure, BP-R2, to quantify signaling strength 
between each GFP-tagged POI and each measured phosphorylation site (Lun et al., 2017) and 
classified all overexpressed kinases and phosphatases based on their abundance-determined 
signaling network states with or without 10-minute EGF stimulation.  
 
Protein abundance and mRNA expression levels of kinases and phosphatases have been 
quantified in normal and diseased tissues by multiple approaches (Petryszak et al., 2016; Uhlen 
et al., 2017; Wang et al., 2015). Our analysis, for the first time, characterized at kinome- and 
phosphatome-wide scope how these proteins differentially modulate network behaviors when 
expressed over a concentration gradient. In the overexpression effect-based functional 
classification, we assigned kinases and phosphatases into 10 clusters, each with a distinct 
95 
 
function in signaling transduction. These clusters only partly agreed with the kinase and 
phosphatase classes based on their sequence of catalytic domain, indicating the dissimilar 
network alterations between signaling protein overexpression and activation. Sequence-based 
classification considers the catalytic specificities of kinases and phosphatases. However, by 
altering the signaling protein expression levels (or concentration), dynamics of both upstream 
and downstream signaling events, and the assembly of multiprotein complexes can be 
modulated, resulting in more complicated network changes.  
 
Interestingly, our kinase and phosphatase classification and the functional enrichment analysis 
suggest that kinases, such as KRS1 (a pseudo-kinase) and ARAF, negatively regulate 
MAPK/ERK signaling when overexpressed, similarly to many tyrosine phosphatases (Figures 
1D, 2A, and 2C). In the MAPK/ERK cascade, dimerization between KSR proteins (KSR1 and 
KSR2) and RAF proteins (ARAF, BRAF, and CRAF), is required for the activation of the 
downstream kinase MEK (Lavoie and Therrien, 2015; Rajakulendran et al., 2009). 
Overexpressing either of KSR1 or ARAF leads to competitive protein binding that disrupts the 
formation of the dimeric protein complex. Interestingly, cells with CRAF (also known as RAF1) 
or KSR2 (both in cluster 6) overexpression showed less degree of MAPK/ERK signaling 
attenuation (Figure S1C), compared to those with KSR1 or ARAF overexpression. This 
suggests the differential capability of individual RAF proteins or KSR proteins in forming 
homodimers that can compensate overexpression-induced signaling disruption. 
 
Phosphatase overexpression is observed to drive tumor progression with unclear signaling 
mechanisms (Julien et al., 2011; Low and Zhang, 2016; De Vriendt et al., 2013). We indicated 
that rather than directly activating a cancer-driven signaling pathway, overexpression of ERK-
specific phosphatases modulates signaling dynamics that leads to prolonged proliferative signal 
in cells. Phosphatases have been suggested in many recent studies as potential therapeutic 
targets (Bollu et al., 2017; Julien et al., 2011; Low and Zhang, 2016). Our result indicates again 
the importance of developing phosphatase inhibitors for cancer treatment. 
 
Following a pilot kinome study on overexpression-related resistance to RAF inhibition 
(Johannessen et al., 2010), we discovered that ligand-independent ERK activation induced by 
kinase overexpression to be the underlying signaling mechanism leading to above drug 
resistance. Our kinome and phosphatome analysis further identified 54 proteins that caused 
ligand-independent ERK activation when overexpressed. These proteins were then suggested 
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as potential biomarkers for RAF inhibitor resistance. Mass cytometry-based single cell analysis 
enables identifying differed signaling responses to a drug treatment in rare cell populations. It is 
therefore more sensitive in identifying biomarkers for overexpression-induced drug resistance, 
compared to the previous population-based assay (Johannessen et al., 2010). Our data can be 
further used to reveal signaling mechanisms in diseased cellular behaviors that are caused by 
kinase or phosphatase overexpression. Then, following the discovered pathological signaling 
behaviors, more biomarkers can be identified for the given disease, based on our kinome- and 
phosphatome-wide analysis. 
 
Our analysis has several limitations. First, the measured overexpression effects can be indirect 
(i.e., a protein overexpression might lead to cellular stress that activates MAPK/p38 and 
MAPK/JNK cascades). However, indirect effects are also important signaling responses that 
can be indicative for any cells with such overexpression. Second, our mass cytometry-based 
analysis applies pre-selected antibodies targeting 30 specific phosphorylation sites that does 
not capture all signaling responses induced by overexpression of a kinase or a phosphatase. 
Nevertheless, our antibody panel is designed based on literature information to cover the most 
critical and informative phosphorylation sites in the cancer-related signaling network. Third, the 
GFP-tag can potentially disrupt the function of a kinase or phosphatase. Likely, a non-functional 
protein does not induce specific signaling network modulation and should therefore yield weak 
BP-R2 values (≤ 0.13) only.  
 
In summary, we demonstrated, in the human kinome- and phosphatome-scale analysis, how 
overexpression of each signaling protein modulates signaling networks in an abundance-
dependent manner. This establishes that protein expression levels can result in different 
signaling states in a heterogeneous population. Our analysis expands the functional 
classification of the human kinases and phosphatases, and suggests 208 novel signaling 
relationships that can be interrogated to improve our understanding of signaling causality and 
network structure. We showed novel oncogenic-like signaling mechanisms and identified cancer 
biomarkers with our analysis. Our data are also suitable for the inference of signaling pathway 
kinetics using mathematical models and for the development of network reconstruction methods. 
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Figure Legend 
Figure 1. Kinome and phosphatome-wide screen for effects of protein abundance on 
signaling states and dynamics.  
A, The experimental workflow: ORFs of 541 human kinases and 108 human phosphatases 
were cloned into a vector to enable expression of GFP-tagged fusion proteins upon transient 
transfection into HEK293T cells. Cells with or without 10-minute EGF stimulation were 
harvested, barcoded, and stained with antibody mix before mass cytometry-based single cell 
analysis. B, Plot of counts vs. BP-R2 values for control and experimental samples. Cut-off value 
was determined by analysis of the BP-R2 values in all control samples. C, Venn diagram 
showing the quantification of POIs with abundance-dependent influences on the AKT pathway 
(p-PDK1, p-GSK3β, β-catenin, p-mTOR, p-p70S6K, p-4EBP1, and p-S6), MAPK/ERK pathways 
(p-RAF, p-MEK1/2, p-ERK1/2, p-p90RSK, p-CREB, and p-SMAD2/3), stress response 
pathways (p-MKK3/6, p-MKK4/7, p-p38, p-JNK, p-MAPKAPK2, p-AMPKα, and p-p53), PKC 
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pathway and STAT pathways (grouped for illustration purposes; p-SRC, p-FAK, p-BTK, p-
PLCγ2, p-MARCKS, p-NFκB, p-STAT1, p-STAT3, and p-STAT5). D, t-SNE analysis of 
overexpressed kinases and phosphatases performed on signed-BP-R2 of all measured 
phosphorylation sites with and without EGF stimulation, color-coded by hierarchical clusters. E, 
The mean signed-BP-R2 values of all measured phosphorylation sites in each cluster of kinases 
or phosphatases shown in a literature-guided canonical signaling network visualization. 
 
Figure 2. Functional enrichment analysis of kinases and/or phosphatases in each cluster. 
A, Unrooted tree shows the hierarchical clustering of the kinases and phosphatases based on 
their signed-BP-R2 scores. Terms of enriched functions (p<0.05) from each cluster are 
annotated with circle color indicating the p-value and circle size showing the coverage of cluster 
components. The percentage of associated proteins is indicated by the size of the adjacent 
circle. B-C, Functional association analysis performed with the STRING database (Szklarczyk et 
al., 2017) for cluster 1 and cluster 7, respectively. Edges with confidence above 0.2 are shown 
in the network. Functional enrichments are shown as color-coded-pies with the pie radius 
indicating the p-value. 
 
Figure 3. Prediction of novel signaling connections by comparison with literature 
evidence in the signaling interaction database OmniPath (Türei et al., 2016). A, 
Abundance-dependent relationship strength for each pair of overexpressed POI and measured 
phosphorylation site, as quantified with signed-BP-R2, plotted on the length of shortest signed 
directed path between the two extracted from the OmniPath database. B, Occurrences of strong 
signaling relationships (BP-R2 > 0.13) with 0-5 or infinite path length (OmniPath) in each 
individual hierarchical cluster. C-D, For clusters 8 and 5, respectively, shortest signed directed 
path length for each determined strong signaling relationships shown in Circos plots (Krzywinski 
et al., 2009).   
 
Figure 4. Effects of EGF stimulation on 39 kinases and phosphatases. A, Heat map of 
signed-BP-R2 scores for measured signaling relationships over a 1-hour EGF stimulation time 
course. Six identified groups of kinases and phosphatases are labeled in color codes. B, For 
one representative POI from each group, signaling relationships to all measured 
phosphorylation sites, as quantified by signed-BP-R2, are shown in the literature-guided 
canonical signaling network map. C-G, Violin plots show cell distribution in each of the ten bins 
divided over the gradients of GFP-tagged POI expression level for EGFR-GFP to p-ERK1/2, 
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DUSP4-GFP to p-ERK1/2, PTPN2-GFP to p-ERK1/2, DUSP4-GFP to p-MEK1/2, and PTPN2-
GFP to p-MEK1/2 over the 1-hour EGF stimulation time course. Medians of all 10 bins are 
connected to indicate the shape of signaling relationships (black lines) with the relationship 
strength quantified by signed-BP-R2, as shown on top of each individual plot. H, Schematic 
illustration of how two sets of phosphatases induce different abundance-dependent influences 
on the signaling dynamics of the MAPK/ERK cascade. 
 
Figure 5. Pairwise overexpression of two-dimensional protein abundance dependency 
analysis of signaling behaviors. A, Workflow of the pairwise overexpression. Two plasmids 
encoding a FLAG-tagged kinase and a GFP-tagged phosphatase were transfected into 
HEK293T cells successively. Cells were binned into 25 groups according to their FLAG and 
GFP abundances. The median level of each measured phosphorylation site was computed for 
each bin. B, Kinases MAP2K2, MAPK1, and RPS6KA1 and phosphatases DUSP4, DUSP7, and 
PTPN2 were selected for the pairwise overexpression, generating nine overexpression 
combinations in total. C, In cells with pairwise overexpression of a FLAG-tagged kinase 
MAP2K2 (MEK2) and a GFP-tagged phosphatase DUSP4, median phosphorylation levels of p-
MEK1/2 and p-ERK1/2 are plotted for all bins over the 1-hour EGF stimulation time course. D, 
Signaling trajectories of p-MEK1/2 and p-ERK1/2 plotted as the medians of each individual bin 
over the 1-hour EGF stimulation time course. E, Schematic illustrating the modulation of 
RAF/MEK/ERK cascade signaling states and dynamics by the pairwise overexpression. F-G, 
Analysis of dependence of p-ERK1/2 and p-MEK1/2 signaling on MAPK1(ERK2)-FLAG and 
DUSP7-GFP. 
 
Figure 6. Kinase overexpression induces vemurafenib resistance in the melanoma A375 
cells by activating ligand-binding independently of ERK signaling. A, Selected kinases 
were transfected into A375 cells and cultured in the inhibitor- or DMSO-containing media for 48 
hours before the signaling states and enrichment of kinase overexpression cells were assessed. 
B, Data from each sample were divided into four bins depending on the expression level of the 
GFP-tagged kinase. Signed-BP-R2 analysis was performed to quantify signaling relationships 
with and without vemurafenib. C, Histogram of abundance-dependent relationship strength for 
each overexpressed POI to p-ERK1/2, quantified as signed-BP-R2 from three replicate 
experiments. D, The mean differences of the three replicates between vemurafenib-treated cells 
and DMSO-treated cells in their signed-BP-R2 scores with p-ERK1/2. E, Proportion of cells in 
bin 4, cells with the highest levels of POI, for each individual overexpressed kinase in 
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vemurafenib-treated cells and DMSO-treated cells. (∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001, n = 3) F, 
Illustrations of how ERK-activating POIs maintain the proliferative state in cells treated with 
vemurafenib and, in the un-drugged condition, how (despite overexpression of these POIs) 
over-activated ERK signaling leads to cell senescence and apoptosis. 
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Methods 
Data availability 
All raw data are available at http://www.cytobank.org/bodenmillerlab. 
 
Cloning 
The human kinase library plasmid kit, containing open reading frames (ORFs) in Gateway Entry 
vectors, was provided by William Hahn and David Root (Johannessen et al., 2010; Yang et al., 
2011) via Addgene (Kit # 1000000014). The human phosphatase library was obtained from 
Dharmacon (OHS4941, ORFeome Human Entry Collection Phosphatase). Destination vectors, 
including pDEST pcDNA5 FRT TO-eGFP and pDEST 3' Triple Flag pcDNA5 FRT TO, were 
kindly provided by Dr. Anne-Claude Gingras at Mount Sinai Hospital, Toronto, Canada 
(Couzens et al., 2013). Expression vectors encoding the FLAG- or GFP-tagged fusion proteins 
were generated via Gateway Cloning and sequenced before transfection. 
 
Cell culture 
HEK293T cells, obtained from ATCC, were cultured in DMEM (D5671, SIGMA), supplemented 
with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 µg/ml streptomycin. A375 cells, 
a gift from Dr. Lukas Sommer at University of Zürich, were cultured in RPMI Medium 1640 
(21875-034, Gibco) with 10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin. For cell 
passaging or harvesting, HEK293T cells and A375 cells were incubated with 1X TrypLE™ 
Express (Life Technologies) at 37 °C for 2 minutes and 5 minutes, respectively. 
 
HEK293T cell transfection and stimulation 
HEK293T cells were seeded at the density of 0.7 million per well in 6-well plates. After 24 hours, 
cells were transfected with 2 μg plasmid and 4 μl of jetPRIME (PolyPlus) per well with the 
standard protocol provided by the manufacturer. For kinase and phosphatase double 
transfection experiments, cells were transfected with plasmids encoding GFP-tagged kinases 
and FLAG-tagged phosphatases 16 hours and 24 hours after seeding, respectively. Half the 
amounts of plasmid and jetPRIME were used in each round for co-overexpression experiments. 
At 18 hours after transfection, EGF (Peprotech) was added to a final concentration of 100 ng/ml. 
At 20 minutes before a given EGF stimulation time point, 5-iodo-deoxycytidine (IdU) was added 
to the medium at the final concentration of 10 μM. At 2 minutes before a given EGF stimulation 
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time point, medium was replaced by 1X TrypLE to induce cell detachment. At the time point, 
paraformaldehyde (PFA, from Electron Microscopy Sciences) was added to the cell suspension 
to a final percentage of 1.6%, and cells were incubated at room temperature for 10 minutes. If 
EGF stimulation was not necessary in the experiment, cells were directly harvested and 
crosslinked with PFA.  
 
A375 cell transfection and vemurafenib treatment 
A375 cells were seeded at the density of 0.15 million per well in 6-well plates. At 24 hours after 
seeding, transfection was performed using 2 μg plasmid and 4 μl of X-treme GENE HP reagent 
(06 366 236 001, Roche) per well with the standard protocol provided by the manufacturer. Pre-
diluted vemurafenib (10 mM/mL in DMSO, Selleckchem) was added to the cells 18 hours after 
transfection, at the final concentration of 1 µM. The same volume of DMSO was added to the 
control samples. After 2 days, cells were labeled with IdU during 20-minute incubation and 
subsequently harvested by 5-minute TrypLE digestion and 10-minute PFA crosslinking as 
described above. 
 
Methanol permeabilization 
Crosslinked cells were washed twice with cell staining media (CSM, PBS with 0.5% BSA). After 
centrifugation, ice-cold methanol was used to resuspend the cells, followed by 10-minute 
permeabilization on ice or for long-term storage at -80 °C.  
 
Antibody conjugation 
The MaxPAR antibody conjugation kit (Fluidigm) was used to generate isotope-labeled 
antibodies using the manufacturer’s standard protocol. After conjugation, the antibody yield was 
determined based on absorbance of 280 nm. Candor PBS Antibody Stabilization solution 
(Candor Bioscience GmbH) was used to dilute antibodies for long-term storage at 4 °C.    
 
Barcoding and staining protocol 
Formalin-crosslinked and methanol-permeabilized cells were washed three times with CSM and 
once with PBS. Cells were incubated in PBS containing barcoding reagents of 89Y (100 nM), 
103Rh (2 µM), 105Pd (100 nM), 106Pd (100 nM), 108Pd (100 nM), 110Pd (100 nM), 113In (200 nM), 
115In (100 nM), and 209Bi (20 nM) for 30 minutes at room temperature and then washed three 
times with CSM. Barcoded cells were then pooled and stained with the metal-conjugated 
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antibody mix (Table S1) at room temperature for 1 hour. The antibody mix was removed by 
washing cells three times with CSM and once with PBS. For DNA staining, iridium-containing 
intercalator (Fluidigm) diluted in PBS with 1.6% PFA was incubated with the cells at 4 °C 
overnight. On the day of the measurement, the intercalator solution was removed, and cells 
were washed with CSM, PBS, and ddH2O. After the last washing step, cells were resuspended 
in ddH2O and filtered through a 70-μm strainer. 
 
Mass cytometry analysis 
EQTM Four Element Calibration Beads (Fluidigm) were added to cell suspensions in a 1:10 ratio 
(v/v). Samples were analyzed on a CyTOF2 (Fluidigm). The manufacturer’s standard operation 
procedures were used for acquisition at a cell rate of ~500 cells per second. After the 
acquisition, all FCS files from the same barcoded sample were concatenated (Bodenmiller et al., 
2012). Data were then normalized, and bead events were removed (Finck et al., 2013) before 
doublet removal and de-barcoding of cells into their corresponding wells using a doublet-filtering 
scheme and single-cell deconvolution algorithm (Zunder et al., 2015). Subsequently, data was 
processed using Cytobank (http://www.cytobank.org). Additional gating on the DNA channels 
(191Ir and 193Ir) and 139La/141Pr was used to remove remained doublets, debris and contaminating 
particulate. 
 
Data preprocessing and BP-R2 analysis 
Bi-axis scatter plots 
Bi-axis scatter plots were generated in Cytobank (http://www.cytobank.org/). 
 
Data preprocessing  
Raw data was transformed using the inverse hyperbolic sine transform with a cofactor of 5: 
 
𝑑𝑑𝑑𝑑 = 𝑑𝑎𝑎𝑎𝑎ℎ(𝑑𝑑𝑑𝑑𝑟𝑟𝑟/5) 
 
Except where use of raw data values is specifically noted, all visualizations and analyses were 
performed using transformed data.    
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Data binning 
For data binning, the range between the lower and upper 2.5% of observations was divided into 
ten equal bins bin1,...,bin10. The observations in the lower and upper 2.5% were assigned to the 
lowest and highest bins, respectively. In order to be able to compare expression levels between 
samples within a time course experiment, all observations of the time course were pooled to 
determine the binning. 
 
BP-R2 
BP-R2 analysis is described in Lun et al., 2017 (https://github.com/BodenmillerGroup/Adnet). In 
brief, the median of a measured marker (𝑦�𝑖) was calculated for each bin 𝑎. Additionally, the 
overall mean of the medians of all the 10 bins (𝜇𝑦� ) was calculated (bins with less than 25 cells 
were discarded). Then, for each bin, we computed the sum of squared deviations from the bin 
medians and the sum of squared deviations from the overall mean of medians. These values 
were summed over all bins and the BP-R2 was defined as one minus the ratio between them: 
 
𝑅𝐵𝐺
2 =  1 − ∑ 1𝑎𝑖 ∑ (𝑦𝑖𝑗 − 𝑦�𝑖)2𝑜𝑖𝑗=1𝑜𝑛𝑖𝑜𝑜𝑖=1
∑ 1𝑎𝑖 ∑ (𝑦𝑖𝑗 − 𝜇𝑦�)2𝑜𝑖𝑗=1𝑜𝑛𝑖𝑜𝑜𝑖=1  
 
Threshold determination 
Following the method described in Lun et al., 2017, we chose the maximum BP-R2 among all 
the 108 control samples (FLAG-GFP overexpression and untransfected cells) as a cutoff. 
Relationships that had a BP-R2 higher than this threshold were considered as sufficiently strong 
to be of interest.  
 
Signed-BP-R2 
The relationship strengths calculated as BP-R2 were mostly positive, with a few exceptions of 
negative BP-R2 values mostly from the cell cycle marker IdU, due to bimodality. These rare and 
weak negative BP-R2 values were considered as negligible and were therefore assigned to 0. 
This allowed the integration of signaling relationship directionalities, determined by Spearman 
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correlation of bin medians (𝜌𝑛𝑖𝑜), with the relationship strengths (𝑅𝐵𝐺2 ). The signed-BP-R
2 score 
(𝑅𝑜𝑖𝑠𝑜𝑜𝑠−𝐵𝐺2 ) was calculated as: 
𝑅𝑆𝑖𝑠𝑜𝑜𝑠−𝐵𝐺
2 = � 𝑅𝐵𝐺2 , 𝜌𝑛𝑖𝑜 ≥ 0
−𝑅𝐵𝐺
2 , 𝜌𝑛𝑖𝑜 < 0 
 
Hierarchical clustering 
Hierarchical clustering was performed for kinases and phosphatases on their abundance-
dependent signaling relationships, as signed-BP-R2, to all measured phosphorylation sites with 
and without 10-minute EGF stimulation. Ward’s method and Euclidean distances (Ward, 1963) 
were used for the clustering, and the hierarchical tree was cut at the height of 5 to obtain 10 
clusters of kinases and phosphatases as shown in Figure S1C. 
 
t-SNE analysis 
t-SNE analysis was performed with the Package Rtsne in R. 
 
Functional enrichment and association analysis using STRING database 
The functional enrichment and interaction enrichment analyses were performed using the 
STRING database v10.5 (Szklarczyk et al., 2017). All the kinases and phosphates tested were 
mapped to STRING protein name-space establishing the background protein set for the further 
analysis. The functional enrichment p-values were corrected using Benjamini and Hochberg 
method (Benjamini and Hochberg, 1995) (the detailed description of the statistical methods can 
be found in Franceschini et al., 2012). To test whether the functional signal within the clusters 
arises exclusively from a homology between the proteins, the homologous proteins were 
grouped together into one node, and, therefore, the proteins that exhibited high or medium 
homology did not contribute independently to the enrichment functional term count. In order to 
form the grouped representation of the STRING network the single-linkage clustering method 
was applied to the homology relationships between the proteins in which neighbors were 
defined as having a self-normalized bit score (BLAST bit score of alignment between the two 
proteins divided by the bit score of self-alignment of shorter of the two proteins) equal to or 
higher than 0.2. For each functional term the grouped node contributed to the enrichment count 
when one or more of the proteins forming the group were annotated with the term in question. 
This process was applied to both the clusters and the background separately to ensure that for 
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the groups in which proteins were shared between the cluster and the background the functional 
term was counted in both sets. 
 
Shortest signed directed path analysis using OmniPath 
The pathway analysis was performed for all signaling relationships between overexpressed 
POIs and measured phosphorylation sites using OmniPath (http://omnipathdb.org/), a collection 
of literature curated human signaling pathways integrated from 25 databases (pathway 
databases: TRIP, SPIKE, SignaLink3, Guide2Pharma, CA1, ARN, NRF2ome, Macrophage, 
DeathDomain, PDZBase, Signor; interaction databases: BioGRID, CancerCellMap, MPPI, DIP, 
InnateDB, MatrixDB; PTM databases: PhosphoSite, DEPOD, LMPID, phosphoELM, ELM, 
DOMINO, dbPTM, HPRD-phos) (Türei et al., 2016). The shortest path was determined based 
on based on Breadth-First Search methods, computed through a Python module called pyPath 
(Türei et al., 2016). 
 
Selection of strong signaling dynamic influencing POIs 
For each pair of signaling relationships between an overexpressed POI and a measured 
phosphorylation site, the delta BP-R2 score was calculated as the signed-BP-R2 value with 10 
minute EGF stimulation minus the signed-BP-R2 value in unstimulated cells. We selected the 
top 10 POIs with a positive difference in signed-BP-R2, the top 10 POIs with negative difference 
in signed-BP-R2, the top 20 POIs with the number of signaling relationships in the 99 percentile 
of the difference in signed-BP-R2, and the 10 central signaling dynamic regulators in the 
MAPK/ERK and AKT pathways known from the literature (Steelman and Chappell, 2011). Some 
POIs were in more than one set, so this resulted in 39 kinases and phosphatases. 
 
Signaling dynamics analysis 
The signaling dynamics analysis was adapted from our previous methods (Lun et al., 2017) that 
characterize two signaling aspects, the protein abundance-dependent signaling amplitudes and 
peak times. For amplitude analysis, the fold change of median phosphorylation abundance for 
each bin in EGF-stimulated samples over the corresponding bin of the unstimulated sample 
(EGF 0 min) was calculated using the raw count. The amplitude for each bin was identified as 
the maximal fold change over all time points. Amplitude ratios between the second highest and 
the second lowest bin amplitudes were computed for all samples, and the highest amplitude 
ratio in all FLAG-GFP overexpression and untransfected controls was used to determine the 
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cutoff for robust and strong abundance-dependent changes. To study protein abundance-
dependent signaling peak times, the time point after EGF addition with maximal amplitude for 
each bin was defined as peak time. We calculated the maximal median variation over all bins for 
each individual sample and selected pairs of relationships with bin variations (at least in one 
time point) higher than all those in control samples. These were defined as peak time shifts. 
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Figure S1. Kinase and phosphatase overexpression impacts cell signaling. A, Top 30 
overexpressed kinases or phosphatases in cancers or cancer cell lines compared to normal 
cells, using data from the Expression Atlas (Petryszak et al., 2016). B, Pie chart shows the 
number of POIs that have strong (BP-R2 > 0.13) overexpression-induced signaling relationships 
to the measured phosphorylation sites. Three-fourths of the POIs modulated one to five 
phosphorylation sites. C, Heat map shows the signed-BP-R2 of all 327 EGFR network-
influencing POIs (i.e., POIs with at least one strong overexpression-induced signaling 
relationship, BP-R2 > 0.13) to every phosphorylation site with or without 10-minute EGF 
stimulation. Hierarchical clustering identified 10 groups of kinases or phosphatases with the 
similar network-influencing properties. D, Corresponding components between identified 
hierarchical clusters (the same cluster color code as in panel (C) and kinase/phosphatase 
classifications based on the sequence of protein catalytic domains. 
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Figure S2. Functional association analysis. Functional association analysis was performed 
for clusters 2, 3, 4, 5, 6, 8, 9, and 10. Edges with confidence above 0.2 are shown in the 
network. Functional enrichments are color-coded and labeled on the nodes.  
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Figure S3. Novel signaling relationships detected by comparison with the OmniPath 
database. A, Counts of strong (BP-R2 > 0.13) abundance-dependent signaling relationships 
with shortest signed directed path length of 0-5 or with infinite path length for each sequenced-
based kinase and phosphatase classification. B, Abundance-dependent signaling relationships 
are indicated as circles with circle size indicating the shortest signed directed path length and 
color the signed-BP-R2 score. C, Shortest signed directed path length for each identified 
signaling relationships shown in Circos plots for the clusters of 1, 2, 3, 4, 6, 7, 9, and 10.   
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Figure S4. Analysis of kinase and phosphatase overexpression-dependent signaling 
dynamics in EGF stimulation time course. A, Variances of signed-BP-R2 between cells with 
or without 10-minute EGF treatment are plotted for all identified clusters in the global analysis. B, 
Correspondence analysis shows to which 10 clusters as derived from the kinome and 
phosphatome analysis, the six dynamic signaling groups belong to. C-D, Violin plots show cell 
distribution in each of the 10 bins based on GFP-tagged POI expression level for (C) DUSP4-
GFP to p-p90RSK, and (D) PTPN2-GFP to p-p90RSK over the 1-hour EGF stimulation time 
course. Medians of all 10 bins are connected to indicate the shape of signaling relationships 
(black lines) with the relationship strength quantified by signed-BP-R2, as shown on top of each 
individual plot. 
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Figure S5. Protein abundance-modulated signaling amplitudes. A, Schematic plots of 
amplitude analysis. The abundance levels of the overexpressed GFP-POI were split into ten 
bins (left). Median phosphorylation in each bin over the 1-hour EGF stimulation time course are 
plotted to visualize abundance dependency of signaling amplitudes (right). B-C, Heat maps 
show pairs of signaling relationships with protein abundance-influenced signaling amplitudes 
with (B) positive relationships and (C) negative relationships determined by the summed 
Spearman correlation over all time points. 
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Figure S6. Protein abundance-modulated signaling peak times. A, Schematic plots of peak 
time analysis. The abundance levels of overexpressed GFP-POI were split into ten bins (left). 
Median phosphorylation in each bin over the one-hour EGF stimulation time course are plotted 
to visualize abundance dependency of signaling peak times (right). B, Heat map shows pairs of 
signaling relationships with strong protein abundance-influenced signaling peak times. 
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Figure S7. Kinase and phosphatase pairwise overexpression. A, For the pairwise 
overexpression of MAP2K2-FLAG and PTPN2-GFP, median phosphorylation levels of p-
MEK1/2 and p-ERK1/2 for all bins over the 1-hour EGF stimulation time course are shown with 
the bar heights and bar colors. B, Signaling trajectories of p-MEK1/2 and p-ERK1/2 are plotted 
by connecting the medians of each individual bin over the 1-hour EGF stimulation time course. 
C, Schematic illustrates the modulation of RAF/MEK/ERK cascade signaling states and 
dynamics by the pairwise overexpression. 
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Figure S8. Kinase overexpression induces vemurafenib resistance in the melanoma A375 
cell. A-B, Signed-BP-R2 values of each overexpressed POI to p-ERK1/2 (A) before and (B) 
after 10-minute EGF stimulation. Kinases previously shown to induce RAF inhibitor resistance in 
A375 cells (identified in Johannessen et al., 2010) are labeled. C-D, Controls of FLAG-GFP 
overexpression and untransfected cells did not have strong signaling relationship to p-ERK1/2 
after 48-hour incubation with vemurafenib or DMSO mock control. 
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Abstract 
Recent studies have shown that cell cycle and cell volume are confounding factors when 
studying biological phenomena in single cells. Here we present a combined experimental and 
computational method, CellCycleTRACER, to account for these factors in mass cytometry data. 
CellCycleTRACER is applied to mass cytometry data collected on three different cell types 
during a TNF-α stimulation time-course. CellCycleTRACER reveals signaling relationships and 
cell heterogeneity that were otherwise masked. 
 
Introduction 
Single-cell analysis technologies are rapidly improving and will soon match the 
performance of their population-level counterparts. RNA transcriptomes can be quantified in 
thousands of single cells, and analyses of transcriptomes of single cells with spatial resolution in 
tissues have been reported (Chen et al., 2015; Tang et al., 2009). Mass cytometry has the 
potential to enable simultaneous detection of up to 50 proteins and protein modifications, such 
as phosphorylation sites, in single cells (Bandura et al., 2009; Bodenmiller et al., 2012). Recent 
developments enable highly multiplexed imaging of similar numbers of markers in adherent cells 
and tissues (Bodenmiller, 2016; Giesen et al., 2014; Schapiro et al., 2017). 
Single-cell data are typically used to identify cell subpopulations that share similar 
transcript or protein expression or functional markers. Analyses of these subpopulations can be 
used to reveal differences between tissue compartments in health and disease (Amir et al., 
2013; Bruggner et al., 2014; Di Palma and Bodenmiller, 2014; Qiu et al., 2011), to reconstruct 
signaling network interactions, to study regulatory mechanisms (Krishnaswamy et al., 2014; Lun 
et al., 2017), and, together with clinical data, to identify single-cell features that predict 
characteristics such as response to treatment and likelihood of relapse (Chevrier et al., 2017b). 
For continuous processes, such as stem cell differentiation and the cell cycle, single-cell data 
allow the in silico reconstruction of the temporal dimension and thus the investigation of the 
underlying molecular changes and circuitries. Several algorithms designed to reconstruct cell 
trajectories from single-cell data are available, each with distinct strengths and weaknesses 
(Bendall et al., 2014; Gut et al., 2015; Kowalczyk et al., 2015; Setty et al., 2016). 
Recent single-cell transcriptomic studies revealed that cell-cycle state and cell volume 
contribute to phenotypic and functional cell heterogeneity even in monoclonal cell lines 
(Buettner et al., 2015; Padovan-Merhar et al., 2015). This heterogeneity can obscure biological 
phenomena of interest (McDavid et al., 2016; Patel et al., 2014). For analysis of single-cell 
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transcriptomic data, computational methods have been developed to reveal variability in cell-
cycle state and cell volume; these methods use principal component analysis, random forests, 
LASSO, logistic regression, support vector machines, and latent variable models (Buettner et al., 
2015; McDavid et al., 2016; Scialdone et al., 2015; Wilson et al., 2015). These methods 
leverage large numbers of previously annotated cell-cycle genes and are thus not transferrable 
to mass cytometry data analyses.  
Here, we developed a combined experimental and computational method, called 
CellCycleTRACER, to quantify and correct cell volume and cell cycle effects in mass cytometry 
data. The application of CellCycleTRACER to measurements of three different cell lines over a 
1-h TNF-α stimulation time course revealed signaling features that had been otherwise 
confounded by cell cycle and cell volume effects. 
 
Results 
Cell cycle and volume effects measured by mass cytometry 
The impact of cell-cycle and cell-volume heterogeneity on mass cytometry data has not 
been addressed. We, therefore, set out to characterize how these factors influence commonly 
employed mass cytometry data analyses. To assess the effect of cell cycle, we exploited the 
simultaneous measurements of four cell-cycle markers recently identified by Behbehani et al., 
2012: phosphorylated histone H3 (p-HH3), which peaks in the mitotic phase; phosphorylated 
retinoblastoma (p-RB), which monotonically increases from late G1 to M phase; cyclin B1, which 
increases from G2 to early M phase and rapidly diminishes during the late M phase; and 5-Iodo-
2′-deoxyuridine (IdU), a thymidine analog incorporated during the S phase. We found that cell 
signaling as measured by protein phosphorylation strongly depended on the cell-cycle phase 
(Supplementary Note 1 and Supplementary Fig. 1). For example, a biaxial plot of 
phosphorylation of Ser241 on PDK1 versus phosphorylation of Thr172 on AMPKα revealed that 
in G2 and M phases, phosphorylation levels were elevated (Fig. 1a). Consequently, the 
estimated Pearson correlation coefficient between these two markers appears to be high due to 
the G2 and M cells that inflate the correlation. Less dramatic cell-cycle effects were also 
observed in published data (Behbehani et al., 2012) from a population of human T cells 
analyzed using a panel of immune-related cell-surface markers (Supplementary Fig. 2). 
To assess the impact of cell volume, we had first to identify a marker that could be used 
to robustly quantify cell volume at a single-cell level. The ruthenium complex bis(2,2’-bipyridine)-
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4’-methyl-4-carboxybipyridine-ruthenium-N-succidimyl ester-bis(hexafluorophosphate) 
(ASCQ_Ru) stains proteins by covalently binding to amino groups (Tokarski et al., 2006) 
(Supplementary Fig. 3a). ASCQ_Ru can be used in mass cytometry to reliably measure cell 
volume, as demonstrated using confocal laser scanning microscopy and three-dimensional cell 
reconstruction (Supplementary Fig. 3b-d), provided that the cells are not under conditions where 
the total protein mass and volume become uncorrelated (e.g., under drastic changes in 
osmolarity). In mass cytometry, ASCQ_Ru is measured by the ion counts of seven ruthenium 
isotopes (96Ru, 98Ru, 99Ru, 100Ru, 101Ru, 102Ru, 104Ru) that do not overlap with channels used for 
antibody measurements. Similarly to what we found for the cell-cycle, the estimated correlation 
coefficients among phosphorylation markers were influenced by cell-volume heterogeneity (Fig. 
1b, Supplementary Fig. 4). Given that the cell-cycle state and cell volume broadly confounded 
marker relationships, it was not surprising that analyses of mass cytometry data using standard 
statistical approaches, such as Pearson or Spearman correlations, or state-of-the-art 
computational methods, such as tSNE or DREMI, resulted in misleading conclusions 
(Supplementary Figs. 1, 4).  
 
CellCycleTRACER: Normalizing cell cycle and volume effects 
Cell volume and cell cycle change in a continuous manner and should be corrected, or 
at least taken into account, accordingly. Therefore, we developed CellCycleTRACER, an 
algorithm for the analysis of single-cell mass cytometry data that enables correction for cell-
cycle-state and cell-volume heterogeneity. CellCycleTRACER is implemented as a simple and 
intuitive graphical user interface and can be applied to any mass cytometry dataset. Its 
application requires that four channels be dedicated to the cell-cycle markers p-HH3, p-RB, 
cyclin B1, and IdU (see Software and Data Availability).  
CellCycleTRACER first exploits the ASCQ_Ru signal to transform raw marker counts 
into single-cell volume-relative intensities (Fig. 1c, Methods and Supplementary Note 2). After 
cell-volume correction, CellCycleTRACER uses data on the aforementioned four cell-cycle 
markers to classify cells into discrete cell-cycle phases and order them on a continuous path 
analogous to cell-cycle pseudotime (Fig. 1d, Methods and Supplementary Notes 3, 4). To 
automatically classify cells according to cell-cycle stage, CellCycleTRACER exploits a new 
machine learning approach that combines decision trees and Gaussian mixture models 
(Supplementary Figs. 5, 6, Methods and Supplementary Note 3); this approach reproduced 
manual gating procedures with 98.9% accuracy (Fig. 1d, Supplementary Fig. 7). Next, the single 
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cells are ordered on a continuum that traces cell-cycle evolution based on a novel trajectory 
reconstruction technique (Fig. 1d, e). To achieve this, CellCycleTRACER exploits the prior cell-
cycle phase assignment and identifies the optimal one-dimensional embedding of the four cell-
cycle markers that preserves the known order of the cell-cycle phases by minimizing ordering 
violations (Fig. 1e, Supplementary Fig. 8, Methods and Supplementary Note 4). Finally, the cell-
cycle trajectories of the measured markers are obtained by projecting single-cell measurements 
onto the pseudotime dimension (Fig. 1d, lower right). 
Reconstructed cell-cycle trajectories of the four markers used for the pseudotime 
inference (p-HH3, p-RB, cyclin B1, and IdU) agreed with their cell cycle-dependent variation (Fig. 
1d, dashed lines)(Behbehani, 2018; Behbehani et al., 2012). Additionally, the pseudotime was 
validated by analyses of two independent cell cycle markers, p-CDK1 (Tyr15) and cyclin E (Fig. 
1d, solid lines). CellCycleTRACER results faithfully recapitulated prior biological knowledge. 
Phosphorylation of Tyr15 on CDK1 progressively increased during S and G2 phase, peaked at 
the G2/M transition and sharply decreased after the entry to M phase. Cyclin E progressively 
accumulated during the G1 phase and reached the maximum at the G1/S transition before 
being degraded during the S phase (Bertoli et al., 2013; Castedo et al., 2002) (Fig. 1d, 
Supplementary Fig. 9). Furthermore, comparison with five state-of-the-art trajectory and 
embedding reconstruction methods showed that these methods failed to reproduce biologically 
relevant orderings of the cell cycle (Supplementary Fig. 10). For example, Wanderlust ordered 
the cells from G1→G2→S→M. Since Wanderlust works by first constructing k I-nearest 
neighbor graphs in the four-dimensional space of the cell-cycle markers and assumes that 
changes in protein abundance levels are gradual in the trajectory, it traversed the data in the 
wrong order because the G1 cluster is closer to G2 than S due to the jump in IdU. The other 
methods tested resulted in different incorrect orderings. SCUBA constructed a G2→S→G0/G1 
trajectory and incorporated the M phase cells in the other clusters; TSCAN constructed a 
M→S/G2→G0/G1 trajectory by mixing together G2 and S cells; and Monocle ordered the data 
as G0/G1→M→G0/G1→G2→S, by ordering M phase cells in the middle of the G0/G1 cluster. 
Last, diffusion maps yielded a non-linear, low-dimensional embedding of the data that did not 
capture the known ordering. Since these methods are unsupervised techniques, they 
reconstruct continuous trajectories of the given measurements with no additional label 
information. It is thus impossible to “force” these methods traverse the data in the known cell-
cycle phase order. CellCycleTRACER, however, exploits the known order of the phases through 
a mathematically well-defined optimization routine and guarantees by design that the known 
ordering will be preserved in the inferred one-dimensional embedding. 
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Reconstructed cell-cycle trajectories of cell-surface markers from a population of human 
T cells (Behbehani et al., 2012) indicated a continuous increase across the cell cycle for many 
of the proteins, peaking at the M phase (Supplementary Fig. 11). CellCycleTRACER can also 
remove cell-cycle-related inter-sample variations (due, for example, to the use of different cell 
lines or of the same cell line at different stimulation time points) and enables unbiased multi-
sample analyses by trajectory alignment. This is achieved using a subsampling strategy that 
equalizes the relative cell-cycle phase proportions either to the mean inter-sample proportions 
or to the proportions of a user-selected sample (Fig. 1f, Methods and Supplementary Note 5). 
Last, CellCycleTRACER can correct for cell-cycle-related intra-sample variations by dividing the 
ordered single-cell values by the normalized mean trajectory (Fig. 1g, Methods and 
Supplementary Note 6). The dataset can be exported after any step of the pipeline, facilitating 
the use of various downstream data analysis approaches. 
 
Assessing CellCycleTRACER with TNF-α stimulation data 
To test the performance of our method, we measured the abundances of 25 protein 
phosphorylation sites, three housekeeping proteins, and three phenotypical markers in 
conjunction with the cell-volume and cell-cycle markers (Supplementary Table 1) in HEK293T 
(embryonic kidney), MDA-MB-231 (breast cancer), and THP-1 (monocyte) cells that had been 
stimulated with TNFα for 0, 5, 10, 15, 30, and 60 minutes (Methods). Analyses of cell volume at 
the control time point (0 minute) showed that MDA-MB-231 cells had on average the largest 
volume, followed by HEK293T and THP-1 cells (Fig. 2a). After cell-volume correction using 
CellCycleTRACER, the single-cell volume distributions in the three cell lines perfectly aligned 
(Fig. 2a). Marker abundances were strongly influenced by the cell-volume correction. For 
example, the amount of phosphorylated MKK4 (Ser257/Thr261) in THP-1 cells was 2-fold lower 
compared to the amounts in the other two cell lines when uncorrected for volume biases; after 
the correction, the amounts were nearly identical in each of the cell lines (Fig. 2a). After cell-
volume correction, the coefficients of variation of the measured markers were reduced, 
indicating that our method corrected for cell-volume-dependent variations (Fig. 2a, bottom). 
We next analyzed the cell-cycle evolution of different phosphorylation markers in 
response to TNFα stimulation. This analysis exposed cell-cycle-specific phosphorylation 
responses to stimulation. For example, in THP-1 cells, phosphorylation of p38 (Thr180/Tyr182) 
in response to TNFα stimulation was 2-fold stronger in G2/M phases compared to G0/G1 phase 
(Fig. 2b, left). The cell-cycle dependency of p38 phosphorylation was confirmed by flow 
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cytometry analysis where a similar fold change across the cell cycle phases was observed 
(Supplementary Fig. 12). It was reported previously that TNFα induces histone H3 
phosphorylation that peaks at 30 minutes post-stimulation; this contributes to chromatin 
remodeling and enhances accessibility of DNA to transcriptional factor NFκB(Seidel et al., 2011). 
Analysis of the TNFα-stimulated THP-1 data using CellCycleTRACER revealed that this effect 
was cell-cycle dependent, as levels of phosphorylated histone H3 (Ser28) in the build up to the 
S phase were twice as high as in early G0/G1 or G2 phases of the cell cycle (Fig. 2b, right). The 
application of CellCycleTRACER aligned the trajectories and removed the bias introduced by 
the cell-cycle stage (Supplementary Fig. 13). 
We next assessed the performance of CellCycleTRACER by comparing data before and 
after cell-volume and cell-cycle correction. First, Pearson correlation, Spearman correlation, and 
DREMI (a mutual information based metric) (Krishnaswamy et al., 2014) were used to quantify 
the relationship strength between measured markers in the unstimulated THP-1 cell data. As 
expected, after cell-volume and cell-cycle correction, Pearson correlation, Spearman correlation, 
and DREMI values for two cell-volume markers, ASCQ_102Ru and ASCQ_104Ru decreased 
significantly (Fig. 2c). For the signaling relationship between p-PDK1 and p-AMPKα, which is 
also affected by cell-cycle stage (Fig. 1a), Pearson correlation, Spearman correlation, and 
DREMI values were reduced from 0.88, 0.58, and 0.60 to 0.49, 0.34, and 0.34, respectively, 
upon application of CellCycleTRACER (Fig. 2c). Importantly, CellCycleTRACER correction had 
a smaller effect on the known direct signaling relationship of p-ERK (Thr202/p-Tyr-204) to p-
p90RSK (Ser380), with a Pearson correlation slightly reduced from 0.77 to 0.69, Spearman 
correlation reduced from 0.75 to 0.67, and DREMI value reduced from 0.55 to 0.45 upon 
CellCycleTRACER application indicating that our method preserves real signaling relationships 
(Fig. 2c).  
Second, we quantified the extent of cell-cycle-induced bias removed by 
CellCycleTRACER using an approach based on principal component analysis on a mixture of 
unstimulated (t=0) and stimulated (t=15 min) THP-1 cells (Fig. 2d). Specifically, after estimating 
the principal components of the data before and after cell-cycle correction, we fitted a linear 
model of the principal components on the cell-cycle-state index (i.e., G1, S, G2, and M phase) 
and the stimulation state and computed the variance explained by the fit (R2) in all cases. Before 
correction, a large percentage of the variance in the first principal component was explained by 
the cell-cycle state; the effect was virtually eliminated by cell-cycle correction using 
CellCycleTRACER (Fig. 2d, left). Conversely, when the cell-cycle effect was eliminated, the 
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increase of R2 for components 2 and 3 indicates that a larger percentage of the variance in the 
data was explained by the stimulation.  
Third, we used CellCycleTRACER to assess the impact of correction on signaling 
network reconstruction with DREMI. Pairwise DREMI analysis on unstimulated THP-1 cells 
indicated that before cell-volume and cell-cycle corrections, phosphorylation sites known to be 
elevated in the M phase, such as Ser529 on NFκB, Thr172 on AMPKα, Thr334 on MAPKAPK2, 
and Ser241 on PDK1, were clustered together (Fig. 2e, left). After CellCycleTRACER was used 
to correct for heterogeneity in cell volume and cell cycle, DREMI scores were reduced in 
general, but a clear pattern consistent with MAPK/ERK and the AKT pathway activation 
appeared (Fig. 2e, right). Without correction for cell-volume and cell-cycle effects, signaling 
networks reconstructed with the top 10 signaling relationships as identified with DREMI in 
unstimulated THP-1 cells did not agree completely with commonly accepted signaling 
knowledge (Fig. 2f, left), whereas with the correction canonical relationships were seen (Fig. 2f, 
right) (Cohen and Frame, 2001; Manning and Cantley, 2007; Mendoza et al., 2011). Thus, pre-
processing to correct mass cytometry data for cell-volume and cell-cycle heterogeneity is 
necessary for accurate analyses of correlation and variance, mutual information-based signaling 
relationship analysis (performed here with DREMI), and signaling network reconstruction.  
Finally, we assessed how the cell-volume and cell-cycle corrections performed with 
CellCycleTRACER influenced the dimensionality reduction of a heterogeneous population of 
single cells with tSNE. Before the correction, the cell cycle confounded the separation of the 
cells in the tSNE plot (Fig. 2g, left), obscuring the cell line identities of the individual cells. The M 
phase cells from all analyzed cell lines were clustered, whereas cells from all other cell-cycle 
phases were mixed, and MDA-MB-231 cells were separated into three clusters. After cell-cycle 
correction, three clusters corresponding to the three different cell lines were observed in the 
tSNE plot, and the cell-cycle origin of each cell in each cluster appeared random (Fig. 2g, right). 
 
Discussion 
 In summary, cell volume and cell cycle can confound downstream mass cytometry data 
analysis. The presented experimental and computational approach, which we call 
CellCycleTRACER, corrects for the influences of volume and cell-cycle phase on mass 
cytometry data. CellCycleTRACER is a supervised manifold learning method that, in contrast to 
existing methods, exploits the cell-cycle phase labels to guarantee that the known ordering will 
be preserved in inferred embedding. With CellCycleTRACER we provide the mass cytometry 
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community with a method for supervised comprehensive analysis of cellular transitions. We 
expect that use of CellCycleTRACER will be particularly important when highly heterogeneous 
cell populations with deregulated cellular processes, as typically found in tumors, are analyzed.  
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Figure captions 
Figure 1. Cell-volume and cell-cycle biases in mass cytometry data and their corrections using 
CellCycleTRACER. (a) Biaxial plot of p-PDK1 (Ser241) versus p-AMPKα (Thr172) in THP-1 
cells, where pre-gated cell-cycle phases are indicated by different colors. Computation of 
Pearson correlation coefficients across cell-cycle phases indicates a strong cell-cycle bias. (b) 
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Biaxial plot of p-PDK1 (Ser241) versus p-AMPKα (Thr172) in G0/G1 phase THP-1 cells that 
were pre-gated by cell volume as indicated by different colors. Pearson correlation coefficients 
are indicative of the cell-volume bias. (c) Cell-volume correction using ASCQ_Ru 
measurements removes cell-volume variability and transforms raw counts of measured markers 
into relative concentrations at single-cell resolution. (d) Construction of cell-cycle pseudotime 
initiates with automatic classification of the cells into discrete cell-cycle phases using 
measurements of IdU, cyclin B1, p-HH3, and p-RB (Behbehani et al., 2012). The optimal 
trajectory across phases is constructed by projecting the data in a one-dimensional embedding 
function analogous to cell-cycle pseudotime. Mean trajectories of all measured cell-cycle 
markers across the reconstructed pseudotime recapitulate known behavior. Markers used to 
construct the pseudotime (IdU, cyclin B1, p-HH3, and p-RB) are shown as dashed lines, 
additional cell cycle markers used as validation (cyclin E and p-CDK1) are shown as solid lines. 
(e) Simplified example of the trajectory reconstruction technique. By exploiting prior information 
of the class labels for each cell and the order of the classes, the best embedding function is 
computed by selecting the one that optimally preserves the known ordering across all cells in 
the new subspace defined by the embedding. (f) CellCycleTRACER aligns cell-cycle 
pseudotime by equalizing cell-cycle phase duration across all analyzed samples. (g) 
CellCycleTRACER correction for cell-cycle redistributes the single cells independently of cell-
cycle variation. 
 
Figure 2. CellCycleTRACER corrects for cell-volume and cell-cycle heterogeneity enabling 
unbiased data visualization and downstream analysis. (a) Overlaid histograms reveal differential 
data observations before and after cell-volume correction. Bar charts show that cell-volume 
correction also reduces intra-sample variation as coefficients of variation of measured markers 
decrease. (b) Abundance of p-p38 (Thr180/Tyr182) and p-HH3 (Ser28) plotted on the cell-cycle 
pseudotime based on data from TNFα-stimulated THP-1 cells. Stimulation time points are 
indicated by different colors. (c) Biaxial plots show signaling relationships between measured 
markers before and after cell-volume and cell-cycle correction. Relationship strengths quantified 
by Pearson correlation, Spearman correlation, and DREMI are indicated in the corresponding 
barplots. (d) Principal component analysis of data originating from a mixed population of 
unstimulated (t=0 min) and stimulated (t=15 min) THP-1 cells. After computing the principal 
components of the data before and after cell-cycle correction, the variances explained by fitting 
a linear model of the principal components on the cell-cycle state index (left) and the stimulation 
state (right) were estimated, indicating removal of cell-cycle confounding effects. (e) 
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Clustergrams of pairwise DREMI analyses of unstimulated THP-1 cells before and after cell-
volume and cell-cycle corrections. After the removal of cell-volume and cell-cycle variability, 
DREMI scores of non-interactive pairs are reduced, and AKT and MAPK/ERK signaling 
pathways become apparent. (f) Network reconstruction using the top 10 DREMI scorers in 
unstimulated THP-1 cells before and after cell-volume and cell-cycle corrections. Network 
reconstructed after correction recapitulates key regulatory interactions in the AKT and 
MAPK/ERK pathways. (g) tSNE maps of THP-1, MDA-MB-231, and HEK293T cell lines before 
and after cell-volume and cell-cycle correction. Cell-cycle and cell-volume markers were not 
included in the tSNE analysis.    
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Methods 
Cell culture 
HEK293T, MDA-MB-231, and THP-1 cells were obtained from ATCC. HEK293T cells were 
cultured in DMEM (D5671, Sigma) supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml 
penicillin, and 100 µg/ml streptomycin. MDA-MB-231 and THP-1 cells were cultured in 
Leibovitz's L-15 Medium (11415064, Gibco) and RPMI-1640 Medium (52400025, Gibco), 
respectively, both supplemented with 10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin. 
For passaging or harvesting, HEK293T and MDA-MB-231 cells were first detached by 
incubating with 1X TrypLE™ Express (Life Technologies) for 2 minutes at 37 °C. 
 
TNFα stimulation 
HEK293T, MDA-MB-231, and THP-1 cells were seeded in 6-well plates at densities of 0.7 
million cells, 0.5 million cells, and 1 million cells per well, respectively. After 2 days, cells were 
stimulated with TNFα (R&D Systems) at 10 ng/ml. Aliquots were collected for analysis at 0, 5, 
10, 15, 30, and 60 minutes (stimulation was performed in reverse order to enable simultaneous 
harvesting of all conditions). At 20 minutes before harvesting, 5-iodo-deoxycytidine (IdU) was 
added to the medium at the final concentration of 10 μM. At 2 minutes before harvesting 
HEK293T and MDA-MB-231 media were replaced with 1X TrypLE to induce detachment. At the 
time of harvest, paraformaldehyde (PFA, Electron Microscopy Sciences) was added to the cell 
suspension at a final percentage of 1.6%, and samples were incubated at room temperature for 
10 minutes. Crosslinked cells were washed twice with cell staining media (CSM, PBS with 0.5% 
BSA, 0.02% NaN3). After removal of supernatant, ice-cold methanol was used to resuspend the 
cells, followed by a 10-minute permeabilization on ice or long-term storage at -80 °C. 
 
Immunofluorescence and three-dimensional reconstruction 
CultureWell™ chambered coverglass wells (16-well, Thermo Fisher Scientific) were pre-coated 
by incubation with 10 μg/ml bovine plasma fibronectin (Thermo Fisher Scientific) at 37 °C for 1 
hour. MDA-MB-231 cells were then seeded at a density of 1500 cells per well. On the second 
day, 4% PFA was used to crosslink the cells at room temperature for 20 minutes. The slide was 
then washed with PBST (0.5% Tween 20 in PBS) three times, and cells were subsequently 
permeabilized for 5 minutes with 0.1% TritonX-100 (diluted in PBS) at room temperature. After 
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washing with PBST three times, cells were incubated in blocking buffer (10% goat serum diluted 
in PBST) for 30 minutes at room temperature. Primary antibody (anti-GAPDH, 6C5, Thermo 
Fisher Scientific, 1 μg/ml; anti-Rab7, D95F2, Cell Signaling Technology, 1:100; or anti-β-actin, 
D6A8, Cell Signaling Technology, 1:200) was added, and slides were incubated overnight at 
4 °C. Secondary antibody (goat anti-mouse Alexa Fluor® 488, 1:200 or goat anti-rabbit Alexa 
Fluor® 555, 1:200), supplemented with Hoechst 33342 at a final concentration of 100 μg/ml, 
was applied, and slides were incubated for 1 hour at room temperature. Antibodies were diluted 
in the blocking buffer. Slides were washed three times with PBST after each incubation step. 
For cell-volume analyses, cells were stained for total proteins with Alexa Fluor® 647 NHS ester 
(Thermo Fisher Scientific) for 10 minutes at a final concentration of 1 μg/ml. Slides were then 
mounted with ProLong Gold Antifade Reagent (Life Technologies) before imaging with a CLSM 
Leica SP5 microscope. Stacks were imaged every 0.5 μm, and the three-dimensional 
reconstruction and quantification of the total cell volume was performed with Imaris 7.7.2. 
  
Antibody conjugation 
Isotope-labeled antibodies were generated with MaxPAR antibody conjugation kit (Fluidigm) 
using the manufacturer’s standard protocol. The antibody yield was determined based on 
absorbance of 280 nm. Candor PBS antibody stabilization solution (Candor Bioscience GmbH) 
was used to dilute antibodies for long-term storage at 4 °C.   
  
Barcoding and staining protocol 
Formalin-crosslinked and methanol-permeabilized cells were washed three times with CSM and 
once with PBS. Cells were incubated in PBS containing barcoding reagents (105Pd, 106Pd, 108Pd, 
110Pd, 113In, 115In, and 139La) at a final concentration of 50 nM for 30 minutes at room 
temperature and then were washed three times with CSM (Lun et al., 2017). Barcoded cells 
were pooled and stained with the metal-conjugated antibody mix (Supplementary Table 1) at 
room temperature for 1 hour. The antibody mix was removed by washing cells three times with 
CSM and once with PBS. For DNA staining, iridium-containing intercalator (Fluidigm) was 
diluted in PBS with 1.6% PFA and incubated with the cells at 4 °C overnight. On the day before 
measurement, the intercalator solution was removed, and cells were washed with CSM, PBS, 
and doubly distilled H2O sequentially. Total protein staining was performed with 25 μg/ml 
ASCQ_Ru (96631, Sigma) in 0.1 M NaHCO3 solution for 10 minutes at room temperature. Cells 
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were then washed with CSM, PBS, and doubly distilled H2O sequentially. After the last wash, 
cells were resuspended in doubly distilled H2O and filtered through a 70-μm strainer. 
  
 
Mass cytometry analysis 
EQTM Four Element Calibration Beads (Fluidigm) were added to the cell suspension at a 1:10 
ratio (v/v). Samples were analyzed on a Helios mass cytometer (Fluidigm). The manufacturer’s 
standard operation procedures were used for acquisition at a rate of ~200 cells per second. 
After data acquisition, all .fcs files from the same barcoded sample were concatenated. Data 
were then normalized, and bead events were removed (Finck et al., 2013). Doublets were 
removed, and cells were de-barcoded into their corresponding wells using a doublet-filtering 
scheme and single-cell deconvolution algorithm (Zunder et al., 2015). Subsequently, data were 
processed using Cytobank (http://www.cytobank.org/). Additional gating on the DNA channels 
(191Ir and 193Ir) was used to remove remained doublets, debris, and contaminating particulates. 
Manual gating was performed on IdU, cyclin B1, p-HH3, and p-RB to identify cell-cycle stages 
(Behbehani et al., 2012). 
 
CellCycleTRACER workflow 
CellCycleTRACER requires as an input measurements of the four cell cycle markers (namely p-
HH3, p-RB, cyclin B1, and IdU) as well as measurements of cell volume, ideally using the 
ASCQ_Ru markers. 
 
Data processing and cell-volume correction  
To determine cell volume at a single cell level, we initially experimented with three 
housekeeping proteins, namely GAPDH, actin, and RAB7 in HEK293T, MDA-MB-231, and 
THP-1 cells. Although all three proteins highly correlate with the total cell volume 
(Supplementary Fig. 14), single-cell measurements from a mixed population of three different 
cell lines revealed a large degree of cell-line-specific variability that surprisingly involved these 
housekeeping proteins (Supplementary Fig. 15). This indicated that these housekeeping 
proteins cannot be used for cell volume correction when heterogeneous populations are 
analyzed. 
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ASCQ_Ru (Supplementary Fig. 3a) is conventionally used in electrophoresis for the 
determination of protein abundance and has been reported to outperform other staining 
reagents with high sensitivity and large linear dynamic range of protein binding. Taking 
advantage of its additional fluorescent property, we validated ASCQ_Ru as a precise cell 
volume indicator using three-dimensional reconstruction of confocal images (Supplementary Fig. 
3b-d)). Measurements across the three cell lines showed reduced cell line variability in 
comparison to housekeeping protein measurements (Supplementary Fig. 16).  
CellCycleTRACER corrects the data (uploaded as .fcs files) on ASCQ_Ru to enable 
correction for cell-volume heterogeneity. Let 𝑗 = 1, … ,𝑚 be the quantified protein marker in the 
𝑎 = 1, … ,𝑎 single cell. Let 𝑦𝑖,𝑗 denote the abundance of marker 𝑗 in cell 𝑎 in raw experimental 
data. At the same time, let 𝑣 = 1, … , 𝑙 denote the subset of the protein markers ({𝑣} ⊂ {j}) that 
contain information on the total cell volume – in our case the ASCQ_Ru markers. During the 
cell-volume correction step, CellCycleTRACER first normalizes the raw cell-volume 
measurements 𝑦𝑖,𝑜 by dividing each marker by its mean value: 
𝑦𝑖,𝑜𝑜𝑜𝑟𝑛 = 𝑦𝑖,𝑜1
𝑎∑ 𝑦𝑖,𝑜𝑜𝑖=1  
The raw measurements of all 𝑗 = 1, … ,𝑚 markers are then corrected for cell-volume variations 
by dividing 𝑦𝑖,𝑗 by the mean value of 𝑦𝑖,𝑜𝑜𝑜𝑟𝑛: 
 𝑦𝑖,𝑗𝑐𝑜𝑟𝑟 = 𝑦𝑖,𝑗1
𝑙 ∑ 𝑦𝑖,𝑜𝑜𝑜𝑟𝑛𝑙𝑜=1  (1) 
 
Results of this process are shown in Supplementary Fig. 17. Comparison of measurements of 
the phosphorylated versus total amount of proteins MEK1/2 and ERK1/2 before and after cell 
volume correction indicated that the correction process was equally effective for both activated 
and total amounts of proteins (Supplementary Fig. 18). To avoid dividing by zero, 
CellCycleTRACER checks the data for zero values and, if found, substitutes zeros with the 
respective mean value. For more details on volume correction see Supplementary Note 2. 
After cell-volume correction, selected channels of the raw measurements are 
transformed using the inverse hyperbolic sine function (asinh): 
 
𝑦𝑖,𝑗𝑡𝑟𝑟𝑜𝑜 = asinh�𝑦𝑖,𝑗𝑐𝑜𝑟𝑟 � = ln�𝑦𝑖,𝑗𝑐𝑜𝑟𝑟𝑐 + ��𝑦𝑖,𝑗𝑐𝑜𝑟𝑟𝑐 �2 + 1� (2) 
where the constant 𝑐, commonly referred to as the cofactor, is set to 5 according to the CyTOF 
community’s standard practice. Unlike the standard logarithmic function that is undetermined at 
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zero values, asinh is linear around zero and becomes logarithmic beyond a threshold 
determined by the cofactor value. The overall effect of this transformation is to selectively 
compress large values, eliminating the typical long tails found in raw cytometry measurements. 
This results in a more symmetrical distribution that facilitates clustering and other machine 
learning analyses. 
 
Cell-cycle phase prediction  
After the volume correction, CellCycleTRACER classifies the single cells into discrete cell-cycle 
phases. To achieve this, we exploit the measurements of the four above-mentioned cell-cycle 
markers (IdU, p-HH3, cyclin B1, and p-RB) that are typically used in mass cytometry for manual 
cell-cycle gating. To eliminate possible biases introduced by variations in antibody 
concentrations and affinities, the data are standardized and set to have zero mean and unit 
variance. The prediction process is based on a hybrid approach that consists of two steps: (i) a 
classification step in which single-cell measurements of the four cell-cycle markers are given as 
input into a decision tree classifier to automatically predict the cell-cycle phase and (ii) a 
clustering step in which a Gaussian mixture model (GMM) is used to fit the data into clusters 
that represent the cell-cycle phases. The GMM is initialized using the predictions of the decision 
tree as prior knowledge.  
Detailed descriptions of the implementation and performance on different datasets are 
given in Supplementary Note 3. In brief, we first used the four cell-cycle marker measurements 
from an experiment using THP-1 cells together with their class labels derived by manual gating 
(Supplementary Fig. 5a) to train a decision tree classifier. The resulting decision tree and the 
class proportions at the terminal nodes are shown in Supplementary Fig. 5b. We observed four 
pure terminal nodes, equal to the number of classes, indicating 100% classification accuracy in 
the training set. The order of the splits was identical to the order in the classification performed 
manually, indicating that the model faithfully captures the manual gating process. The decision 
tree accuracy in the independent test set was also 100%, meaning that all cells were correctly 
classified. After classification performance was validated, new experimental measurements 
were given as inputs and were automatically classified. The results on a HEK293T test set are 
shown in Supplementary Fig. 7a.  
Second, the measurements were clustered using a GMM where the number of 
components was set to four, equal to the number of cell-cycle phases in our model. The 
parameters of the GMMs (mean vectors, covariance matrices, and class proportions) were 
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initialized using the decision tree predictions and iteratively refined until convergence using an 
expectation-maximization (EM) algorithm (Supplementary Fig. 6). After convergence, posterior 
probabilities of each of the four GMM components were computed, and the single cells were 
assigned to the component with the maximal posterior (results in Supplementary Fig. 7b).  
This hybrid approach combines the intrinsic interpretability of decision trees, which 
enable extraction of a set of comprehensive if-else rules from the training data, with the 
probabilistic capabilities of the GMM framework. Specifically, decision trees are ideal for 
partitioning of a space using training data as prior knowledge, but they lack the notion of 
distribution and suffer from rigid boundaries. Since mass cytometry data are produced from 
different cell lines and possibly on different days, these data exhibit inter-experimental variability 
that makes the algorithm prone to misclassifying the points at the tails of the distribution. GMMs, 
on the other hand, allow flexible treatment of outliers. Shortcomings of GMMs – and other 
unsupervised clustering methods – are an inability to match the clusters to the known labels and 
no guarantee of convergence to the optimal solution. These limitations are especially acute 
when the classes are significantly imbalanced, as in the case of cell-cycle fractions which differ 
by an order of magnitude (e.g., G0/G1: 40-60%; M phase: 3-5% of the total cell population). By 
combining decision tree and GMM approaches we benefit from the advantages of decision trees 
to provide an initial guess close to the optimal solution and of GMMs to allow for a probabilistic 
interpretation of the class assignments. This refinement translates into better assignments for 
outliers and captures the classification uncertainty of cells transitioning between phases, a 
subtlety that is entirely missed by the decision tree.  
 
Trajectory reconstruction, alignment, and correction 
Cells progress along the cell cycle in a continuous way, gradually transitioning across 
consecutive phases whose boundaries are not always clearly defined, and exhibiting intra-
phase variability (e.g., cells at early S and late S are drastically different). To better represent 
these pseudo-temporal fluctuations, we devised a method that reconstructs trajectories of 
biological cell-cycle time (pseudotime) from a population of unsynchronized single cells, 
ordering them according to cell-cycle progression. The details of the reconstruction method are 
given in Supplementary Note 4.  
We assume that 𝑎 single cells are classified in four cell-cycle phases. Let 𝑦𝑖 denote a 
four-dimensional vector of cell-cycle marker abundances in each cell. We seek to construct a 
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one-dimensional embedding function of the four-dimensional vectors 𝑦𝑖, denoted as 𝑓𝛼(𝑦), that 
represents pseudotime. One possible choice is to define 𝑓𝑟(𝑦) as a linear combination of 𝑦𝑖: 
𝑓𝛼(𝑦𝑖) = �𝛼𝑗𝑦𝑖,𝑗 4
𝑗=1
, 
where the coefficients 𝛼𝑗 take values in ℝ≥04 . Under this formulation, our problem reduces to 
identifying a vector of coefficients 𝛼 = (𝛼1 𝛼2 𝛼3 𝛼4) that optimally maps the cell-cycle marker 
measurements to pseudotime. Since the ordering of the discrete classes is known a priori 
(G1→S→G2→M), we follow an optimization process that aims to guarantee this ordering in the 
desired embedding by minimizing the difference across cells that belong to adjacent classes 
(see also Supplementary Fig. 8). More specifically, for all cells 𝑎𝑜, 𝑎𝑞  belonging to adjacent 
classes  𝑝, 𝑞 , we estimate 𝛼  such that  𝑓𝛼 �𝑦𝑖𝑜 � < 𝑓𝛼 �𝑦𝑖𝑞 � , a constraint that translates into 
preserving the ordering in the embedding. 
Collapsing the four-dimensional measurements into a lower-dimensional space may not 
result in fully separated clusters, with the implication that the ordering constraints might not be 
satisfied for all cells. To tackle this problem, we introduced slack variables into all constraints; 
these non-negative variables represent a degree of violation of the ordering constraint. We then 
minimize over a weighted sum of all slack variables, which leads to a mathematically well posed 
linear programming (LP) problem. Even though degenerate LPs can have multiple equivalent 
optima (convex set of optimal solutions), due to the presence of extrinsic and intrinsic variability 
in CyTOF data this does not occur in practice. Thus, the LP results in a single, optimal ordering. 
Since the solution time of the resulting LP grows substantially with the number of cells 
(Supplementary Fig. 19a) and can thus be computationally intensive, we randomly picked a 
fixed percentage of cells from each class and computed an optimal set of weights. A numerical 
investigation (Supplementary Fig. 19b) indicated that the solution of the LP, which yields the 
values of parameters 𝛼, is robust to the sampling of cells even when a small percentage of cells 
is considered.  
Once the values of parameters 𝛼  are estimated, CellCycleTRACER visualizes the 
results by ordering the single cells based on their pseudotime values, resulting in single-cell 
trajectories for each marker. Additionally, CellCycleTRACER computes the mean trajectory of 
each marker by applying a mean filter on the single-cell trajectory, where the value for each cell 
is replaced by the mean of the neighboring cells in a sliding window of fixed size. Since different 
samples (e.g., different cell lines) can exhibit strong variations in the relative duration of the cell-
cycle phases, CellCycleTRACER permits multi-sample analysis by either aligning the relative 
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cell-cycle phase proportions across individual samples to the mean vector of cell-cycle phase 
proportions or, alternatively, aligning them to one sample (e.g., one cell line) of interest (Fig. 1f, 
Supplementary Note 5). To remove the effect of the cell cycle on the marker measurements, 
CellCycleTRACER exploits the abovementioned mean trajectory, rescales it around 1 by 
dividing by the mean abundance of the marker and then divides the single-cell trajectory by the 
rescaled mean. This step removes cell-cycle-specific fluctuations and redistributes the single 
cells independently of cell-cycle variation (Fig. 1g, Supplementary Note 6). After every step of 
the analysis (e.g., cell-cycle classification, correction, alignment), data can be exported as .fcs 
files for further analysis.  
 
Implementation 
All methods were implemented using the Statistical and Optimization Toolboxes of MATLAB 
R2011b. 
 
Software and data availability 
CellCycleTRACER is implemented as a web application, accessible using the following link:  
https://www.zurich.ibm.com/compsysbio/publications.html. CyTOF data for the three cell lines at 
all stimulation time-points are available on Cytobank under project 1129.  
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Discussion 
Signaling network analysis at single-cell resolution 
Signaling networks are centrally involved in the process of cellular information processing that 
controls cell functions and cell fate. Deregulated signaling network often leads to the emergence 
of disease. Recent advances in systems biology researchers have identified multiple layers of 
varieties, including genetic and non-genetic alterations, intrinsic and extinct factors that 
contribute to heterogeneous signaling network states and dynamics. Importantly, the essential 
role of signaling network heterogeneity in the initiation and development of diseases, such as 
cancer, has been revealed. Many recently developed techniques are now capable to quantify 
signaling events and network behaviors at the single-cell level. 
Currently, more than 40 phosphorylation sites can be simultaneously quantified in mass 
cytometry-based single cell proteomics analysis (Bodenmiller et al., 2012; Lun et al., 2017). 
Imaging mass cytometry and several sequential imaging approaches now add the spatial 
information on top of the cellular signaling profiling (Giesen et al., 2014; Lin et al., 2015; Wang 
et al., 2017). These methods are ready to be used in systematical inference of signaling network 
behaviors and can be further applied in mechanistically modeling that explains varied signaling 
dynamics at the single-cell resolution (Hasenauer et al., 2014; Loos et al., 2017). Meanwhile, 
transcriptomics can be measured at the single-cell level to indicate activities of particular 
signaling pathways. Integrated with spatial information, transcriptomic methods are powerful in 
understanding paracrine signaling regulation in which secreted signaling proteins are largely 
involved (Lee et al., 2014; Shalek et al., 2014; Tang et al., 2009). 
Technically, efforts have been made to increase the multiplexity of antibody-based single cell 
measurement: current advances in sequential imaging allows unlimited multiplexing (Wang et 
al., 2017). However, a caveat for these approaches is the antibody unavailability, especially for 
membrane-expressed receptor proteins and many intracellular phosphorylation sites. Single cell 
transcriptomic approaches are ready to assess the mRNA expression globally and in an 
unbiased manner. Although these methods are prone to biological and technical noise that 
drop-outs may exist in majority of cells for mRNAs that are not highly expressed, several 
approaches aim to computationally impute these drop-outs are available (Dijk et al., 2017; Li 
and Li, 2017; Ronen and Akalin, 2018). 
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Future questions for single-cell signaling characterization include the integration of multi-omics 
profiling to understand the signaling circuits as well as feedback controlling mechanisms 
between, for instance, signaling pathway activities and transcriptional programs. Applying 
available techniques using DNA-oligo-tagged antibodies (Peterson et al., 2017; Stoeckius et al., 
2017), phosphorylation sites can be measured in combination with the whole transcriptomic 
sequencing in the same measured cells. Imaging mass cytometry now also allows simultaneous 
measurement of protein and RNA (Schulz et al., 2017) that can be further expanded to answer 
the questions regarding signaling controlling mechanisms between the phosphoprotein network 
and transcriptional regulation and the involvement of spatial factors, such as cell-to-cell contacts 
and protein localization, in such networks. 
 
Signaling protein abundance-dependent effects on signaling networks 
Here we describe the establishment and the thorough validation of an approach that measures 
influence of signaling protein overexpression on the signaling network states and dynamics in 
an abundance-dependent manner. Our approach applies mass cytometry-based single-cell 
analysis on samples with artificially induced protein expression variances that are achieved by 
transient transfection. Typically, in bulk measurement, transient transfection is considered 
problematic since it creates heterogeneous protein overexpression levels. Mass cytometry can 
resolve in the expression gradient and comprehensively profile the signaling network 
modulations specific to any range of expression titration. Thus, overexpression-induced network 
alternations can be studied as continuums. 
Our newly developed approach has multiple layers of novelties. First, unlike most of previous 
signaling network studies which were done with cell lysates or in vitro kinase assays 
(Bodenmiller et al., 2010; Mok et al., 2010; Ochoa et al., 2016), we measured the kinase and 
phosphatase influence on signaling networks in undisrupted cells, addressing questions in a 
physiological context where the signaling network parameters can be interpreted at systems 
level. Second, for the first time, we studied overexpression-induced signaling network 
modulation; with the power of mass cytometry to preform single cell analysis, we quantified the 
protein abundance-dependency on network behaviors. Third, applying on a human kinome- and 
phosphatome-wide analysis, we showed our approach as screening approach that helped 
understanding, in global, the signaling effects induced by protein overexpression, and in 
screening for target proteins with specific influence on network states. 
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Using our method to study the key signaling proteins in EGFR network (Lun et al., 2017) and 
subsequently in a human kinome- and phosphatome-wide screen, we also revealed many novel 
biological insights. First, we discovered that overexpressed kinases had self-phosphorylation 
that, however, was often unable to induce downstream signaling activation, indicating proportion 
of phosphorylated proteins from the total to be deterministic for the downstream pathway activity. 
Second, for the first time, we revealed protein overexpression altered signaling dynamics that 
were measured as signaling amplitudes and peak times. This dynamic modulation is crucial for 
understanding oncogenic signaling caused by protein overexpression: the same concentration 
of extracellular stimulation might result in different signaling outcome if overexpression of certain 
kinases prolongs the pathway activation duration. Third, many kinases work in protein complex 
that they coordinate the process signaling transduction events. Our analysis showed that 
overexpression of a single subunit in a protein complex disrupted the complex function, likely 
due to competitive inhibition that typically resulted in dampened downstream signals. Fourth, we 
revealed that 54 kinases, when overexpressed, could induce EGF-independent ERK activation. 
Overexpression of these kinases was validated, in melanoma A375 cells, with the capability to 
induce resistance to a BRAFV600E inhibitor vemurafenib, suggesting that ligang-independent 
ERK activation to be a biomarker for drug resistance. Finally, we discovered that 
overexpression of ERK-specific phosphatases impacted the ERK-to-MEK negative feedback 
and prolonged MEK activation after EGF stimulation. In the context of ERK overexpression, 
prolonged MEK activity increased the duration of proliferative signal that could be an oncogenic-
like signaling mechanism related to phosphatase overexpression which was previously 
unknown. 
It also has to be noted that our analysis does not measure direct protein-protein interaction. 
Rather, we study the protein overexpression-induced network changes that can be resulted 
from direct or indirect effects (i.e., cell cycle- or stress-related signaling behaviors) that 
represent physiological cell signaling states under certain overexpression-induced perturbation. 
Moreover, unlike phosphoproteomics that globally analyzes phosphorylation sites on a signaling 
protein or in a signaling pathway, our antibody-based approach targets those pre-selected 
phosphorylation sites that are known to be critical in the cancer signaling networks. We do not 
measure or infer the absolute copy number of any measured protein or protein modification. 
Using antibodies to target proteins or protein modifications of interest, we compare the relative 
expression levels or phosphorylation variances between different samples. 
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Perspective of abundance-dependency analysis 
By coupling mass cytometry-based single-cell analysis and transient transfection, our approach 
is powerful in the characterization of protein expression-dependency on signaling network 
responses. In general, this approach can be applied to answer questions in other fields of 
biological and biomedical researches that require protein abundance determination or 
quantification indicative for characterizing certain cellular phenotypes: for example, to quantify 
the molecular landscape at the decision point of stem cell differentiation or a phenotypical 
switch, such as epithelial to mesenchymal transition. In combination with the cell volume 
analysis method that is also developed in this thesis, the relative concentration information is 
ready to be determined for each analyzed protein. This reduces the single cell variances form 
the volume differences and is essential for understanding and modeling the cellular biological 
processes in which protein concentrations are deterministic for a biological outcome. Further 
potential technical developments include absolute quantification of overexpressed proteins at 
single-cell resolution by combining mass cytometry measurement with quantitative proteomics. 
Single cell protein absolute copy number information is essential for the development of realistic 
mechanistic modeling (Erickson et al., 2018). 
In the analysis of kinase and phosphatase co-regulatory mechanism on signaling network 
behaviors, we have shown that the abundance-dependency analysis can be performed in a two-
dimensional space that a combination of two proteins, one tagged by GFP and the other tagged 
by FLAG, are simultaneously overexpressed in cells, each with independent expression 
gradient. Further development following the same line may increase the mutliplexity of 
overexpressed proteins by applying other protein tags, such as GST, HA, or V5, or 
implementing PLAYR-based detection methods (Frei et al., 2016) for RNA barcode conjugated 
with the mRNA encoding analyzed protein. For biological processes requiring coordinative 
functions carried out by more than one protein such as the induction of iPS (induced pluripotent 
stem) cells (Takahashi and Yamanaka, 2006), this approach can characterize the multi-
dimensional expression landscape for the cellular decision making. In cancer biology, a 
multiplexed overexpression assay may help identifying and quantifying critical intrinsic factors 
and their combination for acquired drug resistance. 
The current version of our kinome and phosphatome overexpression library is constructed using 
a vector that encodes POIs under a CMV promotor. CMV promotor is typically used to achieve a 
relatively high expression level. In case the cell phenotypes of interest can be induced by low 
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expression level of a protein, the precise determination of protein abundance at the decision 
point can be performed by using a weak promotor, such as Ubiquitin C promoter (UBC) (Qin et 
al., 2010). Moreover, for proteins with high endogenous expression levels, CRISPR-based gene 
editing techniques (Mali et al., 2013) can be used to knock out gene endogenous expression 
before transient transfection.  
In summary, the development of highly-multiplexed single-cell analysis techniques has allowed 
studying cell intracellular signaling networks at single-cell resolution. Here, we describe the 
development of a mass cytometry-based method that enables comprehensive characterization 
of protein abundance-dependent signaling network modulation and illustrate the use of our 
technique in a kinome- and phosphatome-wide analysis. This method can be potentially 
developed to determine the concentration of POIs at the cell fate decision point during 
development and in cancer cell transformation. Further technical development may increase the 
overexpression multiplexity for combinatorial screening. Elements in our expression vectors are 
also exchangeable to fit specific applications.  
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